Detecting MOB-NDR Protein Interactions: A Comprehensive Guide to Co-Immunoprecipitation Methods and Applications

Abstract

This article provides a comprehensive resource for researchers studying the critical interactions between MOB scaffold proteins and NDR/LATS kinases, with a focused guide on Co-Immunoprecipitation (Co-IP) methodologies. It covers the foundational biology of these evolutionarily conserved complexes, detailed Co-IP protocols optimized for MOB-NDR systems, systematic troubleshooting approaches for common experimental challenges, and advanced validation techniques to ensure interaction specificity. By integrating recent findings from proximity mapping studies with practical methodological guidance, this resource supports efforts to elucidate MOB-NDR signaling networks in fundamental cellular processes and disease contexts, particularly cancer.

Understanding MOB-NDR Complexes: From Evolution to Cellular Signaling Networks

The Evolutionary Conservation of MOB Proteins and NDR Kinases

The monopolar spindle-one-binder (MOB) proteins and nuclear Dbf2-related (NDR) kinases form an evolutionarily conserved signaling module that is a fundamental component of Hippo pathways across eukaryotes. These pathways govern essential cellular processes including cell proliferation, morphogenesis, centrosome duplication, apoptosis, and tissue homeostasis [1] [2] [3]. The MOB family comprises small adapter proteins that function as crucial coactivators for the NDR/LATS kinase family, which belong to the AGC superfamily of serine-threonine kinases [4] [5]. The functional partnership between MOB proteins and NDR kinases represents a novel kinase-coactivator system where MOB proteins bind to the N-terminal regulatory (NTR) region of NDR/LATS kinases to facilitate their activation and substrate recognition [5] [3].

The conservation of these proteins is remarkable from both structural and functional perspectives. The founding member of the MOB family was first identified in Saccharomyces cerevisiae more than a decade ago, and subsequent research has revealed that MOB proteins and their associated NDR kinases are present in organisms ranging from unicellular yeasts to mammals [6]. In budding yeast, this kinase-coactivator system is central to two distinct hippo pathways: the Mitotic Exit Network (MEN), where the LATS-related Dbf2 kinase complexes with Mob1 to control mitotic exit and cytokinesis; and the RAM network, where the NDR-related Cbk1 kinase partners with Mob2 to regulate cell separation and morphogenesis [3]. This functional separation into distinct NDR and LATS branches with specific MOB partners is maintained throughout evolution, though with increasing complexity in multicellular organisms [7].

Evolutionary Conservation Across Species

Conservation in Unicellular Organisms

In the budding yeast Saccharomyces cerevisiae, the MOB-NDR/LATS signaling modules are organized into two functionally distinct pathways with minimal crossover. The Mob1 protein forms an essential complex with the LATS-related kinases Dbf2 and Dbf20 as part of the Mitotic Exit Network (MEN), which controls the transition from mitosis to G1 phase and regulates cytokinesis [3]. Simultaneously, the Mob2 protein specifically associates with the NDR-related kinase Cbk1 within the Regulation of Ace2 and Morphogenesis (RAM) network, which governs the final events of cell separation and polarized cell growth [5] [3]. Notably, Cbk1-Mob1 or Dbf2/20-Mob2 complexes do not form despite the simultaneous presence of all proteins in the cytosol, indicating a sophisticated mechanism that enforces kinase-coactivator association specificity [5].

This functional separation is preserved in the fission yeast Schizosaccharomyces pombe, where Sid2 (LATS)-Mob1 and Orb6 (NDR)-Mob2 complexes exhibit highly specific interactions [5]. The structural basis for this specificity lies in the molecular recognition between the kinase NTR and the Mob cofactor, where a short motif in the Mob structure that differs between Mob1 and Mob2 strongly contributes to binding specificity [5]. Alteration of residues in the Cbk1 NTR allows association of the non-cognate Mob cofactor, demonstrating that cofactor specificity is restricted by discrete sites rather than being broadly distributed [5].

Conservation in Multicellular Organisms

In Drosophila melanogaster, the MOB-NDR/LATS network expands to include three MOB proteins (dMOB1/Mats, dMOB2, and dMOB3) and two NDR/LATS kinases (warts and tricornered) [6]. The dMOB1/Mats protein functions as a critical tumor suppressor in the Hippo pathway by binding to and activating the warts (LATS) kinase, thereby controlling organ size through regulation of the Yorkie transcriptional coactivator [6]. The evolutionary conservation of this tumor-suppressive function is demonstrated by the ability of human MOB1A to rescue lethality and overgrowth phenotypes in Drosophila mats mutants [6].

Table 1: MOB and NDR/LATS Family Members Across Model Organisms

Organism	MOB Proteins	NDR/LATS Kinases	Key Functional Complexes
S. cerevisiae	Mob1, Mob2	Dbf2, Dbf20 (LATS), Cbk1 (NDR)	Mob1-Dbf2/Dbf20 (MEN), Mob2-Cbk1 (RAM)
S. pombe	Mob1, Mob2	Sid2 (LATS), Orb6 (NDR)	Mob1-Sid2, Mob2-Orb6
D. melanogaster	dMOB1/Mats, dMOB2, dMOB3	warts (LATS), tricornered (NDR)	Mats-warts (Hippo), dMOB2-tricornered
H. sapiens	MOB1A/B, MOB2, MOB3A/B/C	NDR1/2, LATS1/2	MOB1-LATS, MOB1-NDR, MOB2-NDR

In mammals, the family has further expanded to include up to six MOB proteins (MOB1A, MOB1B, MOB2, MOB3A, MOB3B, and MOB3C) and four NDR/LATS kinases (NDR1, NDR2, LATS1, and LATS2) [6]. This expansion allows for more complex regulatory networks with both conserved and novel functions. While the core MOB1-LATS interaction remains essential for the tumor-suppressive functions of the Hippo pathway, the binding specificities have become less restricted compared to yeast systems [6]. For instance, human MOB1A can activate both NDR1/2 and LATS1/2 kinases, and MOB2 binds specifically to NDR1/2 but not to LATS1 [8] [6].

Structural Conservation

The structural basis for MOB-NDR/LATS interactions has been conserved throughout evolution. Crystal structures of MOB1 bound to the NTR regions of human NDR2 and LATS1 reveal a common binding mode where the NTR forms a V-shaped helical hairpin that engages with the conserved electrostatic surfaces of MOB proteins [9]. Similarly, the structure of budding yeast Cbk1NTR-Mob2 shows the same fundamental architecture, despite significant sequence divergence [5] [3].

The MOB-organized NTR mediates association of the hydrophobic motif (HM) with an allosteric site on the N-terminal kinase lobe, providing a distinctive kinase regulation mechanism that appears unique to NDR/LATS kinases [5]. This structural conservation underscores the fundamental importance of the MOB-NDR/LATS interface as a conserved regulatory platform that has been maintained throughout eukaryotic evolution while allowing for functional diversification through variations in key specificity-determining residues.

Molecular Mechanisms of MOB-NDR Interactions

Binding Specificity and Activation Mechanisms

The molecular interaction between MOB proteins and NDR/LATS kinases is characterized by remarkable specificity and conserved activation mechanisms. MOB proteins function as essential coactivators that bind to the N-terminal regulatory (NTR) region of NDR/LATS kinases, inducing conformational changes necessary for kinase activation [5]. Structural analyses reveal that the NTR forms a bihelical conformation that binds to MOB proteins in a conserved interface, with the MOB-organized NTR positioning the kinase's C-terminal hydrophobic motif (HM) for optimal interaction with an allosteric site on the N-terminal kinase lobe [5].

The specificity of these interactions is maintained through discrete molecular recognition sites. In humans, MOB1A/B proteins activate both NDR1/2 and LATS1/2 kinases, while MOB2 specifically activates NDR1/2 but not LATS1 [6]. This specificity is mediated by key residues in the MOB proteins; for instance, Asp63 in MOB1 specifically bonds with His646 in LATS1, while this interaction does not occur in the MOB1-NDR2 complex [9]. The functional significance of this specific binding is profound, as the MOB1-Warts (LATS) binding is essential for tumor suppression, tissue growth control, and development, while stable MOB1-Hippo (MST) binding is dispensable and MOB1-Tricornered (NDR) binding alone is insufficient for these functions [9].

Table 2: MOB Protein Binding Specificities and Functions with NDR/LATS Kinases

MOB Protein	Binding Partners	Activation Profile	Cellular Functions
MOB1A/B	NDR1/2, LATS1/2	Activates all four kinases	Tumor suppression, centrosome duplication, apoptosis, Hippo signaling
MOB2	NDR1/2 only	Activates NDR1/2, competes with MOB1	Negative regulator of NDR in some contexts, neuronal morphogenesis
MOB3A/B/C	No binding to NDR/LATS	No kinase activation	MOB3C associates with RNase P complex, unrelated to NDR signaling

The activation mechanism of NDR kinases by MOB proteins involves multiple phosphorylation events. Human NDR kinases require phosphorylation on two conserved residues for full activation: a serine residue (Ser281 in NDR1) that is autophosphorylated in a Ca2+-dependent manner, and a threonine residue (Thr444 in NDR1) in the hydrophobic motif that is phosphorylated by an upstream kinase [4]. MOB1 binding dramatically stimulates NDR1 and NDR2 catalytic activity by promoting these phosphorylation events [8]. Spatial regulation is also crucial, as membrane targeting of either NDR kinases or MOB proteins results in constitutive kinase activation, indicating that subcellular localization is an important aspect of the regulatory mechanism [4].

Regulatory Complexities in Multicellular Organisms

In multicellular organisms, the regulatory relationships between MOB proteins and NDR/LATS kinases have increased in complexity. Unlike the strict pairwise specificities observed in yeast, human MOB proteins can exhibit competitive binding relationships. Notably, hMOB2 competes with hMOB1A for NDR binding, with hMOB2 binding preferentially to unphosphorylated NDR and functioning as a negative regulator of NDR kinase activity in certain contexts [6]. RNA interference-mediated depletion of hMOB2 results in increased NDR kinase activity, while hMOB2 overexpression interferes with NDR functions in death receptor signaling and centrosome duplication [6].

This regulatory complexity is further enhanced by the expansion of the MOB protein family in higher eukaryotes. While humans possess six MOB proteins, only MOB1 and MOB2 have been demonstrated to bind and regulate NDR/LATS kinases [1] [6]. The MOB3 proteins (MOB3A, MOB3B, and MOB3C) represent a distinct functional group that neither binds nor activates any of the four human NDR/LATS kinases [6]. Recent research has revealed that MOB3C specifically associates with the RNase P complex, suggesting an exciting connection with RNA biology that is unrelated to NDR kinase signaling [1].

Experimental Approaches for Studying MOB-NDR Interactions

Co-immunoprecipitation Protocols

Co-immunoprecipitation (co-IP) remains a fundamental technique for investigating protein-protein interactions between MOB proteins and NDR kinases. The following detailed protocol has been optimized specifically for studying these interactions in mammalian cell systems, based on methodologies successfully employed in multiple studies [4] [6].

Cell Culture and Transfection

• Cell Lines: HEK293, HeLa, or COS-7 cells are maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum at 37°C with 5% CO2 [4] [6].
• Transfection: Plate cells at consistent confluence (e.g., 1×10^6 cells/10-cm dish) and transfect the following day using appropriate transfection reagents such as Fugene 6 (Roche) or jetPEI (PolyPlus Transfections) according to manufacturer's instructions [6]. Use 2-4 μg of plasmid DNA per co-IP experiment, adjusting based on expression levels.
• Plasmid Constructs: Express MOB and NDR/LATS proteins as N-terminal or C-terminal fusions with epitope tags (e.g., HA, myc, FLAG). For NDR1, the N-terminal region (amino acids 1-83) is sufficient for MOB binding [6]. Include empty vector controls and individual expresion samples for specificity controls.

Cell Lysis and Immunoprecipitation

• Lysis: 24-48 hours post-transfection, wash cells with ice-cold PBS and lyse in 1 mL of co-IP lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10% glycerol) supplemented with fresh protease and phosphatase inhibitors [6].
• Clearing: Centrifuge lysates at 16,000 × g for 15 minutes at 4°C to remove insoluble material. Pre-clear supernatant with 20 μL of Protein A/G Sepharose beads for 30 minutes at 4°C.
• Immunoprecipitation: Incubate pre-cleared lysates with 1-2 μg of appropriate antibody (anti-HA, anti-myc, or anti-FLAG depending on tags) for 2 hours at 4°C with gentle rotation. Then add 20 μL of Protein A/G Sepharose beads and incubate for an additional 1-2 hours.
• Washing: Pellet beads and wash 3-4 times with 1 mL of co-IP lysis buffer. For more stringent washing, include one wash with high-salt buffer (co-IP buffer with 300 mM NaCl).

Detection and Analysis

• Elution: Resuspend beads in 2× Laemmli sample buffer and boil for 5 minutes to elute proteins.
• Western Blotting: Resolve proteins by SDS-PAGE (8-12% gels) and transfer to PVDF membranes. Probe with appropriate primary antibodies (anti-HA 12CA5, anti-myc 9E10, or anti-FLAG M2) followed by HRP-conjugated secondary antibodies. Detect using ECL reagent [6].
• Kinase Activity Assays: For functional validation, perform in vitro kinase assays using immunoprecipitated complexes with appropriate substrates (e.g., histone H1 for NDR kinases) in kinase buffer (25 mM Tris-HCl pH 7.5, 5 mM β-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2) with 100 μM ATP for 30 minutes at 30°C [6].

Proximity-Dependent Biotin Identification (BioID)

For mapping more transient or proximal interactions in the MOB-NDR network, proximity-dependent biotin identification (BioID) has emerged as a powerful approach [1]. This method is particularly valuable for capturing interactions that may be missed by traditional co-IP due to solubility issues or transient nature.

BioID Experimental Workflow

• Fusion Constructs: Generate tetracycline-inducible HEK293 or HeLa Flp-In T-REx cells expressing BirA-FLAG-tagged MOB proteins (all seven human MOBs) [1]. Use BirA-FLAG or BirA*-FLAG-EGFP as negative controls.
• Biotinylation: Induce expression with tetracycline (1 μg/mL) for 24 hours, then supplement with 50 μM biotin for an additional 24 hours to allow proximity-dependent biotinylation.
• Streptavidin Purification: Lyse cells in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) with protease inhibitors. Incubate lysates with streptavidin-coated beads for 3 hours at 4°C.
• Mass Spectrometry Analysis: Wash beads stringently and perform on-bead tryptic digestion. Analyze resulting peptides by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify biotinylated proteins [1].
• Data Analysis: Process MS data using standard proteomics software (e.g., MaxQuant) and apply statistical cutoffs (e.g., significance based on fold-change over controls and p-value) to identify high-confidence interactors.

Diagram 1: BioID Proximity Labeling Workflow for MOB Protein Interactome Mapping. This diagram illustrates the sequential steps for identifying proximal interacting partners of MOB proteins using the BioID methodology, as employed in [1].

Structural Biology Approaches

Structural studies have been instrumental in understanding the molecular basis of MOB-NDR/LATS interactions. The following approaches have yielded key insights into the conserved binding mechanisms:

Crystallography

• Protein Complex Preparation: Express and purify the NTR regions of NDR/LATS kinases (e.g., NDR2 residues 25-88) and MOB proteins (e.g., MOB1 residues 33-216) using bacterial expression systems (pGEX-4T1 or pMal-2c vectors) [9].
• Crystallization: Screen for crystallization conditions using commercial sparse matrix screens. Optimize initial hits to obtain diffraction-quality crystals.
• Data Collection and Structure Determination: Collect X-ray diffraction data at synchrotron facilities. Solve structures by molecular replacement using existing MOB structures as search models [9].

Mutational Analysis

Based on structural insights, generate point mutations in key interfacial residues to validate binding determinants:

• MOB1 Mutants: D63A (impairs LATS1 binding but not NDR2 binding) [9]
• NDR2 Mutants: K25A, Y32A, R42A, R45A (impair MOB1 binding) [9]
• Co-immunoprecipitation Validation: Test these mutants in co-IP experiments to confirm their effects on binding specificity and affinity.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents for MOB-NDR Interaction Studies

Reagent Category	Specific Examples	Key Applications	Functional Notes
Expression Plasmids	pcDNA3-MOB/NDR with HA/myc/FLAG tags, pGEX-4T1, pMal-2c	Mammalian expression, bacterial protein production	N-terminal tagging successful for MOB1A/B; tetracycline-inducible systems for controlled expression
Cell Lines	HEK293, HeLa, COS-7, U2-OS	Co-IP, kinase assays, localization studies	HEK293 and HeLa suitable for BioID; Flp-In T-REx for inducible expression
Antibodies for Detection	Anti-HA (12CA5, Y-11, 3F10), anti-myc (9E10), anti-FLAG (M2)	Western blotting, immunoprecipitation	Commercial antibodies widely validated for MOB-NDR studies
Kinase Assay Components	γ-32P-ATP or ATP, histone H1 substrate, okadaic acid (PP2A inhibitor)	In vitro kinase activity measurement	Okadaic acid treatment (1μM, 60min) dramatically activates NDR kinases
BioID System	BirA*-FLAG vectors, tetracycline-inducible systems, streptavidin beads	Proximity-dependent interactome mapping	Identifies proximal interactions within ~10nm radius; captures transient complexes
Structural Biology Tools	pGEX-4T1-MOB/NDR-NTR, crystallization screening kits	X-ray crystallography, binding interface mapping	NDR2 NTR (residues 25-88) sufficient for MOB1 binding
3-Amino-1,2-oxaborepan-2-ol	3-Amino-1,2-oxaborepan-2-ol|For Research Use	3-Amino-1,2-oxaborepan-2-ol is for research use only (RUO). It is not for human or veterinary use. Explore its applications and value for your studies.	Bench Chemicals
Acridine, 3,8-diamino-	Acridine, 3,8-diamino-, CAS:40504-84-5, MF:C13H11N3, MW:209.25 g/mol	Chemical Reagent	Bench Chemicals

Signaling Pathways and Molecular Interactions

Diagram 2: MOB-NDR/LATS Signaling Network in Hippo Pathways. This diagram illustrates the conserved signaling relationships between MOB proteins and NDR/LATS kinases, highlighting both the canonical Hippo pathway and alternative functional relationships, including the competitive binding between MOB1 and MOB2 and the novel association of MOB3 with the RNase P complex [1] [2] [6].

The evolutionary conservation of MOB proteins and NDR kinases represents a paradigmatic example of how core signaling modules are maintained throughout eukaryotic evolution while acquiring functional specializations. From the relatively simple and highly specific pairwise interactions observed in yeast to the more complex and overlapping interaction networks in mammals, the MOB-NDR/LATS system has maintained its fundamental architecture while expanding its regulatory capacities. The experimental approaches outlined here, particularly co-immunoprecipitation and proximity labeling techniques, provide powerful tools for further elucidating the nuanced relationships between these conserved protein families.

Future research directions will likely focus on several key areas. First, the functional significance of the competitive relationships between different MOB proteins (such as MOB1 and MOB2) in regulating NDR kinase activity requires further investigation in physiological contexts. Second, the discovery of novel associations, such as MOB3C's interaction with the RNase P complex, suggests that MOB proteins may have evolved functions beyond NDR/LATS kinase regulation that remain to be fully explored [1]. Finally, the therapeutic potential of targeting specific MOB-NDR interactions in diseases such as cancer warrants increased attention, particularly given the demonstrated role of these pathways in controlling cell proliferation and apoptosis [10] [2]. As our understanding of these conserved signaling modules deepens, so too will our ability to manipulate them for therapeutic benefit.

The monopolar spindle-one-binder (MOB) proteins and nuclear Dbf2-related (NDR)/Large Tumor Suppressor (LATS) kinases form evolutionarily conserved signaling modules that govern fundamental cellular processes including morphogenesis, cell cycle progression, and cell proliferation [7] [3]. These kinase-coactivator systems are central components of Hippo signaling pathways and function as critical regulatory switches from fungi to humans [1] [3]. Research in model organisms like Neurospora crassa has been instrumental in defining two primary, functionally distinct MOB-NDR/LATS complexes: the MOB1-DBF2 complex that regulates septum formation and cytokinesis, and the MOB2-COT1 complex that controls polar tip extension and branching [7] [11]. These complexes represent ancient, conserved signaling modules where MOB proteins serve as essential coactivators that bind to the N-terminal regulatory region of NDR/LATS kinases to control their activity, localization, and substrate specificity [11] [12] [3]. This application note provides detailed methodologies for investigating these core complexes, with particular emphasis on co-immunoprecipitation techniques suitable for detecting these protein-protein interactions within the broader context of MOB-NDR research.

Table 1: Core MOB-NDR/LATS Complexes and Their Functions

MOB Protein	NDR/LATS Kinase Partner	Primary Cellular Functions	Conservation
MOB1	DBF2/LATS	Septum formation, cytokinesis, mitotic exit, ascosporogenesis	Yeast to humans
MOB2	COT1/NDR	Hyphal tip extension, branching, polar growth, conidiation	Yeast to humans
MOB3/Phocein	Not associated with NDR kinases	Vegetative cell fusion, fruiting body development	Filamentous fungi and higher eukaryotes

Core Complex Definitions and Quantitative Phenotypes

The MOB1-DBF2/LATS Complex

The MOB1-DBF2/LATS complex functions as a conserved regulator of cell division processes. In Neurospora crassa, deletion of mob-1 results in severe phenotypic defects, reducing growth rate to approximately 40% of wild type and diminishing conidiation to <1% of wild type [7]. This complex is essential for proper septum formation in vegetative cells and during conidiation, while also functioning during sexual fruiting body development [7]. The MOB1-DBF2 complex corresponds to the septation initiation network (SIN) in fission yeast and mitotic exit network (MEN) in budding yeast, which coordinate nuclear division with cytokinesis [7]. In human cells, this complex homolog (MOB1-LATS) constitutes the core of the Hippo pathway that phosphorylates and inhibits YAP/Yki transcriptional coactivators, thereby suppressing cell proliferation [1] [3].

The MOB2-COT1/NDR Complex

The MOB2-COT1/NDR complex specifically regulates cellular morphogenesis through controlling polar growth and branching. Neurospora crassa possesses two MOB2-type proteins (MOB2A and MOB2B) that physically interact with the NDR kinase COT1 to regulate its activity [7] [11]. Deletion analyses reveal that Δmob-2a and Δmob-2b mutants display less severe phenotypes than Δmob-1 strains, with growth rates reduced to 70% and 92% of wild type, respectively [7]. Both MOB2A and MOB2B associate with COT1 simultaneously, forming a heterotrimeric complex through interactions with different residues within the COT1 N-terminal region [11]. This complex controls polar tip extension and branching by regulating COT1 kinase activity, with the MOB2 proteins promoting proper hyphal growth through distinct but complementary functions [11].

Table 2: Phenotypic Characterization of MOB Deletion Mutants in Neurospora crassa

Genotype	Growth Rate (% of WT)	Conidiation (% of WT)	Key Morphological Defects
Δmob-1	40%	<1%	Cell lysis, no aerial mycelium, increased branching, defective ascosporogenesis
Δmob-2a	70%	11%	Increased branching, altered aerial hyphae
Δmob-2b	92%	54%	Increased branching, altered aerial hyphae
Δmob-3	89%	76%	Defective vegetative cell fusion, fruiting body defects

Experimental Protocols for MOB-NDR Interaction Analysis

Co-immunoprecipitation (Co-IP) Protocol for MOB-NDR Complexes

Co-immunoprecipitation remains a cornerstone technique for validating protein-protein interactions in MOB-NDR/LATS research. The following optimized protocol is adapted from contemporary methodologies for studying these complexes [13] [14].

Cell Lysis and Protein Extraction

• Prepare Lysis Buffer: Use NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris-HCl pH 8.0) for mild lysis conditions that preserve protein complexes. Add protease inhibitors (e.g., 1 mL/10 mL buffer) and phosphatase inhibitors (e.g., 1 tablet/10 mL buffer) immediately before use [13] [14].

• Harvest Cells: For fungal cultures, harvest mycelia by filtration and snap-freeze in liquid nitrogen. For mammalian cells, wash with PBS and pellet by centrifugation.

• Lyse Cells: Resuspend cell pellet in ice-cold lysis buffer (300 μL for 1-3×10⁷ cells). Incubate on ice for 30 minutes with occasional vortexing [14].

• Clarify Lysate: Centrifuge at 8,000 × g for 10 minutes at 4°C. Transfer supernatant to a fresh tube and determine protein concentration using Bradford or BCA assay. Adjust concentrations to 1-2 mg/mL [14].

Immunoprecipitation Procedure

• Pre-clear Lysate (Optional): Incubate lysate with protein A/G agarose or magnetic beads for 30-60 minutes at 4°C to reduce non-specific binding [14].

• Antibody Binding: Add specific antibody against bait protein (e.g., anti-COT1, anti-NDR, anti-MOB) to lysate. Use 1-5 μg antibody per 500 μg total protein. Include control with normal IgG from same species [13] [14].

• Form Complexes: Incubate with rotation for 2-4 hours at 4°C.

• Capture Complexes: Add pre-washed protein A/G magnetic beads (e.g., Dynabeads) and incubate for 1-2 hours at 4°C with rotation [13].

• Wash Beads: Collect beads magnetically and wash 3-4 times with wash buffer (10 mM HEPES pH 7.4, 10 mM KCl, 50 mM NaCl, 1 mM MgClâ‚‚, 0.05% NP-40) [13].

• Elute Proteins: Elute bound complexes with 2× SDS-PAGE sample buffer by heating at 95°C for 5-10 minutes [14].

Figure 1: Co-immunoprecipitation Workflow for MOB-NDR Complex Analysis

Alternative High-Throughput Interaction Screening Methods

For comprehensive mapping of MOB protein interactomes, proximity-dependent biotin identification (BioID) provides a powerful complementary approach [1]. This method involves fusing MOB baits to a promiscuous biotin ligase (BirA*), enabling biotinylation of proximal proteins within a 10-20 nm radius. Biotinylated proteins are subsequently captured with streptavidin beads and identified by mass spectrometry [1]. Recent BioID studies have revealed over 200 interactions for human MOB proteins, with at least 70% representing previously unreported interactions on BioGrid [1]. This technique is particularly valuable for capturing transient interactions and mapping the spatial landscape of MOB signaling pathways.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for MOB-NDR/LATS Studies

Reagent Category	Specific Examples	Function/Application
Lysis Buffers	NP-40 Lysis Buffer, RIPA Buffer	Protein extraction with varying stringency for complex preservation
Protease Inhibitors	Commercial cocktails (e.g., ab65621)	Prevent protein degradation during extraction
Phosphatase Inhibitors	Sodium fluoride, β-glycerophosphate, commercial cocktails	Preserve phosphorylation status of NDR/LATS kinases
Bead Systems	Dynabeads Protein A/G, Magnetic Separation Racks	Efficient capture and washing of immunocomplexes
Antibodies	Anti-COT1, Anti-NDR1/2, Anti-MOB1/2/3, Anti-phospho-Ser/Thr	Target-specific immunoprecipitation and detection
Detection Reagents	HRP-conjugated secondary antibodies, ECL substrates, Coomassie Brilliant Blue	Visualization of immunoprecipitated complexes
Stilbostemin D	Stilbostemin D	High-purity Stilbostemin D for research applications. This product is For Research Use Only. Not for use in diagnostic or therapeutic procedures.
2,3-Dihydrooxazol-4-amine	2,3-Dihydrooxazol-4-amine|High-Quality Research Chemical	2,3-Dihydrooxazol-4-amine is a versatile heterocyclic building block for pharmaceutical research and synthesis. For Research Use Only. Not for human or veterinary use.

Structural and Mechanistic Insights

Structural studies of NDR/LATS kinase-MOB complexes have revealed unique mechanistic aspects of these signaling modules. The crystal structure of the budding yeast Cbk1-Mob2 complex demonstrates that MOB coactivators organize a novel activation region in NDR/LATS kinases, where a key regulatory motif shifts from an inactive to active binding mode upon phosphorylation [3]. Additionally, these structures have unveiled a previously unknown substrate docking mechanism in AGC family kinases, with docking interactions providing robustness to kinase regulation of in vivo substrates [3]. Biochemical studies demonstrate that MOB binding to the N-terminal region of NDR kinases induces release of an autoinhibitory sequence located within the catalytic domain insert between subdomains VII and VIII [12]. This activation mechanism is conserved across MOB-NDR/LATS complexes, with human MOB1 stimulating NDR kinase activity through interaction with the N-terminal domain [12].

Figure 2: MOB-Mediated Activation of NDR/LATS Kinases

Concluding Remarks

The definitive pairing of MOB1 with DBF2/LATS and MOB2 with COT1/NDR represents a fundamental organizational principle in eukaryotic cell signaling. These complexes function as distinct regulatory modules that control essential cellular processes from fungi to humans. The experimental protocols outlined herein, particularly the optimized co-immunoprecipitation workflow, provide robust methodologies for investigating these complexes in various biological contexts. As research in this field advances, the application of complementary techniques such as BioID proximity labeling and structural approaches will continue to expand our understanding of MOB-NDR/LATS signaling networks and their roles in development and disease.

The monopolar spindle-one-binder (MOB) family of proteins represents a class of highly conserved eukaryotic scaffold proteins that play pivotal roles as adaptors in critical cellular signaling pathways. These proteins, despite their lack of enzymatic activity, function as essential signal transducers by engaging in specific protein-protein interactions to assemble functional complexes. Within the context of a broader thesis on detecting MOB-NDR protein interactions via co-immunoprecipitation research, this application note examines the diverse cellular functions mediated by MOB proteins, with particular emphasis on septum formation, tip growth, and Hippo pathway regulation. Understanding these interactions provides crucial insights into fundamental biological processes including cell division, morphogenesis, tissue growth, and homeostasis, with significant implications for cancer research and therapeutic development [1] [15].

MOB Protein Family: Classification and Conserved Functions

MOB proteins are small, approximately 20 kDa single-domain proteins that share 17-96% structural similarity across different family members. In humans, seven distinct MOB proteins are encoded by different gene loci, categorized into four subfamilies: MOB1A/B, MOB2, MOB3A/B/C, and MOB4. These proteins are conserved throughout the eukaryotic kingdom, with at least two MOB proteins found in every eukaryote analyzed to date [1] [15].

Table 1: Human MOB Protein Family Classification

Protein Name	Alternative Names	Subfamily	Key Functions
MOB1A	MOBKL1B, MOB1α, MATS1	MOB1	Core Hippo pathway component, cell cycle regulation
MOB1B	MOBKL1A, MOB4a, MATS2	MOB1	Core Hippo pathway component, cell cycle regulation
MOB2	MOBKL2, HCCA2	MOB2	NDR kinase regulation, morphogenesis
MOB3A	MOBKL2A, MOB-LAK	MOB3	Poorly characterized, potential RNA biology links
MOB3B	MOBKL2B, C9orf35	MOB3	Poorly characterized
MOB3C	MOBKL2C, MOB2C	MOB3	RNase P complex association
MOB4	MOBKL3, Phocein	MOB4	STRIPAK complex component

The evolutionary conservation of MOB proteins underscores their fundamental biological importance. In unicellular organisms such as yeast, two MOB proteins (Mob1p and Mob2p) coordinate essential functions: Mob1p controls mitotic exit through the mitotic exit network (MEN) and septation initiation network (SIN), while Mob2p regulates cellular morphogenesis and polarized growth through the regulation of Ace2p activity and cellular morphogenesis (RAM) signaling network [15].

MOB Proteins in Septum Formation and Cytokinesis

Septum formation represents a critical stage in cytokinesis, the process that divides a mother cell into two daughter cells at the end of each cell cycle. In fungal systems, this process proceeds via the assembly and constriction of a contractile actomyosin ring (CAR) coupled to the synthesis of a polysaccharide septum [16].

The Septation Initiation Network (SIN) and MOB1 Function

The septation initiation network (SIN) is a signaling cascade that induces cytokinesis only after the decrease in cyclin-dependent kinase (CDK) activity in anaphase, thereby guaranteeing that cytokinesis occurs after chromosome segregation. In fission yeast, the SIN pathway shows remarkable similarity to the mammalian Hippo pathway, with both being kinase cascades containing a highly conserved germinal center kinase (GCK) and an NDR kinase [17].

MOB1 plays an essential role in the SIN, where it functions as a co-activator of the Sid2p kinase (the fission yeast counterpart of mammalian NDR/LATS kinases). This MOB1-Sid2p complex controls the Clp1p phosphatase to support SIN signaling and proper septum formation [15]. The regulation of CAR assembly, maintenance, constriction, and coupling to septum synthesis depends on this signaling cascade [16].

Figure 1: MOB1 Function in the Septation Initiation Network (SIN). The SIN pathway ensures cytokinesis occurs after chromosome segregation, with MOB1 activating Sid2 kinase to promote contractile ring constriction and septum formation.

Experimental Protocol: Analyzing MOB1-NDR Interactions in Septation

Co-immunoprecipitation to Detect MOB1-Sid2/DBF2 Interactions During Septum Formation

Principle: This protocol leverages co-immunoprecipitation (Co-IP) to capture transient interactions between MOB1 and its NDR kinase partners (Sid2 in S. pombe or Dbf2 in S. cerevisiae) during specific phases of septum formation.

Reagents:

• Lysis Buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1.5 mM MgClâ‚‚, 1 mM EDTA, supplemented with fresh protease and phosphatase inhibitors.
• Protein A/G Magnetic Beads
• Anti-MOB1 antibody (species-specific)
• Isotype control antibody
• SDS-PAGE and Western blotting reagents
• Anti-NDR kinase antibody (anti-Sid2 or anti-Dbf2)

Procedure:

• Cell Culture and Synchronization: Grow fission yeast (S. pombe) or budding yeast (S. cerevisiae) to mid-log phase. Synchronize cultures using lactose gradient centrifugation or temperature-sensitive mutants to enrich for cells undergoing septum formation.
• Cell Lysis: Harvest approximately 1×10⁸ synchronized cells by centrifugation. Wash cells with ice-cold PBS and resuspend in 1 mL lysis buffer. Lyse cells using glass bead beating or high-pressure homogenization. Clarify lysates by centrifugation at 16,000 × g for 15 minutes at 4°C.
• Immunoprecipitation: Pre-clear 500 μg of protein lysate with 20 μL Protein A/G magnetic beads for 30 minutes at 4°C. Incubate pre-cleared lysate with 2 μg anti-MOB1 antibody or isotype control overnight at 4°C with gentle rotation. Add 50 μL magnetic beads and incubate for 2 hours. Collect beads and wash three times with lysis buffer.
• Elution and Analysis: Elute bound proteins with 2× Laemmli buffer by heating at 95°C for 5 minutes. Separate proteins by SDS-PAGE and transfer to PVDF membrane. Probe western blots with anti-NDR kinase antibody to detect co-precipitated Sid2 or Dbf2.

Technical Notes: Synchronization efficiency should be monitored by calcofluor staining of septa. Optimal lysis conditions preserve protein complexes while maintaining kinase activity. Include controls for non-specific binding and validate antibodies for specificity in fungal systems [15] [16].

MOB Proteins in Hippo Pathway Regulation

The Hippo pathway represents a highly conserved signaling network that controls tissue growth, organ size, and homeostasis. Dysregulation of this pathway leads to tissue overgrowth and tumor development, electing MOB proteins as potential players in growth-related disorders including cancer [15] [18].

MOB1 as a Core Hippo Pathway Component

MOB1 functions as a critical core component of the Hippo pathway, where it acts as a co-activator of the LATS1/2 kinases (the mammalian orthologs of Drosophila Warts). In the canonical Hippo pathway, the MST1/2 kinase (ortholog of Hippo) phosphorylates MOB1, enabling it to bind and activate LATS1/2. Activated LATS1/2 then phosphorylates the transcriptional coactivators YAP and TAZ, leading to their cytoplasmic retention and degradation [15] [18].

Figure 2: MOB1 Function in the Canonical Hippo Pathway. MOB1 acts as a core component that transduces signals from MST1/2 to LATS1/2 kinases, ultimately controlling YAP/TAZ transcriptional activity.

Experimental Protocol: Co-immunoprecipitation of MOB1-LATS Complexes

Co-immunoprecipitation of MOB1 with LATS1/2 Kinases in Mammalian Cells

Principle: This protocol details the co-immunoprecipitation of endogenous MOB1 with its NDR kinase partners LATS1/2 in mammalian cell lines, allowing assessment of Hippo pathway activation status.

Reagents:

• RIPA Lysis Buffer: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS
• Phosphatase Inhibitor Cocktail
• Protease Inhibitor Cocktail
• Protein A/G Plus Agarose
• Anti-MOB1 antibody (e.g., Rabbit monoclonal D2T6T)
• Anti-LATS1 and Anti-LATS2 antibodies
• Normal Rabbit IgG

Procedure:

• Cell Culture and Treatment: Culture HEK293 or HeLa cells in appropriate medium. At 80-90% confluence, treat cells as required (e.g., serum starvation, contact inhibition, or pathway modulators). Wash cells with ice-cold PBS.
• Cell Lysis: Lyse cells in RIPA buffer supplemented with protease and phosphatase inhibitors. Incubate on ice for 30 minutes with occasional vortexing. Clarify lysates by centrifugation at 14,000 × g for 15 minutes at 4°C.
• Protein Quantification: Determine protein concentration using BCA assay. Use 500-1000 μg total protein per immunoprecipitation reaction.
• Immunoprecipitation: Pre-clear lysates with Protein A/G Plus Agarose for 30 minutes at 4°C. Incubate pre-cleared lysates with 2-4 μg anti-MOB1 antibody or normal rabbit IgG (negative control) overnight at 4°C with gentle rotation. Add 20 μL Protein A/G Plus Agarose and incubate for 2 hours.
• Washing and Elution: Wash beads three times with RIPA buffer. Elute bound proteins with 2× Laemmli buffer by heating at 95°C for 5 minutes.
• Western Blot Analysis: Separate proteins by SDS-PAGE, transfer to PVDF membrane, and probe with anti-LATS1 and anti-LATS2 antibodies. Detect MOB1 in immunoprecipitates to confirm pull-down efficiency.

Technical Notes: Maintain consistent cell confluence across experiments as cell density affects Hippo pathway activity. Include both active (phospho-MOB1) and total MOB1 blots to assess activation status. Optimize antibody concentrations for specific cell types [1] [18].

Emerging Roles: MOB3 Proteins and RNA Biology

Recent proximity-dependent biotin identification (BioID) screens have revealed novel interactions for the poorly characterized MOB3 subfamily. Surprisingly, MOB3C was found to associate with 7 of 10 protein subunits of the RNase P complex, an endoribonuclease that catalyzes tRNA 5' maturation. This discovery suggests an exciting nexus between MOB proteins and RNA biology, potentially representing a previously unrecognized function for MOB3 proteins [1].

Table 2: Quantitative Summary of MOB Protein Interactions from BioID Screening

MOB Protein	Total Interactions	Novel Interactions	Key Functional Associations
MOB1A/B	48 (BioGrid)	>70% of 226 total	Hippo core, cytoskeleton regulators
MOB2	Not specified	>70% of 226 total	NDR kinases (STK38/38L)
MOB3A-C	0 (BioGrid)	>70% of 226 total	RNase P complex, mitochondrial proteins
MOB4	12 (BioGrid)	>70% of 226 total	STRIPAK complex

The BioID screening approach identified over 200 proximity interactions for the MOB family, with at least 70% representing previously unreported associations. This underscores the value of systematic interaction profiling for elucidating novel protein functions [1].

Research Reagent Solutions

Table 3: Essential Research Reagents for MOB-NDR Interaction Studies

Reagent Category	Specific Examples	Function in Research
Cell Lines	HEK293, HeLa, S. pombe, S. cerevisiae	Model systems for studying MOB protein functions in different biological contexts
Antibodies for Co-IP	Anti-MOB1 (D2T6T), Anti-LATS1, Anti-Sid2, Anti-Dbf2	Immunoprecipitation and detection of MOB proteins and their NDR kinase partners
Plasmids	BirA*-FLAG-MOB constructs, TX-TL systems	Proximity labeling, recombinant protein expression, and synthetic biology approaches
Biochemical Assays	BioID, Affinity Purification-MS, pre-tRNA cleavage assays	Mapping interactomes, validating specific interactions, and functional characterization
Synchronization Agents	Lactose gradient, temperature-sensitive mutants	Cell cycle synchronization for studying septum formation

The diverse cellular functions of MOB proteins in septum formation, tip growth, and Hippo pathway regulation highlight their fundamental importance as scaffold proteins in eukaryotic biology. Through specific interactions with NDR family kinases, MOB proteins serve as critical adaptors that coordinate essential processes including cytokinesis, morphogenesis, and tissue growth control. The experimental protocols presented herein for co-immunoprecipitation of MOB-NDR complexes provide standardized methodologies for researchers investigating these protein interactions across different biological contexts.

Recent advances in proximity labeling techniques have dramatically expanded our understanding of MOB protein interactomes, revealing previously uncharacterized associations such as the connection between MOB3C and the RNase P complex. These findings open new avenues for investigating the roles of MOB proteins in RNA biology and other unexplored cellular processes. As research continues to elucidate the complex networks coordinated by MOB proteins, these insights will undoubtedly contribute to our understanding of disease mechanisms, particularly in cancer, and potentially identify new therapeutic targets for intervention.

For researchers conducting MOB-NDR co-immunoprecipitation studies, careful attention to cell culture conditions, synchronization methods, and antibody validation is essential for generating reproducible and biologically relevant results. The integration of these traditional biochemical approaches with modern proteomic techniques will continue to advance our understanding of this functionally diverse protein family.

The monopolar spindle-one-binder (MOB) family of proteins represents a class of highly conserved adaptor proteins crucial for multiple cellular processes. For decades, research has firmly established that a primary function of MOB proteins, including the well-characterized MOB1 and MOB2, is their role as essential regulators of Nuclear Dbf2-related (NDR) kinases within conserved signaling pathways such as the Hippo pathway, mitotic exit network (MEN), and septation initiation network (SIN) [19]. These MOB-NDR kinase complexes are fundamental to the control of tissue homeostasis, cell cycle dynamics, cell division, and morphogenesis [19]. However, the MOB3 subfamily, comprising MOB3A, MOB3B, and MOB3C, has remained relatively enigmatic, with its functions extending beyond these classical kinase partnerships.

Recent high-resolution proteomic studies have fundamentally expanded our understanding of the MOB3 subfamily, revealing unexpected roles that diverge from the established NDR kinase-centric paradigm. Notably, a groundbreaking discovery has identified a specific and robust association between MOB3C and the RNase P complex, an essential ribonucleoprotein endonuclease responsible for catalyzing the 5' maturation of precursor tRNAs [1]. This novel connection places MOB3 proteins at the fascinating nexus of protein-based signaling and RNA biology, suggesting unanticipated functions in fundamental gene expression pathways. This Application Note details the experimental evidence for these non-NDR related functions and provides detailed protocols for researchers aiming to detect and characterize these emerging MOB-protein interactions within the broader context of a thesis on MOB-NDR interactomics.

Key Discoveries: Quantitative Profiling of MOB Interactomes

A systematic proximity-dependent biotin identification (BioID) screen, performed in both HEK293 and HeLa cell lines, has provided the first comprehensive and comparative analysis of the interactomes for all seven human MOB proteins [1]. This approach was crucial for capturing transient interactions and mapping the spatial landscape of MOB signaling, bypassing limitations of traditional co-immunoprecipitation methods.

Table 1: Summary of Key MOB Proximity Interactors from BioID Screening

MOB Protein	Established Kinase Interactors (Validated in Screen)	Novel/Expanded Interactors	Key Non-NDR Related Findings
MOB1A/B	LATS1/2, STK3/4 (MST1/2), PP6 holoenzyme [1]	DOCK6–8, LRCH1–3 [1]	Recalls core Hippo pathway components; confirms screen validity.
MOB2	STK38, STK38L (NDR1/2) [1]	-	Confirms established role as a regulator of NDR kinase activity [19].
MOB4	STRIPAK complex subunits [1]	-	Well-established role in STRIPAK complex confirmed.
MOB3A	Limited previous data	IMMT (MICOS complex), ATP2B1 [1]	Shares interactors with MOB3B and MOB2; potential link to mitochondria and calcium transport.
MOB3B	Limited previous data	IMMT (MICOS complex), ATP2B1 [1]	Shares interactors with MOB3A and MOB2.
MOB3C	No classic NDR kinases identified	7 of 10 subunits of the RNase P complex [1]	Specific and unique association with a central RNA processing complex.

The data revealed over 200 high-confidence proximity interactions, with at least 70% being previously unreported in the BioGrid database [1]. A critical finding was the striking uniqueness of the MOB3C interactome. While MOB1A/B and MOB4 reliably recalled their known partners in the Hippo and STRIPAK complexes, respectively, MOB3C specifically associated with multiple protein subunits of the RNase P complex, an interaction that was absent for MOB1A [1]. This represents a paradigm shift, revealing a function for an MOB protein that is completely distinct from the well-characterized NDR kinase regulation.

Table 2: MOB3-Specific Proximity Interactors and Shared Proteins

Interactor Protein	MOB3A	MOB3B	MOB3C	Functional Association of Interactor
MAP4K4			✓	Non-canonical Hippo pathway regulator [1].
PTPN14			✓	Non-canonical Hippo pathway regulator [1].
IMMT	✓	✓		Subunit of the MICOS complex (mitochondrial organization) [1].
ATP2B1	✓	✓		Plasma membrane calcium transporter [1].
RNase P Subunits			✓	tRNA 5'-end maturation [1].

Experimental Protocols

The following protocols are adapted from the seminal study by [1] and are designed to be integrated into a broader thesis research plan focused on validating protein-protein interactions.

Protocol: Proximity-Dependent Biotin Identification (BioID) for Mapping MOB Interactomes

Application: Unbiased identification of proximal and interacting proteins for MOB proteins in live cells. Key Principle: Expression of a MOB protein fused to a promiscuous biotin ligase (BirA*) results in biotinylation of proteins within a ~10 nm radius, which can be affinity-purified and identified by mass spectrometry [1].

Reagents and Solutions:

• Plasmids: Tetracycline-inducible BirA*-FLAG-MOB constructs (for all seven human MOBs) [1].
• Control Plasmids: BirA-FLAG and BirA-FLAG-EGFP.
• Cell Lines: HEK293 Flp-In T-REx and HeLa Flp-In T-REx cell lines.
• Culture Medium: DMEM + 10% FBS + 1% Pen/Strep + appropriate selection antibiotics (e.g., Blasticidin, Hygromycin).
• Biotin Solution: 50 μM Biotin (prepare fresh in culture medium).
• Lysis Buffer: 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 0.4% SDS, 5 mM EDTA, 1 mM DTT, supplemented with protease inhibitors. Note: This harsh lysis buffer is specific for BioID to disrupt interactions and only capture biotinylated proteins.
• Streptavidin Beads: High-capacity streptavidin-conjugated magnetic beads.
• Wash Buffer 1: 2% SDS in dHâ‚‚O.
• Wash Buffer 2: 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 0.2% Triton X-100.
• Wash Buffer 3: 10 mM Tris-HCl (pH 7.5), 250 mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate.
• Final Wash: 50 mM Tris-HCl (pH 7.5), 50 mM NaCl.

Detailed Procedure:

• Cell Line Generation: Generate stable, inducible cell lines expressing your BirA*-FLAG-MOB baits and controls using the Flp-In T-REx system according to manufacturer's instructions.
• Bait Expression and Biotinylation:
  • Seed cells at 70% confluence in 15-cm dishes.
  • Induce BirA*-MOB expression with 1 μg/mL tetracycline or doxycycline for 24 hours.
  • Add biotin to the culture medium to a final concentration of 50 μM and incubate for an additional 24 hours.
• Cell Lysis and Capture:
  • Wash cells twice with ice-cold PBS.
  • Scrape cells in PBS and pellet by centrifugation.
  • Lyse cell pellet in 1-2 mL of RIPA-like lysis buffer with vigorous vortexing.
  • Sonicate lysates to reduce viscosity and clarify by centrifugation at 16,000 × g for 15 min at 4°C.
  • Incubate the supernatant with pre-washed streptavidin magnetic beads for 3 hours at 4°C with rotation.
• Stringent Washes:
  • Wash beads sequentially with the following buffers (1 mL each) at room temperature:
    • Wash Buffer 1: Two times for 8 minutes each.
    • Wash Buffer 2: One time for 8 minutes.
    • Wash Buffer 3: One time for 8 minutes.
    • Final Wash: Two times for 1 minute each.
• On-Bead Digestion and MS Sample Prep:
  • Perform on-bead tryptic digestion following standard mass spectrometry protocols.
  • Desalt and dry down the resulting peptides for LC-MS/MS analysis.

Protocol: Affinity Purification-Mass Spectrometry (AP-MS) for Validation of MOB3C-RNase P Interaction

Application: Orthogonal validation of specific interactions identified via BioID under native/near-native conditions. Key Principle: Immunoprecipitation of a tagged MOB protein under mild lysis conditions to preserve complexes, followed by identification of co-purifying proteins via mass spectrometry.

Reagents and Solutions:

• Lysis Buffer (Mild): 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.5% Triton X-100, 10% Glycerol, 1.5 mM MgClâ‚‚, 1 mM EGTA, supplemented with protease and phosphatase inhibitors.
• FLAG Beads: Anti-FLAG M2 Affinity Gel.
• FLAG Peptide: For competitive elution (150 ng/μL in TBS).
• Benzonase: To digest nucleic acids and disrupt RNA-mediated interactions (optional, see note).

Detailed Procedure:

• Cell Lysis:
  • Culture and induce MOB3C expression in HEK293 T-REx cells as in Protocol 3.1, but omit the biotinylation step.
  • Lyse cells in 1 mL of mild lysis buffer per 15-cm dish for 30 min at 4°C with rotation.
  • Clarify lysates by centrifugation at 16,000 × g for 15 min at 4°C.
• Immunoprecipitation:
  • Incubate the clarified lysate with pre-washed anti-FLAG M2 beads for 2 hours at 4°C.
  • Pellet beads and wash 3-4 times with 1 mL of mild lysis buffer.
• Elution:
  • Elute bound proteins by incubating beads with 3× FLAG peptide (5 column volumes) for 30 min at 4°C.
  • Alternatively, elute directly with 2× Laemmli buffer for western blot analysis.
• Mass Spectrometry Analysis:
  • Process the eluates for LC-MS/MS as in Protocol 3.1.
  • Note: To confirm the interaction is not RNA-mediated, repeat the lysis and IP in the presence of 25 U/mL Benzonase. Persistence of RNase P subunits in the MS readout confirms a direct protein-protein interaction.

Protocol: Pre-tRNA Cleavage Assay for Functional Validation of RNase P Activity

Application: To confirm that MOB3C associates with a catalytically active RNase P complex. Key Principle: Immunopurified MOB3C complexes are incubated with a synthetic pre-tRNA substrate. Catalytic activity is measured by the cleavage of the 5' leader sequence, detectable by gel electrophoresis.

Reagents and Solutions:

• Pre-tRNA Substrate: Synthetic, radiolabeled (γ-³²P-ATP) or fluorophore-labeled pre-tRNA transcript.
• Reaction Buffer (10X): 500 mM HEPES-KOH (pH 7.5), 1 M NHâ‚„OAc, 100 mM MgClâ‚‚, 10 mM Spermidine.
• Stop Solution: 10 M Urea, 50 mM EDTA, 0.1% Bromophenol Blue, 0.1% Xylene Cyanol.
• Gel: 10% Polyacrylamide/8 M Urea denaturing gel.

Detailed Procedure:

• Isolate MOB3C Complexes: Perform the FLAG immunopurification from MOB3C-expressing cells as described in Protocol 3.2, steps 1-2. Do not elute. Keep the beads in reaction buffer.
• Set Up Catalytic Reaction:
  • Resuspend the washed FLAG-beads (with bound MOB3C/RNase P) in 1X Reaction Buffer.
  • Add the labeled pre-tRNA substrate.
  • Incubate at 37°C for 30-60 minutes.
  • Include controls: Beads from control (BirA*-FLAG) IPs and a no-enzyme background control.
• Analyze Products:
  • Stop the reaction by adding an equal volume of Stop Solution.
  • Heat denature the samples and resolve the RNA products on a pre-run 10% polyacrylamide/8 M urea denaturing gel.
  • Visualize using autoradiography (for radioactive label) or a fluorescence gel scanner.
  • Expected Result: The MOB3C pulldown, but not the control pulldown, should generate a clear band corresponding to the mature tRNA product, indicating the presence of active RNase P.

Signaling Pathways and Experimental Workflows

The following diagrams illustrate the core conceptual shift and key experimental workflows using DOT language.

Diagram 1: Evolving Paradigms of MOB Protein Function. The model contrasts the established role of MOB1/2 as NDR kinase activators with the newly discovered role of MOB3C as a proximal partner of the RNase P complex, linking it directly to RNA biology [1].

Diagram 2: BioID Workflow for Mapping MOB Proximity Interactomes. The core steps for identifying proteins in the vicinity of MOB3C using proximity-dependent biotinylation are shown [1].

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for Studying MOB3 Protein Interactions

Reagent / Resource	Function / Application	Example / Source / Note
Tetracycline-Inducible BirA*-FLAG-MOB Plasmids	Expression of biotin ligase-fused MOB baits for BioID.	N-terminal tagging strategy is recommended for all MOBs [1].
Flp-In T-REx Cell Lines	Generation of isogenic, inducible stable cell lines.	HEK293 and HeLa lines were successfully used [1].
Streptavidin Magnetic Beads	High-affinity capture of biotinylated proteins.	Essential for BioID pull-downs under denaturing conditions.
Anti-FLAG M2 Affinity Gel	Immunopurification of FLAG-tagged MOB complexes for AP-MS.	Used for validation under native conditions.
Biotin	Substrate for BirA* ligase; labels proximal proteins.	Use high-purity, prepare fresh solutions.
Benzonase Nuclease	Digests nucleic acids; tests RNA dependence of interactions.	Critical control for RNA-binding protein complexes like RNase P.
Pre-tRNA Transcript	Synthetic substrate for RNase P activity assays.	Can be in vitro transcribed and radioactively or fluorescently labeled.
MOB Species-Specific Antibodies	Western blot validation, immunofluorescence.	Commercial antibodies vary in quality; validation is crucial.
Non-1-en-4-yn-3-ol	Non-1-en-4-yn-3-ol|C9H14O|Research Chemical	Non-1-en-4-yn-3-ol (C9H14O) is a high-purity reagent for organic synthesis research. This product is for research use only (RUO) and not for human consumption.
Diethyl hexacosanedioate	Diethyl Hexacosanedioate	Diethyl hexacosanedioate is a long-chain diester for material science research, such as polymer synthesis. For Research Use Only. Not for human use.

The Monopolar spindle-one-binder (MOB) family of proteins represents highly conserved regulators of essential cellular processes, functioning primarily as scaffold proteins that lack enzymatic activity themselves [15]. In humans, this family comprises seven members (MOB1A, MOB1B, MOB2, MOB3A, MOB3B, MOB3C, and MOB4) that are subdivided into four subfamilies based on structural similarity [1]. These proteins serve as critical adaptors that mediate their biological functions through engaging with and assembling protein complexes, particularly with the Nuclear Dbf2-related (NDR) serine/threonine kinase family [1] [15].

The MOB-NDR protein interaction axis represents a pivotal signaling nexus with demonstrated roles in regulating tissue homeostasis, cell cycle dynamics, cell division, DNA repair, and morphogenesis [1] [7]. Dysregulation of these pathways has established implications for growth-related disorders, particularly cancer, electing this protein family as potential players in oncogenesis and therapeutic development [1] [15]. This application note details the cancer associations and provides structured protocols for detecting MOB-NDR interactions via co-immunoprecipitation, enabling researchers to investigate these critical protein complexes in disease contexts.

MOB-NDR Interactions: Core Biology and Cancer Associations

Functional Classification of MOB Proteins and NDR Kinases

MOB proteins function as essential co-regulatory proteins that directly bind to and influence the activity of protein kinases, particularly members of the NDR/LATS kinase family [15]. The NDR kinase family in humans includes NDR1 and NDR2, which share approximately 87% sequence identity but exhibit differential subcellular localization - NDR1 is predominantly nuclear while NDR2 displays a punctate cytoplasmic distribution [8]. This differential localization suggests each kinase may serve distinct functions despite their structural similarity.

Table 1: Human MOB Protein Family Classification

MOB Protein	Alternative Names	Subfamily	Established Binding Partners	Primary Cellular Functions
MOB1A/B	MOBKL1A/B, Mats	MOB1	NDR1/2, LATS1/2, MST1/2 [20]	Hippo pathway core component, tissue growth regulation [1]
MOB2	MOBKL2	MOB2	NDR1/2, STK38/38L [1] [4]	Regulation of NDR kinase activity, cellular morphogenesis [7]
MOB3A	MOBKL2A	MOB3	Limited data	Poorly characterized
MOB3B	MOBKL2B	MOB3	Limited data	Poorly characterized
MOB3C	MOBKL2C	MOB3	RNase P complex [1]	tRNA maturation, RNA biology [1]
MOB4	MOBKL3, Phocein	MOB4	STRIPAK complex [1]	Cytoskeletal organization, phosphatase regulation [1]

The interaction between MOB and NDR kinases is evolutionarily conserved from yeast to humans. In yeast, Mob1p complexes with Dbf2p to regulate mitotic exit, while Mob2p associates with Cbk1p to control morphogenesis networks [15]. In mammalian systems, this functional separation becomes less distinct, with multiple MOB proteins capable of interacting with various NDR kinases, creating a complex regulatory network [7].

Quantitative Analysis of MOB Protein Interactomes

Recent proximity-dependent biotin identification (BioID) screens have systematically mapped the interactomes of all seven human MOB proteins, revealing both shared and unique interaction profiles. These studies identified over 200 interactions, with at least 70% representing previously unreported associations in BioGrid databases [1].

Table 2: MOB Protein Interactome Quantitative Profile from BioID Screening

MOB Protein	Total Interactions Identified	Previously Known Interactions	Novel Interactions	Key Cancer-Associated Pathways
MOB1A/B	48 (Primary)	Well-established (Hippo core)	Non-canonical Hippo regulators	Hippo pathway, Tissue homeostasis [1]
MOB2	Multiple	STK38/STK38L (NDR kinases) [1]	Under investigation	Cell proliferation, Morphogenesis [8]
MOB3A/B/C	Numerous	Minimal prior to study	RNase P complex (MOB3C) [1]	RNA biology, Potential cancer metabolism
MOB4	12 (Primary)	STRIPAK complex	Novel regulatory factors	Cytoskeletal organization, Signal transduction [1]

The BioID data reliably recalled established interactions for well-characterized MOBs while revealing previously unknown associations, particularly for the understudied MOB3 subfamily. Notably, MOB3C was found to specifically associate with 7 of 10 protein subunits of the RNase P complex, an endoribonuclease that catalyzes tRNA 5' maturation, suggesting an exciting nexus with RNA biology potentially relevant to cancer [1].

MOB-NDR Signaling Pathways in Cancer Biology

The Hippo Pathway: MOB1 as a Central Integrator

MOB1 proteins (MOB1A/B) serve as core components and integrators within the Hippo pathway, an evolutionarily conserved signaling network that regulates tissue growth, organ size, and cell proliferation [15]. In this pathway, MOB1 functions as a scaffold that binds both upstream kinases (MST1/2) and downstream kinases (LATS1/2), facilitating trans-phosphorylation and pathway activation [20].

The mechanism involves MOB1 binding to MST1/2 kinases through its phosphopeptide-binding infrastructure, while simultaneously engaging LATS and NDR kinases through a distinct interaction surface [20]. This assembly into a single complex enables MOB1 to facilitate the activation of LATS kinases by MST kinases. Additionally, MOB1 itself becomes phosphorylated when bound to upstream partners, differentially regulating its protein interaction activities and creating a sophisticated feedback mechanism [20].

The significance of this pathway in cancer is substantial, as dysregulation of Hippo signaling leads to uncontrolled cell proliferation and impaired contact inhibition - hallmarks of cancer. MOB1's position as a central integrator makes it a potential point of vulnerability in cancer cells and a promising therapeutic target.

NDR Kinase Activation and Oncogenic Signaling

NDR kinases represent crucial effectors downstream of MOB proteins in multiple signaling cascades. Both NDR1 and NDR2 require phosphorylation on two conserved residues (Ser281/Thr444 in NDR1; Ser282/Thr442 in NDR2) for full activation, with MOB binding dramatically stimulating NDR catalytic activity [4] [8].

The activation mechanism involves MOB-mediated recruitment of NDR kinases to cellular membranes, where phosphorylation and activation occur. Studies demonstrate that membrane-targeted MOBs robustly promote NDR activation, and this activation is dependent on their physical interaction [4]. Using inducible membrane translocation systems, researchers have shown that NDR phosphorylation and activation at the membrane occurs within minutes after MOB association with membranous structures [4].

NDR kinases are upregulated in certain cancer types, suggesting potential oncogenic functions, though their precise roles in tumorigenesis remain to be fully defined [4]. The rapid activation mechanism mediated by MOB proteins provides a regulatory node that may be exploited in cancer cells to drive proliferation and survival signaling.

Diagram 1: MOB1 in Hippo Signaling - This pathway illustrates the central role of MOB1 in transducing growth signals through the Hippo pathway to regulate cell proliferation, with dysregulation contributing to cancer phenotypes.

Protocol: Co-immunoprecipitation for MOB-NDR Interaction Analysis

Research Reagent Solutions

Table 3: Essential Research Reagents for MOB-NDR Co-Immunoprecipitation

Reagent Category	Specific Examples	Function & Application Notes
Cell Lysis Buffers	RIPA, NP-40 alternatives	Solubilize proteins while preserving interactions; composition critical for success [21]
Antibodies (MOB Targets)	Anti-MOB1, Anti-MOB2, Anti-MOB4	Pre-validate for IP efficiency; species-matched controls essential [22]
Antibodies (NDR Targets)	Anti-NDR1, Anti-NDR2, Anti-LATS1/2	Confirm interaction partners in WB; phospho-specific variants available [4]
Bead Platforms	Protein A/G, Streptavidin	Solid support for antibody immobilization; choice affects background [21]
Tagging Systems	FLAG, HA, c-Myc, V5 [21]	Enable IP in absence of validated antibodies; N/C-terminal placement matters
Protease/Phosphatase Inhibitors	PMSF, Sodium Fluoride, Aprotinin	Preserve post-translational modifications during processing [21]

Detailed Co-immunoprecipitation Methodology

Sample Preparation and Pre-Clearing

Begin with cell culture systems (HEK293 or HeLa cells recommended) expressing your MOB and NDR proteins of interest, either endogenously or via transfection. Wash cells with ice-cold PBS and lyse using an appropriate lysis buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 10% glycerol) supplemented with fresh protease and phosphatase inhibitors [21]. Incubate on ice for 30 minutes with occasional agitation, then centrifuge at 16,000 × g for 15 minutes at 4°C to pellet insoluble material.

Transfer the supernatant to a fresh tube and determine protein concentration. Use 300-500 μg of total protein as starting material for each co-IP reaction, adjusting upward to 2 mg for low-abundance targets [21]. Pre-clear the lysate by incubating with protein A/G beads for 30 minutes at 4°C to reduce non-specific binding, then centrifuging to remove the beads.

Antibody Immobilization and Antigen Capture

Select either the direct (pre-immobilized) or indirect (free antibody) method based on antibody characteristics [21]. For the direct method:

• Wash 20-50 μL of bead slurry with lysis buffer
• Incubate beads with 1-5 μg of specific antibody for 2 hours at 4°C
• Wash twice with lysis buffer to remove unbound antibody
• Incubate antibody-bound beads with pre-cleared lysate overnight at 4°C

For the indirect method:

• Incubate specific antibody directly with pre-cleared lysate for 2 hours at 4°C
• Add washed beads and incubate for an additional 2 hours at 4°C

Always set up parallel control reactions with species-matched non-specific IgG to identify non-specific interactions [22] [21].

Washes, Elution, and Downstream Analysis

Pellet beads by brief centrifugation and carefully remove supernatant. Wash beads 3-4 times with ice-cold lysis buffer (or higher stringency wash buffers if background is high), resuspending completely with each wash. After final wash, completely remove residual wash buffer.

Elute bound proteins by adding 2× Laemmli sample buffer and heating at 95°C for 5-10 minutes. Analyze eluates by SDS-PAGE and western blotting using antibodies against hypothesized binding partners (e.g., anti-NDR for MOB baits) [21]. Always include input lanes (1-10% of starting material) as positive controls and to confirm negative results when prey proteins are absent from IP lanes despite being present in inputs [21].

Diagram 2: Co-IP Workflow - This diagram outlines the key decision points and steps in the co-immunoprecipitation protocol for analyzing MOB-NDR protein interactions.

Critical Controls and Optimization Strategies

Essential Experimental Controls

• Input Control: Reserve 1-10% of lysate before any IP steps to verify presence of target proteins [21]
• Negative IgG Control: Use species-matched non-specific IgG to identify non-specific binders [22]
• Bait Detection: Always probe for the bait protein to confirm successful IP
• Prey Specificity: Include unrelated prey proteins to test interaction specificity
• Tagging Controls: For tagged systems, include empty vector or tag-only controls

Troubleshooting Common Issues

• High Background: Increase wash stringency (higher salt, add detergent), optimize antibody amount, change bead type [21]
• Weak or No Signal: Increase starting material, try different antibody epitope tags, test multiple lysis conditions [22]
• Inconsistent Results: Standardize cell culture conditions, use fresh protease inhibitors, control passage number
• Transient Interactions: Consider chemical crosslinking before lysis to capture brief interactions

Therapeutic Targeting and Future Directions

The MOB-NDR interaction network represents a promising but challenging therapeutic target. Current strategies focus on developing small molecules that disrupt specific protein-protein interactions within this pathway, particularly those with established roles in cancer progression such as MOB1-NDR/LATS complexes [20]. The availability of detailed structural information for MOB1-phosphopeptide complexes provides a foundation for structure-based drug design approaches targeting these interactions [20].

Future research directions should prioritize:

• Functional characterization of the poorly understood MOB3 subfamily and its potential connections to RNA biology in cancer [1]
• Development of selective inhibitors targeting specific MOB-NDR interfaces while sparing others to minimize toxicity
• Exploration of combination therapies targeting MOB-NDR signaling alongside conventional chemotherapy
• Investigation of tissue-specific functions of different MOB-NDR complexes to identify context-dependent vulnerabilities

The protocols and reagents detailed in this application note provide the foundational methodology required to advance these research avenues, enabling systematic investigation of MOB-NDR interactions in both basic and translational cancer research contexts.

Optimized Co-IP Protocols for Capturing MOB-NDR Interactions

The MOB (Mps one binder) proteins and NDR (Nuclear Dbf2-related) kinases form an evolutionarily conserved signaling network that regulates fundamental cellular processes including cell polarity, mitotic exit, apoptosis, and centrosome duplication [7] [6]. In fungal systems such as Neurospora crassa, these complexes function as distinct modules: the MOB1-DBF2 complex is essential for septum formation and sexual development, while MOB2 proteins interact with the COT1 kinase to control polar tip extension and branching [7]. In humans, this network expands in complexity, with six MOB proteins (hMOB1A, -1B, -2, -3A, -3B, and -3C) interacting with four NDR/LATS kinases [6]. The functional interplay between these components is critical; for instance, hMOB2 competes with hMOB1A for NDR binding and acts as a negative regulator of NDR kinase activity, whereas hMOB1 proteins are potent activators [6]. Detecting these physiologically relevant protein-protein interactions requires carefully optimized co-immunoprecipitation (co-IP) strategies. The selection of specific reagents—including antibodies, beads, and tagging strategies—is therefore paramount to the successful investigation of these complexes.

Critical Reagent Selection

Tagging Strategies: The GFP-Trap System

For co-immunoprecipitation studies of MOB-NDR complexes, leveraging a tagged "bait" protein is a reliable strategy. The GFP-Trap system utilizes a high-affinity nanobody derived from camelid heavy-chain antibodies, specifically recognizing GFP and its derivatives (e.g., eGFP, YFP, CFP) [23] [24] [25]. This nanobody is coupled to a beaded support (agarose or magnetic), creating a ready-to-use affinity resin.

• Key Advantages:

  • High Affinity and Specificity: The GFP-Trap nanobody has an extraordinarily high affinity, with a dissociation constant (K_D) of 1 pM. This enables near-quantitative pulldown of GFP-fusion proteins, even when expressed at low levels [24] [25].
  • No Antibody Contamination: Unlike traditional IPs using conventional antibodies, the small, single-domain nanobody does not co-elute as heavy and light chains. This eliminates antibody band interference in downstream SDS-PAGE and western blot analysis [24] [26].
  • Robustness and Flexibility: The complex is stable under harsh washing conditions, including high salt (2 M NaCl), detergents (e.g., 1% SDS, 2% NP-40), and chaotropic agents (8 M Urea). This allows for stringent washing to reduce background and compatibility with specialized lysis buffers [23] [24].

• Considerations for MOB-NDR Research: When studying MOB-NDR interactions, it is crucial to validate that the GFP tag does not impair the function or localization of the bait protein, particularly as these interactions often depend on proper protein folding and localization signals [7] [12].

Bead Matrix Selection

The choice of bead matrix is critical for balancing binding capacity, ease of use, and background levels.

Table 1: Comparison of Bead Matrices for Co-Immunoprecipitation

Matrix Type	Binding Capacity	Key Advantages	Ideal Use Cases
Agarose Beads [24] [25]	High (porous surface)	Low background, high capacity	Standard Co-IPs; low-abundance complexes
Magnetic Agarose Beads [24] [26]	High	Ease of handling, efficient separation, low non-specific binding	High-throughput applications; quick protocol steps
Magnetic Particles (M-270) [24]	Specific for large complexes	Non-porous surface, minimal co-purification of contaminants	Pull-down of large protein complexes/assemblies

For most MOB-NDR co-IP applications, GFP-Trap Agarose is recommended for its excellent balance of low background and high binding capacity. If processing many samples or using automated platforms, GFP-Trap Magnetic Agarose provides a significant advantage in processing speed [24].

Antibody Specificity and Validation

In the absence of a tagged bait protein, traditional antibodies are required. The success of the co-IP hinges entirely on the specificity and affinity of the antibody used [26].

• Validation is Critical: An antibody used for co-IP must be validated for specificity in the application and species. This includes demonstrating that it can immunoprecipitate the target protein from a relevant cell lysate and that signal is lost in knockout or knockdown controls [26].
• Avoiding Antibody Contamination: To prevent co-eluting antibody heavy (~50 kDa) and light (~25 kDa) chains from obscuring potential interacting partners on SDS-PAGE gels, crosslinking the antibody to Protein A/G beads or using directly conjugated/covalent immobilization strategies is recommended [26].

Experimental Protocol: Co-IP of MOB-NDR Complexes using GFP-Trap

This protocol is designed for the immunoprecipitation of a GFP-tagged NDR kinase (the "bait") and its associated MOB proteins (the "prey") from mammalian cell lysates.

Reagents and Buffers

• Lysis Buffer (Non-denaturing): 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA. Supplement fresh with protease and phosphatase inhibitors.
  • Rationale: Low ionic strength and non-ionic detergents help maintain native MOB-NDR interactions [26]. The specific composition can be adjusted; for example, NaCl can be titrated from 120 mM to 1 M to optimize stringency [26].
• Wash Buffer: 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40.
• Elution Buffer: 2x Laemmli SDS-PAGE sample buffer.
• GFP-Trap Agarose (e.g., ChromoTek, GTA) [23] [24].

Step-by-Step Procedure

• Cell Lysis:

  • Culture cells expressing the GFP-tagged NDR kinase and harvest. A negative control (e.g., cells expressing GFP alone or untagged protein) is essential.
  • Lyse cells in ice-cold lysis buffer (e.g., 500 µL per 10-cm dish) for 30 minutes on ice. Gently agitate the tubes.
  • Critical: Avoid sonication or vigorous vortexing after lysis to preserve weak or transient protein-protein interactions [26].
  • Clarify the lysate by centrifugation at 15,000 x g for 15 minutes at 4°C. Transfer the supernatant to a new tube.

• Pre-Clearing (Optional):

  • Incubate the lysate with bare agarose beads or an irrelevant bead-bound antibody for 30-60 minutes at 4°C. This can reduce non-specific binding to the beads.

• Immunoprecipitation:

  • Equilibrate a suitable volume of GFP-Trap Agarose bead slurry (e.g., 20 µL per sample) in lysis buffer.
  • Incubate the pre-cleared lysate with the equilibrated GFP-Trap beads for 1-2 hours at 4°C with end-over-end rotation.
  • Note: The high affinity of the GFP-Trap allows for shorter incubation times (30-60 minutes) compared to conventional antibodies [24].

• Washing:

  • Pellet the beads by gentle centrifugation (2,500 x g, 2 minutes).
  • Carefully remove the supernatant (flow-through).
  • Wash the beads 3-4 times with 1 mL of wash buffer. Resuspend the beads gently and avoid disturbing the pellet.
  • For stringent washing, the buffer can be modified with higher salt (e.g., 500 mM NaCl) or mild detergents to disrupt non-specific interactions without dissociating the MOB-NDR complex [23] [24].

• Elution:

  • After the final wash, completely remove the wash buffer.
  • Elute the bound protein complexes by adding 2x SDS-PAGE sample buffer and heating at 95°C for 5-10 minutes.

• Analysis:

  • Analyze the eluates by SDS-PAGE followed by western blotting. Probe for the GFP-tagged bait (NDR kinase) and suspected interacting MOB proteins (e.g., hMOB1, hMOB2) [6].

The following workflow diagram summarizes the key stages of this protocol.

Troubleshooting and Optimization

• High Background: Increase the salt concentration (up to 500 mM NaCl) or change detergents in the wash buffer. Ensure all wash steps are performed thoroughly. Pre-clearing the lysate can also help [26].
• Weak or No Interaction Signal: Verify the expression and functionality of the GFP-tagged bait. Ensure lysis and wash buffers are non-denaturing and avoid mechanical disruption of the complexes. Consider crosslinking to stabilize transient interactions [26].
• Co-elution of Antibody Chains (with traditional IP): If using a conventional antibody, switch to a crosslinked antibody protocol or use the GFP-Trap system to eliminate this issue [24] [26].

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions for MOB-NDR Co-IP

Reagent / Solution	Function / Role	Example Product / Composition
GFP-Trap Affinity Resin [23] [24] [25]	One-step immunoprecipitation of GFP-fusion proteins and their endogenous binding partners.	ChromoTek GFP-Trap Agarose (GTA)
Non-denaturing Lysis Buffer [26]	Extracts proteins while preserving native protein-protein interactions.	20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, protease inhibitors
Phosphatase Inhibitors	Preserves phosphorylation status of NDR kinases, which is critical for their activity and MOB binding [6] [12].	Sodium orthovanadate, sodium fluoride, beta-glycerophosphate
Stringent Wash Buffers [23] [24]	Removes non-specifically bound proteins without disrupting the specific complex.	Buffers containing high salt (e.g., 500 mM NaCl) or chaotropic agents (e.g., Urea)
SDS-PAGE & Western Blot System	Analyzes immunoprecipitated complexes and confirms interactions.	Standard SDS-PAGE equipment; antibodies against MOB and NDR proteins
Protease Inhibitor Cocktail	Prevents proteolytic degradation of target proteins and complexes during extraction.	Commercial cocktails (e.g., EDTA-free)
2-Iminoethane-1-thiol	2-Iminoethane-1-thiol, MF:C2H5NS, MW:75.14 g/mol	Chemical Reagent
2,3-Diethynylpyridine	2,3-Diethynylpyridine

Visualizing the MOB-NDR Signaling Network

Understanding the biological context of the MOB-NDR interaction is crucial for interpreting co-IP results. The following diagram illustrates the core relationships and regulatory functions of these key components, based on findings in both fungal and human systems.

The meticulous selection of reagents—from the high-affinity GFP-Trap and appropriate bead matrix to validated antibodies and optimized buffers—forms the foundation for robust co-immunoprecipitation of MOB-NDR protein complexes. The protocols and guidelines detailed herein provide a reliable framework for researchers to investigate these critical signaling interactions. By applying these optimized strategies, scientists can generate reproducible and biologically relevant data, ultimately advancing our understanding of the MOB-NDR network's role in cell growth, polarity, and disease.

The successful detection of protein-protein interactions (PPIs), such as those within the MOB-NDR kinase network, is fundamentally dependent on the initial cell lysis conditions. The composition of the lysis buffer directly influences the equilibrium between solubilizing membrane and scaffold-associated proteins and preserving transient, native protein complexes. This application note provides a detailed framework for optimizing cell lysis buffers, specifically tailored for the co-immunoprecipitation (Co-IP) of MOB-NDR complexes, which are crucial regulators of cell differentiation and polar morphogenesis [11]. The MOB-NDR interaction is a classic example of a PPI that requires a carefully balanced approach. NDR kinases require physical interaction with MOB proteins for their activity and functions, a process mediated by the kinase's N-terminal region and specific conserved residues [11]. The methodological guidance that follows is designed to enable researchers to effectively capture these biologically critical complexes for downstream analysis.

Scientific Background: The MOB-NDR Interaction

The Core Signaling Module

The NDR (Nuclear Dbf2-related) kinase family and their MOB (MPS1-binding) protein partners form an evolutionarily conserved signaling module. In the model system Neurospora crassa, the NDR kinase COT1 and its binding partners MOB2A and MOB2B are essential for proper hyphal elongation, branching, and asexual development [11]. Dysfunction in this complex leads to severe morphological defects, including the cessation of tip extension and hyperbranching. Research indicates that while MOB2A and MOB2B have some overlapping functions in regulating hyphal tip extension, they perform distinct, non-redundant roles and can simultaneously associate with COT1 to form a hetero-trimeric complex [11]. This specific interaction is mediated by distinct residues within the COT1 N-terminal region (NTR), highlighting the precise and potentially sensitive nature of the complex's architecture [11].

Significance in Cellular Regulation and Disease

The MOB-NDR kinase network regulates fundamental processes including cell cycle progression, morphogenesis, and cytoskeletal organization. In humans, the family comprises seven MOB proteins (MOB1A/B, MOB2, MOB3A/B/C, and MOB4) which act as critical adaptors in pathways such as the Hippo tumor suppressor pathway and the STRIPAK complex [1]. Given their central role in tissue growth and homeostasis, dysregulation of MOB proteins is implicated in cancer and other growth-related disorders [1]. Consequently, reliably studying these interactions, beginning with effective extraction from the cellular environment, is of paramount importance for both basic and translational research.

Lysis Buffer Composition: A Quantitative Guide

The table below summarizes the key components of lysis buffers and their optimization for preserving MOB-NDR interactions, based on standard biochemical principles and reported methodologies.

Table 1: Key Components of Lysis Buffers for PPI Preservation

Component	Function	Recommended Types/Concentrations	Considerations for MOB-NDR Co-IP
Detergent	Solubilizes membranes; disrupts lipid-lipid & lipid-protein interactions.	Non-ionic (Gentle): 0.1-1% Triton X-100, NP-40 [27] [28]	Preserves native protein complexes; preferred for initial solubilization.
		Ionic (Strong, Denaturing): 0.1-1% SDS [27]	Disrupts PPIs; use for controls or total protein extraction.
Salt	Modulates ionic strength; disrupts electrostatic interactions.	150 mM NaCl (physiological) [28]	Reduces non-specific binding; high salt (>500 mM) may disrupt weak PPIs.
Buffering Agent	Maintains stable pH.	20-50 mM Tris-HCl, HEPES; pH 7.4-8.0 [27] [28]	Neutral pH helps maintain protein stability and interactions.
Protease Inhibitors	Prevents proteolytic degradation.	Commercial cocktails (e.g., Roche) [28]	Essential for all steps to protect the protein complex integrity.
Phosphatase Inhibitors	Preserves phosphorylation status.	Sodium fluoride, β-glycerophosphate	Critical as NDR kinase activity is regulated by phosphorylation [11].
Reducing Agents	Prevents disulfide bridge formation.	1-10 mM DTT, β-mercaptoethanol [28]	Can be added after lysis and IP to avoid disrupting natural folding.

Detailed Experimental Protocol for MOB-NDR Co-IP

This protocol is optimized for adherent mammalian cells (e.g., HEK293, HeLa) but can be adapted for other cell types.

Materials and Reagents

• Lysis Buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1x Protease Inhibitor Cocktail, 1x Phosphatase Inhibitor Cocktail. Chill to 4°C before use [28].
• Phosphate-Buffered Saline (PBS): Ice-cold.
• Protein A/G Agarose Beads
• Antibodies: Specific antibody against your bait protein (e.g., anti-COT1/NDR kinase or anti-MOB2) and a species-matched control IgG.
• Cell Scraper
• Refrigerated Centrifuge

Step-by-Step Procedure

• Cell Culture and Treatment: Culture cells in 15-cm plates until they reach 70-90% confluency. Induce protein expression if using an inducible system [28]. Treat cells with ligands or inhibitors as required by your experimental design.
• Cell Washing and Harvesting:
  • Aspirate the growth medium.
  • Gently wash the cell monolayer twice with 20 mL of ice-cold PBS [28].
  • Completely remove PBS after the final wash.
• Cell Lysis:
  • Add 1.0 mL of chilled lysis buffer per 15-cm plate.
  • Incubate the plates on a rocking platform at 4°C for 20-30 minutes to ensure complete lysis [28].
  • Scrape the lysate off the plate and transfer it to a pre-chilled 1.5 mL microcentrifuge tube.
• Clarification of Lysate:
  • Centrifuge the lysates at 14,000 x g for 15 minutes at 4°C to pellet insoluble debris, including nuclei and cytoskeletal components [28].
  • Carefully transfer the supernatant (the solubilized protein fraction) to a new, pre-chilled tube. This supernatant contains the proteins for Co-IP.
• Co-Immunoprecipitation:
  • Pre-clear Lysate (Optional): Incubate the lysate with Protein A/G beads for 30 minutes at 4°C to reduce non-specific binding. Centrifuge and collect the supernatant.
  • Incubate with Antibody: Add the primary antibody (e.g., 1-5 µg of anti-MOB2 or anti-NDR) to the lysate. Incubate for 2 hours to overnight at 4°C with gentle rotation.
  • Capture Immune Complexes: Add 50 µL of a 50% slurry of Protein A/G beads to the lysate-antibody mixture. Incubate for 2-4 hours at 4°C with gentle rotation.
• Washing and Elution:
  • Pellet the beads by brief centrifugation (e.g., 2000 x g for 2 minutes) and carefully aspirate the supernatant.
  • Wash the beads 3-4 times with 1 mL of ice-cold lysis buffer (without inhibitors) to remove non-specifically bound proteins.
  • After the final wash, completely remove the wash buffer.
  • Elute the bound proteins by adding 2X Laemmli SDS-PAGE sample buffer and boiling for 5-10 minutes.
• Downstream Analysis: Analyze the eluted proteins by Western blotting to confirm the presence of the interaction (e.g., probe for COT1 in a MOB2 immunoprecipitate, or vice versa) [11].

Workflow and Pathway Visualization

MOB-NDR Signaling Pathway and Co-IP Strategy

Lysis Buffer Optimization Workflow

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagent Solutions for MOB-NDR Co-IP Studies

Reagent / Solution	Critical Function	Application Notes
Triton X-100 / NP-40	Non-ionic detergent for solubilizing membrane and scaffold-associated proteins while preserving PPIs.	The cornerstone of native Co-IP lysis buffers; effective for extracting the MOB-NDR complex from the plasma membrane [11] [27].
Protease Inhibitor Cocktail	Broad-spectrum inhibition of serine, cysteine, aspartic proteases, and aminopeptidases.	Absolutely essential to prevent degradation of MOB and NDR proteins during the lengthy lysis and IP process [28].
Phosphatase Inhibitors	Preserve the native phosphorylation status of proteins.	Critical for studying NDR kinases, as their activity is regulated by phosphorylation on activation segments and hydrophobic motifs [11].
Protein A/G Agarose Beads	High-affinity binding to antibody Fc regions for immunoprecipitation.	The solid support for capturing antibody-protein complexes; ensure compatibility with the host species of your primary antibody.
Anti-MOB2 & Anti-NDR Antibodies	Specific recognition and pulldown of the bait protein.	Validate antibodies for IP efficacy. Use quality-controlled, specific antibodies to avoid non-specific results [11] [1].
HEK293/HeLa Cell Lines	Mammalian model systems for recombinant protein expression.	Commonly used for studying human MOB-NDR interactions; allow for efficient transfection and protein production [1] [28].
1-Phenyl-1,2-butanediol	1-Phenyl-1,2-butanediol, CAS:22607-13-2, MF:C10H14O2, MW:166.22 g/mol	Chemical Reagent
Bicyclo[1.1.1]pentan-2-one	Bicyclo[1.1.1]pentan-2-one	Bicyclo[1.1.1]pentan-2-one is a key BCP ketone building block for drug discovery. This product is for research use only. Not for human or veterinary use.

Step-by-Step Co-IP Workflow for MOB-NDR Complex Isolation

NDR (Nuclear Dbf2-related) kinases are crucial regulators of growth, differentiation, and morphogenesis across eukaryotic organisms [7]. Their activity and cellular functions are dependent on interaction with MOB (Mps One Binder) proteins, which act as essential activators and adaptors [7]. In the filamentous fungus Neurospora crassa, which serves as an excellent model for studying these conserved pathways, two distinct NDR kinase-MOB complexes have been characterized: the MOB1-DBF2 complex, which is essential for septum formation in vegetative cells and during conidiation, and the MOB2-COT1 complex, which controls polar tip extension and branching by regulating COT1 activity [7]. A third MOB protein, MOB3/phocein, appears to function in vegetative cell fusion and fruiting body development through mechanisms unrelated to NDR kinase signaling [7].

The co-immunoprecipitation (Co-IP) technique is particularly valuable for investigating these protein complexes because it allows researchers to capture physiologically relevant protein-protein interactions under near-native conditions [29] [30]. This protocol details a optimized Co-IP workflow specifically tailored for the isolation and study of MOB-NDR complexes, enabling researchers to better understand their composition, regulation, and function in cellular signaling networks.

Key Reagent Solutions for MOB-NDR Co-IP

Table 1: Essential reagents for successful Co-IP of MOB-NDR complexes

Reagent Category	Specific Examples	Function and Application Notes
Lysis Buffers	NP-40 Lysis Buffer, RIPA Buffer [14]	Releases proteins while preserving native interactions; choice depends on protein localization and complex stability.
Antibodies	Anti-tag (HA, c-Myc, FLAG, V5) [29] [21], Target-specific antibodies [31]	Enable specific capture of bait protein; anti-tag antibodies minimize interference with complex formation.
Bead Supports	Protein A/G agarose or magnetic beads [29] [14]	Solid support for immobilizing antibody-antigen complexes; magnetic beads offer easier handling.
Protease Inhibitors	Commercial protease inhibitor cocktails [14]	Prevent protein degradation during extraction and immunoprecipitation.
Phosphatase Inhibitors	Commercial phosphatase inhibitor cocktails [14]	Preserve phosphorylation states of NDR kinases, which are crucial for their regulation.
Wash Buffers	High-salt buffers, Non-ionic detergent buffers [29]	Remove nonspecifically bound proteins while maintaining complex integrity.
Elution Buffers	Low pH buffers, SDS sample buffer [29]	Release captured complexes from beads for downstream analysis.

Experimental Workflow Visualization

Co-IP Workflow for MOB-NDR Complexes

MOB-NDR Interaction Network

Step-by-Step Co-IP Protocol

Stage 1: Sample Preparation and Lysis

Materials Required:

• Suitable lysis buffer (NP-40 or RIPA) [14]
• Protease inhibitor cocktail (e.g., ab65621) [14]
• Phosphatase inhibitor cocktail (optional, for phosphorylated proteins) [14]
• PBS (phosphate-buffered saline)
• Refrigerated centrifuge

Procedure:

• Prepare Lysis Buffer: Use NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris-HCl pH 8.0) for cytoplasmic/membrane proteins or RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) for nuclear proteins [14]. Add protease inhibitors immediately before use. For MOB-NDR complexes that involve phosphorylated kinases, include phosphatase inhibitors.

• Harvest Cells: Isolate cells and wash with PBS. For adherent cells, detach using enzymatic (TrypLE) or mechanical means. Wash cells 2-3 times in PBS to remove media components [14].

• Cell Lysis: Add ice-cold lysis buffer directly to cell pellet (300 μL for 1-3×10⁷ cells). Resuspend gently and incubate on ice for 10 minutes without agitation [14]. For tissue samples, homogenize using a bead beater or similar homogenizer.

• Clarify Lysate: Centrifuge at 8,000 × g for 10 minutes at 4°C. Transfer supernatant to a fresh tube kept on ice. This supernatant is your protein lysate [14].

• Quantify Protein: Determine protein concentration using Bradford or BCA assay. Adjust concentrations as needed for consistency across samples.

Critical Note: Maintain samples at 4°C throughout the procedure to preserve complex integrity and prevent protein degradation [14].

Stage 2: Pre-clearing (Optional)

Materials Required:

• Isotype control antibody
• Protein A/G beads

Procedure:

• Incubate with Control: Add isotype control antibody (same species as IP antibody) to lysate and incubate for 30-60 minutes at 4°C with gentle rotation [14].

• Add Beads: Add Protein A/G beads and incubate for an additional 30-60 minutes at 4°C with rotation.

• Remove Beads: Centrifuge briefly to pellet beads. Transfer supernatant to a fresh tube. This pre-cleared lysate is ready for immunoprecipitation.

Note: Pre-clearing can reduce non-specific binding but may not be necessary when using high-quality beads with low non-specific adsorption [14].

Stage 3: Immunoprecipitation

Materials Required:

• Specific antibody against bait protein or anti-tag antibody
• Protein A/G-coupled agarose or magnetic beads
• IP buffer (same composition as lysis buffer but without detergents that disrupt interactions)

Procedure:

• Form Immune Complexes: Add specific antibody to pre-cleared lysate (1-10 μg antibody per 500 μg total protein). Incubate for 2 hours to overnight at 4°C with gentle rotation [14]. Longer incubation may increase yield but also potentially increase background.

• Capture Complexes: Add pre-washed Protein A/G beads (20-50 μL bead slurry per reaction). Incubate for 2 hours to overnight at 4°C with gentle rotation [29] [14].

• Collect Beads: Pellet beads by brief centrifugation (500-1000 × g for 1-2 minutes) or using a magnetic rack if using magnetic beads. Carefully remove supernatant without disturbing bead pellet.

Optimization Tip: For low-affinity or transient interactions, consider crosslinking antibodies to beads to prevent co-elution of antibody fragments that can interfere with downstream analysis [29].

Stage 4: Washing and Elution

Materials Required:

• Wash buffer (lysis buffer with optional increased salt concentration up to 500 mM NaCl)
• Elution buffer (low pH buffer or 1× SDS-PAGE sample buffer)

Procedure:

• Wash Beads: Resuspend bead pellet in 500 μL-1 mL wash buffer. Rotate for 5-10 minutes at 4°C. Pellet beads and carefully remove supernatant. Repeat for 3-5 washes [14]. For MOB-NDR complexes, use wash buffers with low ionic strength (<120 mM NaCl) and non-ionic detergents to maintain complex stability [29].

• Elute Proteins: After final wash, completely remove wash buffer. Add appropriate elution buffer:

  • For non-denaturing elution: Use 100 mM glycine (pH 2.5-3.0) or 0.1 M triethylamine. Neutralize immediately with Tris-HCl (pH 8.0-9.0) [29].
  • For denaturing elution: Use 1× SDS-PAGE sample buffer and heat at 95°C for 5-10 minutes [14].

• Collect Eluate: Centrifuge briefly and transfer eluate to a fresh tube. The eluate contains your immunoprecipitated complexes and is ready for downstream analysis.

Downstream Analysis Methods

Table 2: Analysis methods for MOB-NDR complexes isolated by Co-IP

Analysis Method	Application in MOB-NDR Research	Key Parameters
Western Blotting	Confirm presence of specific proteins in complex; test hypotheses about known interactions [31] [21]	Band intensity normalized to input; comparison between bait and prey signals
Mass Spectrometry	Identify novel binding partners; characterize complete complex composition [31]	Spectral counts; peptide abundance; interaction stoichiometry
Functional Assays	Determine biochemical activity of isolated complexes (e.g., kinase assays) [7]	Enzyme activity; substrate phosphorylation
Quantitative PCR	Detect RNA components in ribonucleoprotein complexes [32]	Cycle threshold (Ct) values; comparison to controls

Troubleshooting and Optimization

Common Co-IP Problems and Solutions:

Table 3: Troubleshooting guide for MOB-NDR Co-IP experiments

Problem	Potential Causes	Solutions
High Background	Non-specific antibody binding; insufficient washing; antibody concentration too high	Titrate antibody; increase salt concentration in wash buffers; include more stringent washes [29]
No Detection of Prey	Weak or transient interaction; antibody interferes with binding; complex disruption during lysis	Use crosslinking; try different antibody epitopes; optimize lysis buffer conditions [29] [30]
Low Yield of Bait	Inefficient antibody binding; insufficient incubation time; protein degradation	Validate antibody efficiency; extend incubation times; ensure proper inhibitor usage [31]
Antibody Contamination	Co-elution of antibody heavy/light chains	Use crosslinked antibody beads; employ biotin-streptavidin system; use different detection antibodies [29]

Essential Controls for Interpretation:

• Positive Control: Known interacting pair to validate protocol
• Negative Control: Non-specific IgG or isotype control antibody
• Input Lane: 1-10% of starting lysate to confirm presence of target proteins
• Beads-Only Control: Beads without antibody to assess non-specific binding to resin
• Knockout Control: Cells lacking bait protein (if available) to confirm specificity

Application Notes for MOB-NDR Complexes

Biological Context: In Neurospora crassa, the MOB-NDR network consists of two NDR kinases (COT1 and DBF2) and four MOB proteins (MOB1, MOB2A, MOB2B, and MOB3) that form distinct functional complexes [7]. The MOB1-DBF2 complex is essential for septum formation in vegetative cells, conidiation, sexual fruiting body development, and ascosporogenesis. In contrast, MOB2 proteins interact with COT1 kinase to control polar tip extension and branching [7]. Understanding these specific interactions requires a Co-IP protocol that preserves these distinct complexes.

Technical Considerations:

• Interaction Stability: MOB-NDR interactions can vary in stability. The MOB2-COT1 interaction appears stable, as deletion of mob-2 genes affects COT1 activity and stability [7].
• Post-Translational Modifications: NDR kinases require phosphorylation for full activation. Maintain phosphatase inhibitors throughout the procedure to preserve these regulatory modifications [7] [14].
• Complex-Specific Optimization: Different MOB-NDR complexes may require slightly different buffer conditions. MOB1-DBF2 complexes may be more stable than MOB2-COT1 under certain conditions.

Advanced Applications:

• Time-Course Experiments: Study complex formation during cell cycle or differentiation
• Drug Treatment Studies: Investigate how signaling inhibitors affect complex assembly
• Mutational Analysis: Determine how specific mutations disrupt complex formation
• Crosslinking Approaches: Stabilize transient interactions for better detection

This optimized Co-IP protocol provides a robust framework for isolating and studying MOB-NDR complexes, enabling researchers to advance our understanding of these crucial regulators of cell growth and morphology.

Co-immunoprecipitation (Co-IP) serves as a cornerstone technique for investigating protein-protein interactions in native cellular environments, providing critical insights into signaling pathways, complex formation, and functional regulatory networks [22] [21]. Within the context of MOB-NDR protein interaction research, proper experimental controls transform Co-IP from a simple association assay into a rigorous, interpretable scientific method. Controls are essential for confirming the accuracy, reliability, and sensitivity of Co-IPs, and they provide indispensable tools for troubleshooting spurious results [33]. Without appropriate controls, researchers cannot distinguish specific protein interactions from non-specific background binding, potentially leading to false conclusions about protein interaction networks in the Hippo pathway and related signaling cascades.

The mammalian MOB protein family, comprising seven members divided into four subfamilies (MOB1A/B, MOB2, MOB3A/B/C, and MOB4), regulates crucial cellular processes including cell cycle dynamics, tissue growth, and centrosome duplication [1] [6]. Particularly relevant to this protocol, MOB proteins function as adaptors that engage in specific interactions with NDR/LATS kinases - interactions that must be precisely characterized to understand their biological functions [6] [8]. For instance, while MOB1A/B activates NDR1/2 kinases by stimulating autophosphorylation, MOB2 competes with MOB1 for NDR binding and functions as a negative regulator of NDR kinase activity [6]. This nuanced interplay highlights why properly controlled experiments are indispensable for accurate mechanistic insights.

The MOB-NDR/LATS Signaling Network

Biological Context of MOB-NDR Interactions

MOB proteins constitute a family of small (~20 kDa) single-domain proteins that share 17-96% structural similarity and primarily function as scaffolds or adaptors that mediate their biological roles through engaging with and assembling protein complexes [1]. The MOB-NDR/LATS interaction network represents a crucial signaling axis conserved from yeast to humans, with mammalian MOB proteins engaging in specific, functionally distinct interactions with NDR/LATS kinases [6]. MOB1A/B serves as bona fide regulators of the Hippo pathway, forming complexes with LATS1/2 kinases that ultimately phosphorylate and inhibit the transcriptional coactivator YAP1 [1]. Meanwhile, MOB2 specifically binds NDR1/2 kinases but not LATS1, and surprisingly functions as a negative regulator of NDR kinase activity by competing with MOB1A/B for NDR binding [6]. The MOB3 subfamily (MOB3A/B/C) represents a less characterized group that neither binds nor activates any of the four human NDR/LATS kinases, suggesting divergent functional roles [6].

Recent proximity labeling studies have revealed unexpected dimensions of MOB protein interactions, with MOB3C specifically associating with 7 of 10 protein subunits of the RNase P complex, suggesting exciting connections with RNA biology beyond the canonical kinase regulatory functions [1]. This expanding network of MOB interactions underscores the necessity of carefully controlled interaction studies to distinguish direct binding partners from indirect associations and to validate specific functional relationships within this complex signaling landscape.

The following diagram illustrates the key interactions and functional relationships within the MOB-NDR/LATS network:

Key Functional Relationships in the MOB-NDR/LATS Network

The standard Co-IP workflow involves multiple critical steps where appropriate controls ensure the validity of results. The process begins with sample preparation, followed by antigen-antibody complex formation, capture of immune complexes on beads, thorough washing to remove non-specifically bound material, and finally elution and analysis of precipitated proteins [21] [34]. Two primary approaches exist for Co-IP: the pre-immobilized antibody method (direct method), where antibody is first immobilized onto beads before antigen capture; and the free antibody method (indirect method), where antibody is added to the sample first, allowing antigen-antibody complexes to form before bead capture [21].

The following diagram outlines the key decision points and procedural flow in a standard Co-IP experiment:

Co-Immunoprecipitation Workflow Decision Points

Essential Controls for MOB-NDR Co-IP Experiments

Positive Controls

Positive controls demonstrate that the immunoprecipitation works effectively under the chosen experimental conditions. For MOB-NDR interaction studies, this typically involves:

• Input Control: Reserve 1-10% of the starting lysate before adding any antibodies or beads [33] [21]. This sample demonstrates successful immunoprecipitation when the bait protein appears in both input and IP lanes. The input control also confirms negative results by showing that prey proteins successfully blot in input but not IP lanes, indicates Co-IP efficiency by comparing band intensities between IP and input lanes, and reveals IP specificity by comparing non-specific band patterns [33].

• Known Interaction Validation: For MOB1A/B, demonstrate interaction with core Hippo pathway components (LATS1/2, MST1/2) which should be consistently recaptured in well-controlled experiments [1]. For MOB2, verify interaction with NDR1/2 kinases, which represent established binding partners [6] [8].

• Bait Expression Control: Express the GFP-tagged bait protein in the absence of prey protein to confirm successful precipitation under the chosen conditions [34].

Negative Controls

Negative controls identify non-specific binding and false positive interactions, which is particularly crucial when characterizing less-studied MOB family members like MOB3 proteins:

• Bead-Only Control: Perform the Co-IP identically but omit the antibody [33]. This control identifies proteins that non-specifically bind to the beads themselves. While potentially redundant with isotype controls (which also detect non-specific bead binding), bead-only controls provide specific troubleshooting information when unexpected results occur [33].

• Isotype Control: Replace the specific antibody with a non-specific antibody from the same species and subclass [33]. This identifies non-specific binding to the antibody's Fc region or other constant domains. For MOB protein studies, this control is essential for distinguishing specific interactions from background binding.

• Knockdown/Knockout Control: Perform Co-IP using samples lacking the bait protein due to genetic knockout or knockdown [33]. For MOB proteins, this could involve using MOB1A/B knockout cells or tissues where these proteins are naturally absent. This control definitively confirms antibody specificity.

• Tag-Only Control: When studying tagged MOB proteins (e.g., GFP-MOB3C), include a control with the tag alone (e.g., GFP only) in the presence of the putative prey protein [34]. The prey protein should appear in the input fraction but not the bound fraction, confirming that interaction requires the specific MOB protein rather than occurring non-specifically with the tag.

Confirmatory Controls

• Bidirectional Co-IP: Once an interaction is identified, reverse the bait and prey roles [33]. For example, if MOB3C co-precipitates with RNase P subunits, subsequently use antibodies against RNase P subunits to precipitate MOB3C [1]. This provides strong evidence for physiological interaction rather than experimental artifact.

• Competition Controls: For MOB2-NDR studies, demonstrate competition with MOB1A as evidence of specific binding [6]. The observation that MOB2 competes with MOB1A for NDR binding provided key insights into MOB2's function as a negative regulator of NDR kinases [6].

Quantitative Analysis of MOB-NDR/LATS Interactions

Research on MOB protein interactions with NDR/LATS kinases has yielded quantitative data that illustrates the specificity and functional outcomes of these interactions. The following table summarizes key findings from controlled interaction studies:

Table 1: Experimentally Determined MOB-NDR/LATS Interaction Specificity

MOB Protein	NDR1/2 Interaction	LATS1/2 Interaction	Functional Outcome	Key Experimental Evidence
MOB1A/B	Yes [6]	Yes [6]	Activates NDR/LATS kinases; stimulates autophosphorylation [6]	Co-IP with NDR1/2 and LATS1/2; kinase activation assays [6] [8]
MOB2	Yes [6]	No [6]	Competes with MOB1; inhibits NDR kinase activity [6]	Competitive Co-IP; RNAi depletion increases NDR activity [6]
MOB3A/B/C	No [6]	No [6]	No kinase activation detected [6]	Comprehensive binding assays with all human NDR/LATS kinases [6]
MOB4	Not determined	Not determined	STRIPAK complex component [1]	Proximity labeling recalls STRIPAK components [1]

The following table presents quantitative data from a systematic BioID proximity labeling study that revealed the interaction landscape across the human MOB family:

Table 2: MOB Protein Interactome Profiling by Proximity Labeling (BioID)

MOB Protein	Total Interactions Identified	Previously Known Interactions	Novel Interactions	Key Novel Finding
All MOBs Combined	>200 [1]	62 (27%) [1]	>70% unreported [1]	Expanded interaction landscape beyond kinases
MOB1A/B	Not specified	48 interactions [1]	Not specified	Recalled core Hippo components (LATS1/2, MST1/2) [1]
MOB3 Subfamily	Not specified	0 interactions [1]	Multiple novel interactions [1]	MOB3C specifically associates with RNase P complex [1]
MOB4	Not specified	12 interactions [1]	Not specified	Recalled STRIPAK complex components [1]

Detailed Co-IP Protocol for MOB-NDR Interaction Studies

Reagent Preparation

• Lysis Buffer Optimization: For MOB-NDR interactions, use a mild non-denaturing lysis buffer. One effective formulation includes: 10 mM HEPES (pH 7.4), 10 mM KCl, 50 mM NaCl, 1 mM MgClâ‚‚, and 0.05% Nonidet P-40 [13]. Always supplement with fresh protease and phosphatase inhibitors immediately before use. The choice of lysis buffer is critical for preserving labile protein complexes [21].

• Antibody Selection and Validation: For endogenous Co-IP, select antibodies that recognize native MOB or NDR proteins without disrupting interaction interfaces. Validate antibodies using knockdown/knockout controls [33]. For tagged approaches, FLAG-, Myc-, HA-, or GFP-tagged MOB constructs can be employed with corresponding tag antibodies [21].

• Bead Preparation: Couple specific antibodies to magnetic beads (e.g., Dynabeads) according to manufacturer protocols [13]. Always include parallel preparations with isotype control antibodies for negative controls.

Step-by-Step Protocol

• Cell Lysis and Sample Preparation:

  • Grow HEK293 or HeLa cells to 80% confluency (approximately 2.5 mg total protein needed per Co-IP sample) [13].
  • Lyse cells in ice-cold optimized lysis buffer with gentle agitation for 30 minutes on ice.
  • Clear lysates by centrifugation at 13,000 × g for 15 minutes at 4°C.
  • Reserve 1-10% of supernatant as input control [33] [21].

• Pre-clearing (Optional):

  • Incubate lysate with bare beads or isotype-control beads for 30-60 minutes at 4°C.
  • Collect supernatant while leaving beads behind.

• Immunoprecipitation:

  • Incubate lysate with antibody-coupled beads for 2-4 hours or overnight at 4°C with gentle rotation.
  • For MOB-NDR studies, include these essential controls in parallel: bead-only control, isotype control, and knockdown control if available [33].

• Washing:

  • Pellet beads magnetically or by gentle centrifugation.
  • Wash 3-5 times with appropriate wash buffer (e.g., 10 mM HEPES pH 7.4, 10 mM KCl, 0.07% Nonidet P-40) [13].
  • Retain supernatant from first wash for troubleshooting if needed [33].

• Elution:

  • Elute bound complexes using SDS sample buffer (for WB analysis) or acidic elution buffer (e.g., 0.5 M NHâ‚„OH, 0.5 mM EDTA) for functional assays [13] [34].
  • For mass spectrometry analysis, consider on-bead digestion as an alternative to elution [13].

• Analysis:

  • Analyze input and IP samples by SDS-PAGE followed by Western blotting with antibodies against MOB and NDR proteins.
  • For unknown interaction partners, use mass spectrometry-based identification [1] [13].
  • Perform semi-quantitative immunoblot densitometry to statistically assess interaction strengths under different conditions [35].

Research Reagent Solutions

The following table catalogues essential reagents and their specific applications in MOB-NDR interaction studies:

Table 3: Essential Research Reagents for MOB-NDR Co-IP Studies

Reagent Category	Specific Examples	Application in MOB-NDR Research	Technical Considerations
Cell Lines	HEK293, HeLa Flp-In T-REx [1]	Inducible expression of tagged MOB proteins; interaction studies	Maintain consistent confluence (80%) for reproducible lysis [13]
Lysis Buffers	HEPES-based with 0.05-0.07% Nonidet P-40 [13]	Extract MOB-NDR complexes while preserving interactions	Avoid harsh denaturants; include fresh protease/phosphatase inhibitors
Bead Systems	Dynabeads [13]	Antibody immobilization for immunoprecipitation	Covalent coupling minimizes antibody leaching; use magnetic separation
Protease Inhibitors	Commercial cocktail (e.g., Sigma-Aldrich P8340) [13]	Prevent protein degradation during extraction	Add fresh before lysis; compatible with downstream MS analysis
Phosphatase Inhibitors	Commercial cocktail (e.g., Fisher Scientific A32957) [13]	Preserve phosphorylation status of NDR/LATS kinases	Critical for detecting activation-specific phosphorylation events
Tag Systems	GFP-Trap [34], FLAG, Myc [21]	Precipitation of tagged MOB proteins	GFP-Trap uses nanobodies for high-affinity capture; validate tag doesn't alter function
Antibody Validation	Knockout controls [33]	Confirm antibody specificity for MOB proteins	Use MOB-knockout cells when available for definitive specificity testing
Elution Buffers	SDS sample buffer, acidic elution (0.5 M NHâ‚„OH) [13] [34]	Release complexes from beads	SDS buffer denatures for WB; mild elution preserves complex integrity for functional assays

Troubleshooting and Optimization

Common Challenges in MOB-NDR Co-IP

• Weak or Transient Interactions: MOB-NDR interactions can be transient and regulated by phosphorylation status [6]. If detecting weak interactions, consider crosslinking prior to lysis or using proximity labeling techniques like BioID, which successfully captured MOB interactions in recent studies [1].

• Non-specific Binding: High background signals often result from inadequate washing or antibody concentration issues. Optimize wash stringency by adjusting salt concentration (50-150 mM NaCl) and detergent concentration (0.05-0.1% NP-40). The bead-only and isotype controls are essential for diagnosing this issue [33].

• Antibody Interference: The capture antibody might bind near the MOB-NDR interaction interface, disrupting complex formation. Test multiple antibodies recognizing different epitopes, or employ tagged versions where the tag is positioned on the opposite side from the predicted interaction surface [21].

Advanced Methodological Extensions

• Quantitative Multiplex Co-IP (QMI): This flow cytometry-based approach enables simultaneous assessment of multiple protein interactions in small sample volumes, detecting fold changes in native protein-protein interactions without genetic engineering [36]. QMI could quantitatively compare MOB family member interactions with NDR/LATS kinases under different cellular conditions.

• Proximity Labeling (BioID): As employed in recent MOB interactome studies, BioID uses a promiscuous biotin ligase fused to bait proteins to label proximate proteins, capturing transient interactions in live cells [1]. This approach revealed previously unknown associations like MOB3C with the RNase P complex.

• Semi-quantitative Immunoblot Densitometry: Implement standardized imaging and densitometry protocols to quantitatively compare interaction strengths under different experimental conditions, moving beyond simple presence/absence assessments [35].

Rigorous experimental controls transform Co-IP from a simple pull-down assay into a powerful tool for deciphering the complex interaction networks governing MOB-NDR/LATS signaling. The essential controls outlined in this protocol - including positive controls (input, known interactions), negative controls (bead-only, isotype, knockout), and confirmatory controls (bidirectional Co-IP) - provide the necessary framework for distinguishing specific physiological interactions from experimental artifacts. As the MOB protein family continues to reveal unexpected biological roles beyond the canonical Hippo pathway, these controlled interaction studies will remain fundamental to understanding their diverse functions in cell regulation, signaling, and connections to RNA biology. The integration of traditional Co-IP with emerging techniques like proximity labeling and quantitative multiplex approaches promises to further illuminate the complex interactome of this crucial protein family.

Adapting Protocols for Different MOB-NDR Pairs and Cellular Contexts

The monopolar spindle-one-binder (MOB) proteins and nuclear Dbf2-related (NDR) kinases form evolutionarily conserved signaling hubs that regulate crucial cellular processes including cell cycle progression, morphogenesis, polarity, and tissue growth [15]. In humans, seven MOB proteins (MOB1A/B, MOB2, MOB3A/B/C, and MOB4) interact with NDR kinases (NDR1/2 and LATS1/2) through specific pairings to control distinct biological pathways [1] [15]. The Hippo pathway, a key regulator of tissue homeostasis and organ size, represents the most characterized MOB-NDR network, where MOB1 proteins activate LATS kinases to control YAP/TAZ transcriptional co-activators [1] [15].

Understanding the molecular specificity between MOB and NDR family members is essential for elucidating their physiological and pathological roles, particularly in cancer [10] [15]. However, detecting these interactions presents significant technical challenges due to the transient nature of some complexes, differential expression across cellular contexts, and structural similarities among family members. This application note provides adapted co-immunoprecipitation (co-IP) protocols to address these challenges, enabling researchers to accurately capture specific MOB-NDR interactions across diverse experimental systems.

MOB-NDR Interaction Landscape and Biological Significance

Classification and Partner Specificity

MOB proteins function as crucial scaffold proteins that form specific complexes with NDR/LATS kinase family members [15]. These interactions follow conserved patterns across evolutionary models, from yeast to humans, yet exhibit distinct pairing specificities:

• MOB1 primarily interacts with and activates LATS1/2 kinases in the Hippo pathway and can also bind to NDR1/2 kinases [15].
• MOB2 shows specific binding to NDR1/2 kinases (STK38/STK38L in humans) and regulates processes including neuronal remodeling and morphogenesis [1] [37].
• MOB4 functions within the STRIPAK complex and exhibits more complex regulatory relationships with NDR kinases [1].
• MOB3 proteins represent the least characterized subfamily, with recent BioID proximity labeling revealing a unique association between MOB3C and the RNase P complex, suggesting connections to RNA biology beyond traditional NDR kinase signaling [1].

Table 1: MOB-NDR/LATS Kinase Interaction Specificity

MOB Protein	Primary Kinase Partner(s)	Cellular Functions	Conservation
MOB1A/B	LATS1/2, NDR1/2	Hippo pathway, tissue growth control, mitotic exit	High (85% identity to dMOB1)
MOB2	NDR1/2 (STK38/STK38L)	Neuronal remodeling, morphogenesis, polarity	Moderate
MOB3A/B/C	Poorly characterized	Potential RNA processing (MOB3C-RNase P)	Variable
MOB4	STRIPAK complex components	Regulation of phosphorylation signaling	High (80% identity to dMOB4)

Structural Basis of MOB-NDR Interactions

The activation of NDR kinases requires a multi-step process involving MOB protein binding to the N-terminal region (NTR) of the kinase, followed by phosphorylation events [11]. Studies in Neurospora crassa demonstrate that the NDR kinase COT1 physically associates with both MOB2A and MOB2B simultaneously, with this interaction mediated by different residues within the COT1 NTR, suggesting formation of a hetero-trimeric complex [11]. This structural insight highlights the importance of conserving interaction domains when designing bait constructs for co-IP experiments.

Optimized Co-Immunoprecipitation Workflow for Endogenous MOB-NDR Complexes

The following protocol provides a optimized framework for capturing endogenous MOB-NDR interactions, adapted from Lagundžin et al. (2022) [38] [39]. This two-step methodology ensures preservation of native complexes while minimizing non-specific binding:

Critical Protocol Adaptations for MOB-NDR Pairs

Cell Lysis and Buffer Optimization

Lysis buffer composition must preserve interactions while maintaining cellular context:

• Standard Lysis Buffer: 40 mM HEPES (pH 7.4), 120 mM NaCl, 1 mM EDTA, 0.3% CHAPS, 10 mM pyrophosphate, 10 mM glycerophosphate, 50 mM NaF, 1.5 mM sodium vanadate, and EDTA-free protease inhibitors [38].
• Detergent Considerations: CHAPS generally preserves MOB-NDR interactions better than Triton X-100 for transient complexes. For stable complexes (MOB1-LATS), Triton X-100 (0.5-1%) can be used.
• Phosphatase Inhibitors: Essential for preserving phosphorylation-dependent interactions in Hippo signaling [1].
• Sonication vs Mechanical Disruption: Brief sonication (3 × 5 s pulses) improves extraction of nuclear-associated complexes without disrupting interactions.

Antibody Immobilization and Bead Selection

• Dynabeads (Protein A/G) provide superior recovery and lower non-specific binding compared to agarose resins [38] [39].
• Antibody Crosslinking: Use DSS (disuccinimidyl suberate) or equivalent crosslinkers to prevent antibody leaching during prolonged incubations, particularly crucial for low-abundance MOB-NDR pairs.
• Control Antibodies: Species-matched IgG controls must be included for each experimental condition to account for non-specific binding.

Immunoprecipitation and Wash Conditions

• Incubation Duration: 2 hours at 4°C with rotation captures most MOB-NDR complexes without increasing non-specific binding.
• Stringency Washes:
  • Low Stringency (stable complexes): 150 mM NaCl, 0.1% CHAPS, 10 mM HEPES (pH 7.4)
  • Medium Stringency (transient interactions): 300 mM NaCl, 0.1% CHAPS, 10 mM HEPES (pH 7.4)
  • High Stringency (validation): 500 mM NaCl, 0.5% CHAPS, 10 mM HEPES (pH 7.4)

Elution and Downstream Analysis

• Non-Denaturing Elution: Competitive elution with 0.5 mg/mL peptide corresponding to the epitope recognized by the antibody preserves complex integrity for functional assays.
• Denaturing Elution: 2× Laemmli buffer for western blot analysis or mass spectrometry.

Context-Specific Protocol Modifications

Adaptations for Cellular Contexts

Table 2: Cell Line-Specific Protocol Optimization

Cellular Context	Key Considerations	Protocol Modifications	Expected Outcomes
HEK293 & HeLa Cells	High transfection efficiency, endogenous MOB-NDR expression	Standard protocol effective; inducible expression systems recommended for stoichiometry control	Robust detection of MOB1-LATS and MOB2-NDR interactions [1]
Neuronal Cells	Complex morphology, low expression levels	Increased starting material (3-5 mg), gentle lysis without detergents for soma vs processes	Capture of MOB2-NDR complexes in dendrite remodeling [37]
Cancer Cell Lines	Pathway dysregulation, aberrant phosphorylation	Enhanced phosphatase inhibition, hypoxic conditions for solid tumor models	Altered MOB1-LATS interaction dynamics in Hippo-deregulated cancers [10] [15]
Primary Cells	Limited material, sensitive to manipulation	Miniaturized scale (100-200 μg total protein), extended incubation (4h), crosslinking	Preservation of native complex composition in physiological contexts [22]

MOB-NDR Pair-Specific Considerations

MOB1-LATS Complexes (Hippo Pathway)

• Stability: High affinity, stable interactions [1] [15]
• Regulation: Phosphorylation-dependent; MOB1 phosphorylation by MST1/2 enhances LATS binding
• Protocol Modifications:
  • Include phospho-MOB1 (T35) antibodies for immunoprecipitation of active complexes
  • Phosphatase inhibitors are absolutely essential
  • Standard stringency washes (150-300 mM NaCl) sufficient

MOB2-NDR Complexes

• Stability: Moderate affinity, potentially more transient [37]
• Cellular Context: Particularly important in neuronal remodeling and morphogenesis
• Protocol Modifications:
  • Crosslinking (1-3 mM DSS, 30 min, 4°C) before lysis recommended
  • Reduced stringency washes (150 mM NaCl maximum)
  • Co-localization studies essential for functional validation

MOB3 Complexes

• Unique Features: MOB3C associates with RNase P complex rather than traditional NDR kinases [1]
• Protocol Modifications:
  • RNase treatment controls required to distinguish protein-RNA-protein from direct protein-protein interactions
  • Specialized lysis conditions to preserve RNA-protein complexes
  • Pre-tRNA cleavage assays for functional validation of MOB3C-RNase P interactions [1]

MOB4-STRIPAK Complexes

• Complexity: Multi-subunit complexes with regulatory phosphatases and kinases [1]
• Protocol Modifications:
  • Larger pore size gels for high molecular weight complexes
  • Extended wash times to remove non-specifically associated proteins
  • Tandem affinity purification for comprehensive complex characterization

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for MOB-NDR Co-IP

Reagent/Category	Specific Examples	Function/Application	Considerations
Cell Lysis Reagents	CHAPS, NP-40, Triton X-100	Membrane solubilization while preserving protein complexes	CHAPS optimal for transient interactions; concentration critical
Immunoprecipitation Beads	Dynabeads Protein A/G	Antibody immobilization and complex capture	Superior recovery vs. agarose; reduced non-specific binding [38] [39]
Protease Inhibitors	EDTA-free protease inhibitor cocktails	Prevent protein degradation during processing	Essential for preserving complex integrity
Phosphatase Inhibitors	NaF, β-glycerophosphate, sodium vanadate	Preserve phosphorylation status	Critical for Hippo pathway interactions [1]
Crosslinkers	DSS (Disuccinimidyl suberate)	Stabilize transient interactions	Particularly important for MOB2-NDR complexes [40]
Validation Antibodies	Phospho-specific MOB1 (T35), pan-MOB, NDR/LATS	Detection and validation of interaction partners	Species compatibility crucial for co-IP applications
Mass Spectrometry	LC-MS/MS systems	Comprehensive identification of interactors	Requires specialized equipment and expertise [38] [41]
3,4-Diaminoanisole sulfate	3,4-Diaminoanisole sulfate, CAS:1084893-44-6, MF:C7H12N2O5S, MW:236.25 g/mol	Chemical Reagent	Bench Chemicals

Troubleshooting and Quality Control

Common Challenges and Solutions

• High Background/Non-specific Binding: Increase wash stringency progressively; optimize antibody concentration; include additional pre-clearing step.
• Weak or No Signal: Verify antibody specificity for endogenous proteins; check protein degradation; consider crosslinking for transient interactions.
• Inconsistent Results Between Replicates: Standardize cell culture conditions; ensure consistent lysis timing and procedure; use freshly prepared inhibitors.

Essential Controls and Validation

• Negative Controls: Species-matched non-specific IgG; beads alone; bait knockout/knockdown cells.
• Positive Controls: Known interactors for each MOB-NDR pair (e.g., LATS1 for MOB1).
• Validation Methods: Reciprocal co-IP; proximity ligation assays; functional validation (e.g., kinase assays).

The adapted co-immunoprecipitation protocols presented here provide a robust framework for investigating specific MOB-NDR interactions across diverse cellular contexts. By understanding the unique biochemical properties of each MOB-NDR pair and implementing appropriate technical adjustments, researchers can overcome the challenges associated with capturing these biologically critical complexes. These optimized methods will facilitate deeper investigation into MOB-NDR signaling networks, accelerating both basic mechanistic understanding and drug discovery efforts targeting these pathways in cancer and other diseases.

Solving Common Co-IP Challenges in MOB-NDR Interaction Studies

The detection of protein-protein interactions (PPIs) via co-immunoprecipitation (co-IP) is a cornerstone of molecular biology, particularly in the study of signaling pathways such as the MOB-NDR network, which is crucial for cell cycle regulation, growth control, and Hippo pathway signaling [15]. A frequent and critical point of failure in these assays is the "no pulldown" result, often stemming from low solubility of the bait protein or suboptimal bait design. This directly hinders the isolation and analysis of protein complexes [35]. This Application Note provides a structured, experimental framework to overcome these challenges, ensuring reliable detection of MOB-NDR interactions.

Understanding MOB Proteins and NDR Kinases

The Monopolar spindle-one-binder (MOB) family comprises small, evolutionarily conserved adapter proteins that function as crucial regulators of NDR (Nuclear Dbf2-related) kinases [1] [15]. In humans, there are seven MOB proteins (MOB1A, MOB1B, MOB2, MOB3A, MOB3B, MOB3C, and MOB4), which are subdivided into four subfamilies. They lack enzymatic activity and instead act as scaffold proteins to mediate the assembly and regulation of protein complexes [1].

A primary function of MOB proteins, particularly MOB1A/B, is their role as co-activators of NDR/LATS kinases within the Hippo pathway, a key regulator of tissue homeostasis and organ size [1] [15]. Disruptions in these interactions are linked to cancer and other diseases. The following diagram illustrates the core signaling relationships and experimental context of the MOB-NDR network.

Addressing Protein Solubility Challenges

Poor solubility of recombinant bait proteins leads to aggregation and precipitation, resulting in failed pulldown experiments. Solubility is a key indicator of proper protein folding, and enhancements often correlate with improved activity [42]. The following table summarizes the effectiveness of various solubility enhancement techniques.

Table 1: Strategies for Improving Protein Solubility and Activity

Method	Mechanism	Typical Improvement	Key Considerations
Negatively-Charged Peptide Tags [42]	Increases surface charge, enhancing interaction with solvent.	Solubility: >100% increase. Activity: Up to 250% [42].	Tag size and placement (N- vs. C-terminal) are critical to avoid functional interference.
Machine Learning-Guided Tag Design [42]	Uses Support Vector Regression (SVR) models to predict solubility from sequence and optimize tag composition in silico.	Substantial increase in success rate for experimental validation [42].	Requires a dataset for model training; effective for designing short, optimized tags.
Chaperone Co-expression [42]	Assists in proper folding of the target protein in vivo, reducing aggregation.	Varies by protein; can significantly improve soluble yield.	Requires screening of different chaperone systems; can increase metabolic burden on host.
Culture Condition Optimization [42]	Modulates temperature, inducer concentration, and media to favor soluble expression.	A foundational step; improvements are protein-specific.	Often used in combination with other methods; requires empirical testing.

Protocol: Machine Learning-Optimized Solubility Enhancement

This protocol uses a support vector regression (SVR) model to design short, negatively-charged peptide tags that enhance the solubility of bait proteins like MOB isoforms [42].

Workflow Overview

Procedure

• Data Pre-processing: Input the amino acid sequence of your bait protein (e.g., MOB3C). Calculate its amino acid composition, converting the sequence into numerical descriptors [42].
• Model Application: Use a pre-trained SVR model to predict the baseline solubility of your bait protein.
• In Silico Tag Optimization:
  • A genetic algorithm is employed to generate a population of potential short peptide tags (e.g., 6-12 amino acids) [42].
  • The algorithm iteratively:
    • Mutates: Introduces random changes to the tag sequences.
    • Evaluates: Uses the SVR model to predict the solubility of the bait protein fused with each new tag.
    • Selects: Keeps the tag sequences that yield the highest predicted solubility for the next generation.
• Output: The process yields a list of top-performing peptide tag sequences predicted to maximize solubility.
• Experimental Validation:
  • Cloning: Fuse the coding sequences of the top candidate tags to your bait protein gene (N- or C-terminal).
  • Expression: Express the tagged and untagged proteins in your host system (e.g., E. coli or HEK293 cells).
  • Solubility Assay: Lyse cells and separate soluble and insoluble fractions via centrifugation. Analyze fractions by SDS-PAGE and densitometry to quantify the solubility ratio (soluble protein / total protein) [42].
  • Activity Check: Perform a functional assay (e.g., kinase activation assay for MOB-NDR) to confirm that the tag does not disrupt protein function.

Optimizing Bait Protein and Experimental Design

Beyond solubility, the strategic design of the bait protein itself is paramount for a successful co-IP. Proximity-dependent biotin identification (BioID) studies have revealed that different MOB family members have distinct interaction profiles, underscoring the need for careful bait selection [1].

Protocol: Computational Bait Set Optimization with GENBAIT

For large-scale or repeated studies, a computational approach can identify a minimal set of optimal bait proteins that maximally represent the full interactome, saving time and resources [43].

Procedure

• Input Reference Data: Use an existing large-scale BioID or co-IP dataset for MOB-NDR proteins as a reference (e.g., from databases like BioGrid or recent literature [1]).
• Define Subset Size: Determine the desired number of baits for your targeted study (e.g., one-third of the original set) [43].
• Run GENBAIT Algorithm:
  • Initialization: Generate random subsets of baits of the defined size.
  • Fitness Evaluation: For each subset, perform Non-negative Matrix Factorization (NMF) and calculate a fitness score by comparing the component correlation to the full dataset.
  • Evolution: Apply genetic algorithm operations (crossover, mutation) to create new, "evolved" bait subsets from the best-performing ones [43].
  • Iteration: Repeat the evaluation and evolution steps over multiple generations until the fitness score converges on an optimal solution.
• Output: GENBAIT provides an optimized, minimal bait set predicted to retain high coverage of the original network.

Table 2: Key Research Reagent Solutions

Reagent / Material	Function in Protocol	Example & Notes
BirA* Biotin Ligase [1]	Proximity-dependent labeling of proteins interacting with the bait in BioID.	Used as a fusion protein (e.g., BirA*-FLAG-MOB1) to identify novel interactors.
Streptavidin Beads [1]	Affinity purification of biotinylated proteins in BioID or pull-down assays.	High binding capacity and specificity for biotin.
Epitope Tags [35]	Enables immunoprecipitation and detection of recombinant bait proteins.	FLAG, HA, Myc. Allows standardized protocols regardless of the bait protein.
Support Vector Regression (SVR) Model [42]	Predicts protein solubility from amino acid sequence to guide tag design.	Trained on databases like eSol; requires feature input (e.g., amino acid composition).
Genetic Algorithm (GA) [43]	Solves complex optimization problems, such as selecting bait subsets or peptide tags.	Implemented in tools like GENBAIT for bait selection and in tag optimization workflows.
Non-negative Matrix Factorization (NMF) [43]	Identifies co-localization patterns in proteomic data to define subcellular components.	Used to evaluate how well a bait subset recapitulates the full spatial proteome.

Protocol: A Robust Co-Immunoprecipitation Workflow

This optimized co-IP protocol incorporates semi-quantitative immunoblotting to increase reliability and reproducibility in detecting MOB-NDR interactions [35] [44].

Workflow Overview

Procedure

• Cell Lysis (Day 1):

  • Culture and transfect cells (e.g., HEK293) with your optimized, solubility-enhanced bait plasmid.
  • Lyse cells using a non-denaturing, mild lysis buffer (e.g., containing 1% NP-40 or Triton X-100) to preserve protein complexes. Include protease and phosphatase inhibitors.
  • Critical: Centrifuge the lysate at high speed (e.g., >16,000 × g) to remove insoluble debris. Transfer the soluble supernatant to a new tube [35].

• Immunoprecipitation (Day 2):

  • Pre-clear the lysate by incubating with control beads (e.g., Protein A/G) for 30 minutes.
  • Incubate the pre-cleared lysate with antibody-coated beads specific to your epitope tag (e.g., anti-FLAG M2 affinity gel). Include an isotype control antibody for a negative control IP.
  • Rotate the mixture for 2-4 hours at 4°C.

• Washing and Elution (Day 3):

  • Pellet the beads and wash thoroughly 3-5 times with ice-cold wash buffer.
  • Elute the bound proteins by boiling the beads in 1X Laemmli SDS-PAGE sample buffer.

• Semi-Quantitative Immunoblotting (Day 3-4):

  • Separate the eluted proteins by SDS-PAGE and transfer to a membrane.
  • Probe the membrane with antibodies against your bait (e.g., anti-FLAG) and prey (e.g., anti-NDR1/STK38).
  • Use fluorescent or chemiluminescent secondary antibodies and capture the signal.
  • Quantitative Analysis: Perform densitometry analysis on the bands. Compare the signal intensity of the prey in the bait IP to the control IP and the input lysate to statistically validate the interaction [35] [44].

Successfully mapping MOB-NDR interactions requires a multi-faceted strategy that addresses both protein biochemistry (solubility) and experimental design (bait optimization). By integrating machine learning-guided protein engineering, computational bait selection, and a rigorously quantitative co-IP protocol, researchers can systematically overcome the challenge of "no pulldown." These approaches provide a robust framework for generating high-quality, reproducible data that can deepen our understanding of this critical signaling pathway.

In co-immunoprecipitation (co-IP) research focused on MOB-NDR protein interactions, eliminating background signal caused by non-specific binding to beads is a fundamental prerequisite for obtaining reliable, interpretable data. The MOB family of proteins, particularly the less-characterized members like MOB3C, often have low-abundance or transient interactions that can be completely obscured by high background [1]. Non-specific binding occurs when proteins adhere to the affinity beads or to the affinity reagent (e.g., an antibody or Nanobody) through means other than the specific bait-prey interaction, such as via exposed hydrophobic patches on unfolded proteins [45]. This application note provides detailed, actionable protocols to minimize this background, thereby enhancing the specificity and success of co-IP experiments within the context of MOB-NDR pathway research.

A systematic approach to reducing background begins with understanding its origins. In a typical co-IP workflow, non-specific signal can arise from multiple sources [45] [46]:

• Binding to the Bead Matrix: Proteins in the lysate can interact non-specifically with the chemical surface of the agarose or magnetic beads.
• Binding to the Affinity Reagent: Non-specific proteins may bind to the framework of the antibody or Nanobody used for capture.
• Carryover of Insoluble Material: Incomplete centrifugation can leave insoluble cellular debris in the supernatant, which is then precipitated alongside the beads.
• Protein Aggregation and Degradation: Overly long incubation times can lead to protein unfolding and aggregation, increasing hydrophobic interactions and background levels [45].
• Excessive Input Material: Using too much cell lysate or too much antibody can saturate the system and promote non-specific binding [46].

Optimized Protocols for Background Reduction

Lysate Preparation and Pre-Clearing

Proper sample preparation is the first and most critical step. The goal is to obtain a clarified, soluble protein extract while preserving the native interactions of the MOB protein complexes.

Detailed Pre-Clearing Protocol [45] [14]:

• Lyse cells or tissue using an appropriate, non-denaturing lysis buffer. For MOB proteins, which are often involved in large complexes, a mild NP-40 based buffer (e.g., 150 mM NaCl, 1% NP-40, 50 mM Tris-HCl pH 8.0) is recommended to maintain protein-protein interactions [14]. Always include fresh protease and phosphatase inhibitors.
• Clarify the lysate by centrifugation at 8,000–12,000 x g for 10 minutes at 4°C. Transfer the supernatant to a new tube, carefully avoiding the pellet.
• Pre-clear the lysate to remove proteins that bind non-specifically to the bead matrix.
  • Equilibrate binding control beads (plain beads without coupled antibody) in your lysis buffer.
  • Add the binding control beads to the cell lysate.
  • Rotate end-over-end for 30 minutes at 4°C.
  • Separate the beads from the lysate by centrifugation or magnetic separation.
  • Transfer the pre-cleared lysate to a new tube for the immunoprecipitation step.

Bead Selection and Blocking

The choice of beads and their preparation significantly impacts background.

• Bead Type: Magnetic bead-based kits are increasingly popular due to superior recovery rates and easier, more efficient washing, which directly contributes to lower background [47].
• Blocking: If using unblocked beads, pre-block them by incubating with 1% Bovine Serum Albumin (BSA) in PBS for at least one hour before use. This saturates non-specific binding sites on the beads [46]. Wash the beads 3-4 times in PBS before adding them to the lysate.

Incubation and Stringent Washing

Optimizing the binding and washing conditions is where significant gains in specificity can be made.

• Incubation Time: Keep the incubation of the lysate with the bead-antibody complex to a minimum. The binding reaction is often complete within 30–60 minutes at 4°C. Prolonged incubation increases protein degradation and aggregation, elevating background [45].
• Wash Buffer Optimization: After the IP, perform multiple washes with stringent buffers. The stability of certain affinity systems, like the GFP-Trap, allows for very harsh washing conditions that effectively remove background proteins while retaining the specific bait-prey complex [45]. The table below summarizes compatible buffer ingredients and their maximum effective concentrations.

Table 1: Compatible Wash Buffer Ingredients for Stringent Washing [45]

Buffer Ingredient	Function	Compatible with Agarose Beads	Compatible with Magnetic Particles M-270
NaCl	Disrupts ionic interactions	Up to 2 M	Up to 2 M
Nonidet P40 Substitute	Non-ionic detergent	Up to 2%	Up to 2%
Triton X-100	Non-ionic detergent	Up to 1%	Up to 1%
SDS	Ionic detergent; very stringent	Up to 1%	Up to 0.2%
Urea	Denaturant	Up to 8 M	Up to 8 M
Guanidine HCl	Denaturant	Up to 4 M	Not Tested
DTT	Reducing agent	1 mM	10 mM
TCEP	Reducing agent	0.2 mM	Not Tested

Recommended Wash Protocol for MOB Protein Co-IP:

• Wash 1: Quick wash with standard lysis buffer to remove unbound proteins.
• Wash 2: Wash with lysis buffer containing 0.1% Triton X-100 and 150-500 mM NaCl.
• Wash 3 (Stringent): Wash with a high-salt buffer (e.g., 1 M NaCl in lysis buffer) to disrupt weak, non-specific ionic interactions.
• Final Wash: A final wash with standard lysis buffer or PBS to remove the stringent agents before elution.

Critical Controls for Specificity

Including the right controls is non-negotiable for interpreting your co-IP results correctly, especially when investigating novel interactions in the MOB-NDR axis [21].

• Negative Control IgG: Use a non-specific antibody (same species and isotype) to establish the baseline level of non-specific binding to the antibody itself.
• Beads-Only Control: Perform the co-IP with bare beads (no antibody) to identify proteins that stick to the bead matrix.
• Input Lane: Reserve 1-10% of your pre-cleared lysate as "Input." This confirms the presence of both bait and prey proteins in the starting material [21].
• Knockout/Knockdown Control: If possible, using a cell line where the MOB bait protein is absent or depleted provides the most robust control for antibody specificity.

The Scientist's Toolkit: Essential Reagents for Low-Background Co-IP

Table 2: Key Research Reagent Solutions for Optimized Co-IP

Reagent / Kit	Function	Key Characteristic
GFP-Trap	Affinity resin for GFP-tagged bait proteins	Recombinant nanobody allows for exceptionally harsh washing conditions (e.g., 1% SDS, 8M Urea) [45].
Binding Control Beads	For pre-clearing lysates	Plain beads without coupled antibody to remove proteins that bind non-specifically to the matrix [45].
Magnetic Co-IP Kits	Bead platform for IP	Magnetic beads enable faster separation, better recovery, and reduced background from mechanical handling [47].
Universal Magnetic Co-IP Kit	For standard antibody-based IP	Designed for ease of use and low background with a variety of antibodies.
Nuclear Complex Co-IP Kit	For isolating nuclear protein complexes	Specialized lysis and buffer conditions for challenging nuclear targets like transcription factors.
Protease/Phosphatase Inhibitor Cocktails	To preserve sample integrity	Prevents protein degradation during lysis and incubation, reducing background from protein fragments [14].

For researchers dissecting the intricate interactions within the MOB-NDR signaling network, a clean co-IP with minimal background is not merely a technical goal—it is a scientific necessity. By systematically implementing the strategies outlined here—pre-clearing, optimizing wash stringency, controlling incubation times, and employing rigorous controls—the confounding effects of non-specific binding can be substantially mitigated. This enables the confident detection of true interacting partners, paving the way for novel discoveries in the biology of MOB proteins and their roles in cellular homeostasis and disease.

Visualized Workflow and Pathway

The following diagram illustrates the logical workflow for troubleshooting and minimizing non-specific binding in co-immunoprecipitation experiments.

Low-Background Co-IP Workflow

In co-immunoprecipitation (co-IP) research aimed at detecting MOB-NDR protein interactions, maintaining protein integrity is paramount. The MOB (Monopolar spindle-one-binder) family proteins, including MOB1, MOB2, MOB3, and MOB4, function as crucial adaptor proteins that engage in complex interactions with NDR (Nuclear Dbf2-related) kinases and other signaling components [1] [15]. These interactions regulate fundamental cellular processes including the Hippo pathway, tissue growth, cell cycle dynamics, and cytoskeletal organization [1]. Protein degradation during sample preparation can significantly compromise data quality, leading to loss of weak or transient interactions, increased background noise, and false negative results. This application note provides detailed protocols for implementing a two-pronged strategy combining pharmacological protease inhibition with precise temperature control to preserve native protein complexes throughout co-IP workflows.

The Scientist's Toolkit: Research Reagent Solutions

Table 1: Essential reagents for preventing protein degradation in MOB-NDR interaction studies

Reagent Category	Specific Examples	Function & Application Notes
Broad-Spectrum Protease Inhibitor Cocktails	Commercial tablets/ solutions containing AEBSF, Aprotinin, Bestatin, E-64, Leupeptin, Pepstatin A	Provides simultaneous inhibition of serine, cysteine, aspartic, and metalloproteases; ideal for initial lysis steps in co-IP to protect diverse MOB family proteins [48].
Serine Protease Inhibitors	AEBSF (0.2-1.0 mM), Aprotinin (100-200 nM), PMSF (0.1-1.0 mM)	Inhibits trypsin-like serine proteases; AEBSF is preferred over PMSF due to better water solubility and stability [48].
Cysteine Protease Inhibitors	E-64 (1-20 µM)	Irreversibly inhibits cysteine proteases by covalently modifying the active site cysteine; highly specific and soluble [48].
Metalloprotease Inhibitors	EDTA (2-10 mM)	Chelates divalent metal ions (Zn²⁺, Mg²⁺) required for metalloprotease activity; incompatible with metal affinity purification [48].
Aspartic Protease Inhibitors	Pepstatin A (1-20 µM)	Inhibits aspartic proteases like cathepsin D; requires DMSO for solubilization [48].
Temperature Control Systems	Controlled-rate freezers (e.g., RoSS.pFTU), Ultra-low temperature freezers (-75°C to -80°C)	Maintain precise temperature control during protein storage and processing; critical for preserving labile MOB-NDR complexes [49].

Protease Inhibition: Mechanisms and Practical Application

Understanding the Protease Threat

Cell lysis disrupts cellular compartmentalization, releasing endogenous proteases that can rapidly degrade MOB proteins and their interacting partners. MOB proteins are particularly vulnerable as they function as adaptor proteins with extensive protein-protein interaction networks [1] [15]. The effectiveness of protease inhibition depends on matching the inhibitor to the protease classes present in your experimental system.

Table 2: Protease inhibitor properties and usage considerations

Inhibitor	Target Protease Classes	Mechanism of Action	Stock Solution	Working Concentration	Stability & Safety Notes
AEBSF	Serine proteases	Irreversible; covalently modifies active site serine	100 mM in H₂O	0.2-1.0 mM	Stable at -20°C for 3 months; may modify other proteins [48].
Aprotinin	Serine proteases	Reversible; competitive substrate analog	10 mg/mL in H₂O	100-200 nM	Stable at -70°C for 6 months; dissociates at extreme pH [48].
E-64	Cysteine proteases	Irreversible; covalent modification of active site cysteine	1 mM in H₂O	1-20 µM	Stable at -20°C for 6 months; highly specific [48].
EDTA	Metalloproteases	Reversible; chelation of essential metal cofactors	0.5 M (pH 8) in H₂O	2-10 mM	Stable at 20°C for 1 year; strips nickel from purification columns [48].
Leupeptin	Serine, cysteine, and threonine proteases	Reversible; aldehyde inhibitor	10 mM in H₂O	10-100 µM	Stable at 4°C for 1 week; may interfere with Bradford assay [48].
Pepstatin A	Aspartic proteases	Reversible; transition-state analog	1 mM in DMSO	1-20 µM	Stable at -20°C for 6 months; poorly water-soluble [48].
PMSF	Serine proteases	Irreversible; sulfonylation of active site serine	1 M in DMSO or ethanol	0.1-1.0 mM	Unstable in aqueous solutions (half-life ~30-120 min); neurotoxic [48].

Detailed Protocol: Implementation in MOB-NDR co-IP Workflow

Step 1: Lysis Buffer Preparation Prepare fresh lysis buffer appropriate for your MOB protein of interest. For MOB1A/B studies in Hippo pathway research, use RIPA or NP-40 based buffers. Add protease inhibitors immediately before use:

• 1x complete protease inhibitor cocktail (or)
• 0.5 mM AEBSF (serine proteases)
• 10 µM E-64 (cysteine proteases)
• 1 µM Pepstatin A (aspartic proteases)
• 5 mM EDTA (metalloproteases, if not using metal affinity purification)

Note: For MOB3 subfamily studies, particularly MOB3C which associates with the RNase P complex [1], consider adding RNase inhibitors to prevent RNA degradation that might destabilize complexes.

Step 2: Cell Lysis and Extraction

• Harvest HEK293 or HeLa cells (common systems for MOB protein studies [1]) at 70-90% confluency
• Wash cells with ice-cold PBS
• Add chilled lysis buffer with inhibitors (1 mL per 10⁷ cells)
• Incubate on ice for 15-30 minutes with gentle agitation
• Clarify by centrifugation at 14,000 × g for 15 minutes at 4°C
• Proceed immediately to co-IP or flash-freeze supernatants in aliquots

Step 3: Co-Immunoprecipitation

• Pre-clear lysates with protein A/G beads for 30 minutes at 4°C
• Incubate with anti-MOB or anti-NDR antibodies (2-4 µg per 500 µg lysate) for 2 hours at 4°C
• Add protein A/G beads and incubate overnight at 4°C with gentle rotation
• Wash beads 3-4 times with lysis buffer containing reduced protease inhibitors (0.5x concentration)
• Elute with 2x Laemmli buffer for western analysis or mild elution conditions for functional assays

Temperature Control: Principles and Practices

Temperature Effects on Protein Stability

Temperature profoundly influences protein structural integrity, complex stability, and enzymatic activity. Recent advances in structural biology demonstrate that proteins exist as conformational ensembles where temperature directly affects the population of functional states [50]. For MOB-NDR interactions, maintaining physiological temperatures (37°C) during certain steps or strict cold temperatures (4°C) during others is essential for preserving native complexes.

Detailed Protocol: Temperature Management Throughout co-IP

Short-term Processing (Same Day Analysis)

• Maintain samples at 0-4°C throughout processing using pre-chilled equipment and cold rooms
• Use ice baths rather than refrigerated centrifuges alone for better temperature control
• Process samples rapidly to minimize cumulative exposure to proteases

Long-term Storage Considerations Table 3: Protein storage conditions and stability expectations

Storage Temperature	Stability Duration	Recommended Applications	Optimization Strategies
Room Temperature	Hours (not recommended)	Emergency short-term holding only	Add stabilizers (BSA, glycerol); avoid for MOB complexes [49]
4°C	Up to 1 month (diluted proteins)	Frequently used antibodies/ buffers	Use antimicrobial agents (e.g., sodium azide) [49]
-20°C	Up to 1 year	Lysates for western analysis	Add cryoprotectants (20-50% glycerol); store in single-use aliquots [49]
-80°C	Several years	Long-term storage of precious samples	Use controlled-rate freezing; avoid repeated freeze-thaw cycles [49]
Liquid Nitrogen (-196°C)	Indefinite	Irreplaceable samples, biotherapeutics	Best preservation; requires specialized equipment [49]

Freeze-Thaw Best Practices

• Aliquot protein samples to avoid repeated freezing and thawing
• Use controlled-rate freezing when possible (e.g., RoSS.pFTU systems [49])
• Thaw samples rapidly in 37°C water bath, then immediately transfer to ice
• For large volumes, thaw overnight at 4°C with gentle agitation
• Never refreeze samples for sensitive interaction studies

Workflow Integration and Troubleshooting

Integrated Workflow for MOB-NDR Interaction Studies

The following diagram illustrates the complete integrated workflow for preserving MOB-NDR interactions throughout co-immunoprecipitation:

Troubleshooting Common Issues

Problem: Inconsistent MOB-NDR interaction results

• Potential Cause: Protease inhibitor degradation due to improper storage or outdated solutions
• Solution: Prepare fresh inhibitor stocks; verify pH stability requirements; use commercial cocktails for consistency

Problem: Poor MOB3C-RNase P complex recovery [1]

• Potential Cause: RNase contamination degrading RNA components essential for complex stability
• Solution: Add RNase inhibitors to lysis buffer; optimize salt conditions for ribonucleoprotein complexes

Problem: Loss of MOB1 phosphorylation-dependent NDR interactions

• Potential Cause: Phosphatase activity not controlled during processing
• Solution: Add phosphatase inhibitors ( sodium fluoride, beta-glycerophosphate, sodium orthovanadate) to lysis buffer

Problem: Reduced signal in subsequent co-IPs from stored lysates

• Potential Cause: Protein aggregation during freeze-thaw cycles
• Solution: Implement single-use aliquots; add cryoprotectants ( glycerol, sucrose); optimize protein concentration

Successful detection of MOB-NDR protein interactions through co-immunoprecipitation requires vigilant protection against protein degradation throughout the experimental workflow. The combination of appropriate protease inhibitor cocktails tailored to the specific MOB family member under investigation, coupled with stringent temperature control from cell lysis through long-term storage, preserves the native state of these critical signaling complexes. Implementation of these detailed protocols will enhance reproducibility, increase interaction yield, and provide more reliable data for understanding the complex roles of MOB proteins in cellular regulation and disease pathways.

The study of monopolar spindle-one-binder (MOB) proteins and their interactions with nuclear Dbf2-related (NDR) kinases is fundamental to understanding highly conserved signaling pathways, such as the Hippo pathway, which control crucial cellular processes including cell proliferation, morphogenesis, and tissue homeostasis [1] [15]. MOB proteins function primarily as scaffold or adaptor proteins, mediating their biological roles through the assembly of specific protein complexes [1]. A significant challenge in this field is the accurate detection and characterization of these interactions, which are often weak or transient in nature. These elusive binding characteristics have impeded a comprehensive understanding of the full functional scope of MOB proteins, particularly the less-characterized members like the MOB3 subfamily [1].

Traditional co-immunoprecipitation (co-IP) methods often rely on stable, high-affinity interactions that can withstand stringent lysis and washing conditions. Consequently, they frequently fail to capture the dynamic and temporary associations that are a hallmark of many MOB-NDR complexes and their associated regulatory networks. This application note details robust methodological strategies, centered on chemical crosslinking and the use of mild buffer systems, to overcome these limitations. By stabilizing these fleeting interactions, researchers can achieve a more accurate and complete picture of the MOB protein interactome, thereby advancing our knowledge of their role in health and disease.

Key Methodological Strategies

Chemical Crosslinking Strategies

Chemical crosslinking creates covalent bonds between interacting proteins or proteins in close proximity, effectively "freezing" the interaction at a specific moment and allowing for subsequent analysis under denaturing conditions.

On-Bead Crosslinking Immunoprecipitation-MS (xIP-MS)

The xIP-MS protocol is a powerful technique that combines a single affinity purification step with on-bead crosslinking, enabling the structural probing of protein complexes from small volumes of mammalian whole cell lysates [51].

Detailed xIP-MS Protocol [51]:

• Cell Lysis: Resuspend cell pellets (e.g., HeLa Kyoto cells expressing GFP-tagged bait) in five pellet volumes of lysis buffer (e.g., 150 mM NaCl, 50 mM Tris pH 8.0, 1 mM EDTA, 20% glycerol) supplemented with 1% Nonidet P-40, 1 mM DTT, and EDTA-free protease inhibitors. Rotate the lysate at 4°C for two hours, then centrifuge at 4,000 rcf for 30 minutes. Collect the supernatant (typical protein concentration: ~10 mg/mL).
• Affinity Purification: Pre-wash 30 µL of GFP-binding bead slurry three times with a suitable buffer (e.g., Buffer C: 300 mM NaCl, 20 mM HEPES pH 7.9, 20% glycerol, 2 mM MgCl2, 0.2 mM EDTA, supplemented with 1% Nonidet P-40, 0.5 mM DTT, and protease inhibitors). Incubate 1 mL of whole cell lysate (~10 mg total protein) with the pre-washed beads for one hour at 4°C on a rotating wheel.
• High-Stringency Washes: Wash the beads twice with a high-salt buffer (e.g., Buffer C with NaCl increased to 1 M, plus 1% Nonidet P-40, 0.5 mM DTT, and protease inhibitors) to remove non-specifically bound proteins. Perform subsequent washes with PBS supplemented with 1% Nonidet P-40, and finally with PBS alone. Carefully remove all supernatant.
• On-Bead Crosslinking: Resuspend the beads in 50 mM borate-buffered saline containing 1 mM bis(sulfosuccinimidyl)suberate (BS3). Incubate the crosslinking reaction for 1 hour at room temperature with shaking at 1000 rpm.
• Quenching: Quench the reaction by adding 100 mM ammonium bicarbonate and incubating for 10 minutes at room temperature with shaking.
• Sample Preparation for MS: Denature and reduce the cross-linked proteins directly on the beads using elution buffer (2 M urea, 100 mM ammonium bicarbonate, 10 mM DTT). Alkylate with 50 mM iodoacetamide, and digest with 0.25 µg of trypsin overnight at room temperature. Acidify the digested peptides prior to LC-MS/MS analysis.

Table 1: Common Crosslinkers for Protein Interaction Studies

Crosslinker	Type	Spacer Arm Length	Key Features & Applications
BS3 (bis(sulfosuccinimidyl)suberate)	Homobifunctional, NHS-ester	11.4 Ã…	Membrane permeable; targets primary amines (lysine); widely used for in-situ crosslinking [51].
DSS (disuccinimidyl suberate)	Homobifunctional, NHS-ester	11.4 Ã…	Membrane permeable; analogous to BS3 but water-insoluble.
Formaldehyde	Homobifunctional	~2 Ã…	Small and reversible; rapidly penetrates cells; effective for capturing very transient interactions.
DSG (disuccinimidyl glutarate)	Homobifunctional, NHS-ester	7.7 Ã…	Shorter spacer arm than BS3; useful for mapping closer proximity interactions.

Proximity-Dependent Biotin Identification (BioID)

BioID is an alternative proximity-labeling technique that uses a promiscuous biotin ligase (BirA) fused to a bait protein. In the presence of biotin, BirA biotinylates proximate proteins (~10 nm radius), which can then be captured with streptavidin beads under fully denaturing conditions after a labeling period, capturing transient interactions in the native cellular environment [1].

Key Workflow Steps for BioID [1]:

• Generate stable, inducible cell lines (e.g., HEK293 or HeLa Flp-In T-REx) expressing BirA*-FLAG-tagged MOB proteins.
• Induce bait expression and incubate with biotin for a defined period (typically 18-24 hours) to allow labeling.
• Lyse cells and capture biotinylated proteins with streptavidin-conjugated beads under stringent conditions.
• Process captured proteins for identification by mass spectrometry.

Mild Buffer Strategies

The composition of lysis and immunoprecipitation buffers is critical for preserving weak interactions that might be disrupted by high ionic strength or harsh detergents.

Principles of Mild Buffer Formulation:

• Reduced Ionic Strength: Use lower NaCl concentrations (e.g., 150 mM) to maintain electrostatic interactions while minimizing non-specific binding [51].
• Non-Denaturing Detergents: Employ mild, non-ionic detergents like Nonidet P-40 (NP-40) at concentrations of 0.1-1% to solubilize membranes without denaturing protein complexes [51].
• Stabilizing Additives: Include glycerol (e.g., 20%) to stabilize protein interactions and protease/phosphatase inhibitor cocktails to prevent post-lysis degradation [51].
• Physiological pH: Maintain a pH between 7.4 and 8.0 using buffers like Tris or HEPES to mimic the intracellular environment [51].

Table 2: Key Research Reagent Solutions for MOB-NDR Interaction Studies

Research Reagent	Function/Application in MOB-NDR Research
BS3 Crosslinker	Stabilizes weak, transient MOB-NDR complexes prior to lysis and IP, enabling their capture for MS analysis [51].
GFP-Trap Beads	Single-step, high-affinity affinity resin for purifying GFP-tagged MOB or NDR baits from whole cell lysates under mild or stringent conditions [51].
BirA* (R118G mutant)	Engineered biotin ligase used in BioID; fused to MOB proteins to label proximate interacting partners like NDR kinases with biotin [1].
Streptavidin Beads	High-affinity resin for capturing biotinylated proteins in BioID experiments; allows for stringent washing to reduce background [1].
Protease Inhibitor Cocktails	Essential for preventing proteolytic degradation of MOB and NDR proteins during cell lysis and immunoprecipitation [51].
Nonidet P-40 Alternative	Mild, non-ionic detergent for solubilizing membranes and extracting protein complexes without disrupting weak protein-protein interactions [51].

Application in MOB-NDR Research: A Case Study

A 2023 study systematically mapped the interactome of all seven human MOB proteins using the BioID approach in HEK293 and HeLa cells [1]. This work highlights the success of proximity-labeling in overcoming traditional co-IP limitations.

The study uncovered over 200 proximal interactions, more than 70% of which were previously unreported in the BioGrid database [1]. It successfully recalled the well-established, stable interactions, such as MOB1A/B with core Hippo pathway components (LATS1/2, MST1/2) and MOB4 with the STRIPAK complex [1]. More importantly, it revealed novel and specific interactions for the poorly characterized MOB3 subfamily. A key finding was the unique association between MOB3C and seven out of ten protein subunits of the RNase P complex, an interaction that was subsequently validated using affinity purification–mass spectrometry and functional pre-tRNA cleavage assays [1]. This discovery, which would have been challenging with conventional co-IP alone, links MOB3C to RNA biology and reveals a function entirely distinct from other MOB family members.

Experimental Workflow and Pathway Diagrams

Experimental Workflow for Crosslinking co-IP (xIP-MS)

The following diagram outlines the key steps in the xIP-MS protocol for capturing and identifying weak or transient MOB-NDR interactions.

Diagram 1: xIP-MS Workflow for MOB-NDR Interactions

MOB-NDR Kinase Interactions in Hippo Signaling

This diagram contextualizes the MOB-NDR kinase relationships within the broader Hippo signaling pathway, illustrating the key complexes that crosslinking strategies aim to capture.

Diagram 2: MOB Protein Complexes in Cellular Signaling

In co-immunoprecipitation (Co-IP) research focused on MOB-NDR protein interactions, Western blotting remains an indispensable technique for validating protein complexes. However, the detection phase is frequently compromised by two persistent challenges: IgG interference and epitope masking. These issues are particularly problematic in Co-IP experiments where the presence of immunoprecipitation antibodies can obscure target protein signals or reduce assay sensitivity. Effectively addressing these challenges is crucial for obtaining reliable data, especially when working with low-abundance protein complexes or expensive antibody reagents. This application note provides detailed protocols and strategic approaches to optimize detection specificity and sensitivity in Western blot assays, with specific application to MOB-NDR interaction studies.

Core Challenges in Western Blot Detection

IgG Interference

IgG interference occurs when detection antibodies nonspecifically bind to the heavy (~50 kDa) and light (~25 kDa) chains of the antibodies used for immunoprecipitation, which co-migrate with the target proteins on the blot. This phenomenon is especially problematic when the target protein's molecular weight is similar to that of IgG chains, a common scenario when studying MOB proteins (typically 25-35 kDa) and NDR kinases (45-55 kDa). The interference manifests as prominent bands at ~50 kDa and ~25 kDa that can mask or be mistaken for true target signals, compromising data interpretation.

Epitope Masking

Epitope masking refers to the inaccessibility of antibody epitopes on the target protein due to protein-protein interactions, complex tertiary structures, or inefficient transfer and denaturation. In the context of MOB-NDR complexes, the conformational changes upon binding may shield critical epitopes, while inefficient transfer or renaturation during blotting can further reduce antibody accessibility. This results in diminished target signal despite successful protein transfer and presence.

Strategic Approaches and Quantitative Comparison

The table below summarizes the primary strategies for addressing these challenges, along with their key advantages and limitations.

Table 1: Comparison of Western Blot Troubleshooting Strategies

Strategy	Primary Mechanism	Advantages	Limitations
Cross-Adsorbed Secondary Antibodies	Minimal recognition of IgG from other species	Reduces background from IP antibodies; no additional steps	Higher cost; may not eliminate all interference
Blocking Buffer Optimization [52]	Occupies nonspecific binding sites on membrane	Improves signal-to-noise ratio; multiple formulations available	Requires empirical testing for each antibody pair
Immunizing Peptide Blocking [53]	Competitively inhibits specific antibody binding	Confirms antibody specificity; definitive validation	Requires specific blocking peptides; additional controls needed
Sheet Protector Method [54]	Minimizes antibody volume while maintaining distribution	Reduces antibody consumption 50-100 fold; faster incubation	Requires optimization of antibody concentration

The selection of an appropriate blocking buffer is system-dependent and significantly impacts the signal-to-noise ratio. The following table compares the performance characteristics of common blocking agents for chemiluminescent Western blotting:

Table 2: Performance Comparison of Blocking Buffers for Chemiluminescent Detection [52]

Blocking Buffer	Sensitivity	Background	Compatibility Notes
2-5% Non-fat Milk	Moderate	Low	Contains biotin and phosphoproteins; may mask some antigens
2-3% BSA	High	Moderate	Preferred for phosphoprotein detection and biotin-streptavidin systems
Purified Casein	High	Low	Ideal when milk blocks antigen-antibody binding
Specialty Commercial Blockers	Variable	Low	Formulation-dependent; often optimized for specific applications

Detailed Experimental Protocols

This innovative protocol utilizes common stationery sheet protectors to distribute minimal antibody volumes over the membrane surface, significantly reducing reagent consumption and incubation time while maintaining detection sensitivity.

Materials and Reagents

• Nitrocellulose or PVDF membrane with transferred proteins
• Primary antibody at working concentration
• HRP-conjugated secondary antibody
• Sheet protector (transparent, standard office quality)
• TBST washing buffer: 10 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.6
• Blocking buffer (5% skim milk or 3% BSA in TBST)
• Chemiluminescent substrate
• Paper towels

Procedure

• Post-Transfer Processing: Following protein transfer, confirm transfer efficiency using Ponceau S staining. Wash membrane three times with TBST for 5 minutes each at 200 RPM.

• Blocking: Incubate membrane in appropriate blocking buffer for 1 hour with gentle rocking at room temperature.

• Membrane Preparation: Briefly immerse the blocked membrane in TBST to remove excess blocking buffer. Thoroughly blot residual moisture using paper towels to achieve a semi-dried state.

• Antibody Application:

  • Place the membrane on a cropped sheet protector leaflet.
  • Apply the primary antibody working solution at a volume of 20-150 µL, depending on membrane size. For a standard mini-gel membrane (4.5 cm), use approximately 20 µL.
  • Gently overlay with the upper leaflet of the sheet protector, allowing the antibody solution to disperse as a thin layer by surface tension.

• Incubation:

  • For incubations ≤2 hours: Maintain at room temperature without agitation.
  • For extended incubations (>2 hours): Place the sheet protector unit on a wet paper towel and seal inside a zipper bag to prevent evaporation.

• Post-Incubation Processing: Remove membrane from sheet protector and wash three times with TBST for 5 minutes each with agitation.

• Secondary Antibody Detection: Incubate with HRP-conjugated secondary antibody in container for 1 hour with gentle agitation. Proceed with standard chemiluminescent detection.

Optimization Notes

• Antibody concentration may require increase (typically 1.5-2×) compared to conventional method to compensate for lack of bulk reservoir.
• The required antibody volume can be calculated based on membrane size: for a 4.5 cm-long NC membrane, estimate 20-150 µL depending on the number of lanes.
• This method enables antibody incubation at room temperature without agitation, reducing total procedure time from overnight to just 2-3 hours.

This protocol validates antibody specificity through competitive inhibition using the immunizing peptide, essential for confirming target identity in MOB-NDR complexes.

Materials and Reagents

• Primary antibody
• Immunizing (blocking) peptide corresponding to the antibody epitope
• Blocking buffer (TBST with 5% non-fat dry milk or 3% BSA)
• Identical membrane strips or sections with transferred proteins

Procedure

• Antibody Preparation:

  • Dilute the primary antibody to the optimal working concentration in blocking buffer, preparing sufficient volume for two identical samples.
  • Divide the antibody solution equally into two tubes labeled "Blocked" and "Control."

• Peptide Blocking:

  • Add a 5× excess (by weight) of immunizing peptide to the "Blocked" tube. For example, if using 1 µg of antibody, add 5 µg of peptide.
  • Add an equivalent volume of buffer only to the "Control" tube.

• Pre-incubation:

  • Incubate both tubes with agitation for 30 minutes at room temperature or overnight at 4°C.

• Detection:

  • Apply the blocked antibody to one membrane strip and the control antibody to the identical strip.
  • Proceed with standard washing, secondary antibody incubation, and detection steps.

• Interpretation:

  • Specific binding is indicated by the disappearance of bands in the "Blocked" sample compared to the "Control."
  • Multiple disappearing bands may indicate antigen fragments or complexes sharing the same epitope.

Protocol 3: Buffer Optimization for Reduced IgG Interference

Materials and Reagents

• Cross-adsorbed secondary antibodies (species-specific)
• Alternative blocking buffers (see Table 2)
• High-stringency wash buffer: TBST with 250-500 mM NaCl

Procedure

• Blocking Buffer Selection:

  • Test multiple blocking buffers (BSA, milk, casein, commercial specialty blockers) to identify the optimal formulation for your specific antibody pair.
  • For phosphoprotein detection or biotin-streptavidin systems, prefer BSA-based blockers [52].
  • For general applications with high background, test casein or specialty commercial blockers.

• Cross-Adsorbed Secondary Antibodies:

  • Use secondary antibodies that have been cross-adsorbed against the species of your IP antibody to minimize recognition.
  • Increase secondary antibody dilution (1:5000 to 1:10000) to reduce nonspecific binding while maintaining signal.

• High-Stringency Washes:

  • Incorporate one or two washes with high-salt TBST (350-500 mM NaCl) after secondary antibody incubation.
  • Follow with standard TBST washes to remove residual salt before detection.

Visualizing Key Concepts and Workflows

Epitope Masking and Blocking Strategies

Sheet Protector Method Workflow

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagents for Optimizing Western Blot Detection

Reagent/Category	Function/Purpose	Application Notes
Cross-Adsorbed Secondary Antibodies	Minimal recognition of immunoprecipitation antibody reduces background	Essential when target MW overlaps with IgG heavy/light chains
Sheet Protectors (Office Quality) [54]	Enables minimal-volume antibody distribution	Reduces antibody consumption 50-100 fold; suitable for rare/expensive antibodies
BSA-Based Blocking Buffers [52]	Reduces nonspecific binding without biotin interference	Preferred for phosphoprotein detection and biotin-streptavidin systems
Casein-Based Blocking Buffers [52]	Single-protein blocker with minimal cross-reactivity	Ideal when traditional milk blockers mask antigens or cause high background
Immunizing Peptides [53]	Validates antibody specificity through competitive inhibition	Critical for confirming band identity in MOB-NDR complexes
High-Stringency Wash Buffers	Removes weakly-bound antibodies without disrupting specific binding	Add 250-500 mM NaCl to standard TBST for reduced background
No-Stain Protein Labeling Reagents [55]	Enables total protein normalization for accurate quantitation	Superior to housekeeping proteins for loading controls

Effective troubleshooting of IgG interference and epitope masking in Western blot detection requires a systematic approach combining appropriate blocking strategies, validated detection reagents, and innovative techniques like the sheet protector method. For MOB-NDR protein interaction studies specifically, implementing these protocols will enhance detection specificity, conserve valuable antibody reagents, and generate publication-quality data that meets current journal standards. The integration of total protein normalization and careful attention to buffer selection further ensures quantitative accuracy in these critical protein complex studies.

Validating MOB-NDR Interactions: Beyond Basic Co-IP

The study of MOB-NDR protein interactions represents a critical area of cellular signaling research, particularly within the Hippo pathway and related networks that regulate cell division, morphogenesis, and apoptosis [56]. MOB proteins act as essential adaptors and allosteric activators for NDR (Nuclear Dbf2-related) kinases, with human cells containing multiple MOB isoforms (MOB1A, MOB1B, MOB2, MOB3A-C) that exhibit distinct binding specificities and functional outcomes [6] [56]. For instance, while hMOB1A robustly activates NDR1/2 kinases, hMOB2 competes for binding and functions as a negative regulator of the same kinases [6]. These precise interaction profiles make rigorous validation methodologies essential for accurate pathway mapping.

Orthogonal validation using both proximity ligation (BioID) and pull-down assays provides a powerful framework for confirming MOB-NDR interactions identified through initial co-immunoprecipitation screens. While co-immunoprecipitation captures stable complexes under physiological conditions, it may miss transient interactions or be susceptible to artifactual associations. Proximity labeling techniques like BioID overcome some of these limitations by capturing both stable and transient interactions within a defined spatial context, while pull-down assays offer controlled in vitro validation of direct binding relationships [57] [58] [59]. Together, these methods form a complementary toolkit for building high-confidence interaction maps within the MOB-NDR signaling axis.

Methodological Principles and Comparative Analysis

Proximity-Dependent Biotin Identification (BioID)

BioID utilizes a promiscuous mutant of the Escherichia coli biotin ligase (BirA*, R118G) fused to a protein of interest (bait) [57] [60]. This fusion protein catalyzes the activation of biotin to biotinoyl-5'-adenylate (bioAMP), which diffuses from the enzyme and covalently attaches to proximate proteins (within ~10 nm) via lysine residues [57] [60] [61]. These biotinylated proteins can then be captured under denaturing conditions using streptavidin beads and identified by mass spectrometry [57]. A key advantage of BioID is its ability to capture weak and transient interactions that occur over the labeling period (typically 15-18 hours), providing a "history" of protein associations [57]. Since its development, enhanced versions have been engineered, including the smaller, more sensitive BioID2, and the rapidly acting TurboID and miniTurbo, which reduce labeling times to approximately 10 minutes [57] [61].

Pull-Down Assays

Pull-down assays are in vitro affinity purification methods designed to detect direct physical interactions between proteins [59] [62]. In this approach, a "bait" protein (e.g., a MOB isoform) is immobilized on a solid support via an affinity tag (e.g., GST, polyhistidine, or biotin). The immobilized bait is then incubated with a source of "prey" proteins (e.g., cell lysates or purified proteins containing NDR kinases) [59]. After washing, specifically bound prey proteins are eluted and detected, typically by immunoblotting or mass spectrometry [59]. Pull-down assays are particularly valuable for confirming suspected direct interactions and for mapping binding domains under controlled conditions, but they may not recapitulate the full complexity of native cellular environments [59].

Comparative Method Characteristics

Table 1: Comparative analysis of BioID and pull-down assays for studying MOB-NDR interactions.

Parameter	BioID/Proximity Labeling	Pull-Down Assays
Interaction Type Detected	Proximal proteins (within ~10 nm); direct, indirect, and transient interactions [57]	Direct and stable protein-protein interactions [59]
Temporal Resolution	Hours (BioID: 15-18h; TurboID: ~10 min) [57] [61]	Minutes to hours (controlled incubation) [59]
Cellular Context	Living cells [57]	Cell-free system [59]
Key Advantage	Captures weak/transient interactions and provides spatial context [57]	Confirms direct binding and allows for precise control of conditions [59]
Primary Limitation	Proximity does not guarantee direct physical interaction [57] [58]	May miss interactions requiring cellular environment or post-translational modifications [59]
Typical Application in MOB-NDR Research	Identifying novel components of MOB-NDR complexes in living cells; mapping microenvironment [57]	Validating direct binding between specific MOB and NDR isoforms; mapping binding domains [6] [12]

Experimental Protocols for MOB-NDR Interaction Studies

BioID Protocol for MOB-NDR Proximity Labeling

A. Fusion Construct Validation

• Clone your MOB protein cDNA (e.g., hMOB1A, hMOB2) into an appropriate BioID vector (e.g., pcDNA3-BioID) to generate an N- or C-terminal fusion with the promiscuous biotin ligase (BirA*) [57].
• Transfect the construct into a relevant cell line (e.g., HEK 293, HeLa, or U2-OS) and validate the fusion protein's expression and correct subcellular localization by immunofluorescence and western blotting using antibodies against the tag or BioID itself [57]. This critical step ensures the fusion protein behaves similarly to the endogenous protein, as proper localization is essential for NDR activation [4].

B. Biotin Labeling and Cell Lysis

• Culture transfected cells in standard medium supplemented with 50 μM biotin for 15-18 hours (for BioID) to induce proximity-dependent labeling [57].
• Wash cells with PBS and lyse using RIPA buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate) supplemented with protease inhibitors [57].
• Clarify the lysate by centrifugation at 14,000 × g for 15 minutes.

C. Streptavidin Affinity Capture and Protein Identification

• Incubate the clarified lysate with streptavidin-conjugated agarose beads for 3 hours at 4°C [57].
• Wash beads sequentially with RIPA buffer, 1 M KCl, 0.1 M Na2CO3, and 2 M urea in 10 mM Tris-HCl pH 8.0 to remove nonspecifically bound proteins [57].
• Perform on-bead trypsin digestion or elute biotinylated proteins with SDS-PAGE sample buffer for analysis by mass spectrometry or immunoblotting with anti-NDR antibodies [57].

Pull-Down Assay Protocol for Direct MOB-NDR Binding Validation

A. Bait Protein Immobilization

• Express and purify a recombinant MOB protein (e.g., hMOB1A) fused to an affinity tag such as GST [6] [12]. As a negative control, purify the tag alone (e.g., GST).
• Immobilize the purified GST-MOB fusion protein (approximately 1-5 μg) onto glutathione-sepharose beads by incubating for 1 hour at 4°C in binding buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.1% Triton X-100) [59].

B. Prey Protein Incubation and Washing

• Prepare prey protein source containing the NDR kinase, such as lysate from cells expressing NDR1/2 or in vitro translated NDR protein [6] [59].
• Incubate the prey source with the immobilized GST-MOB bait for 2 hours at 4°C with gentle agitation.
• Wash beads 3-5 times with ice-cold binding buffer to remove unbound proteins. To confirm binding specificity, include washes with increasing salt concentration (e.g., up to 300 mM NaCl) [59].

C. Complex Elution and Detection

• Elute specifically bound proteins by boiling in 2× SDS-PAGE sample buffer or by competitive elution with 10-20 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0 [59].
• Analyze eluates by SDS-PAGE and immunoblotting using anti-NDR antibodies (e.g., anti-NDR CT) [4] [6]. Successful pull-down of NDR by MOB bait, but not by the tag-alone control, confirms a direct interaction.

The MOB-NDR Signaling Pathway and Experimental Workflow

Diagram 1: MOB-NDR/LATS signaling pathway. Class I MOBs (MOB1) activate NDR/LATS kinases, while MOB2 competes for binding and inhibits NDR. Key cellular outcomes include regulation of growth, apoptosis, and centrosome duplication [6] [56].

Orthogonal Validation Workflow

Diagram 2: Orthogonal validation workflow. Initial co-immunoprecipitation results are validated through parallel BioID (to identify proximal proteins in cells) and pull-down assays (to confirm direct binding in vitro), followed by integrated data analysis [57] [58] [59].

Research Reagent Solutions

Table 2: Essential research reagents for studying MOB-NDR interactions.

Reagent / Tool	Function / Application	Example Use in MOB-NDR Research
BioID Vectors	Express bait protein (MOB) fused to promiscuous biotin ligase [57]	Identify proteins proximal to MOB1 at the plasma membrane, where NDR activation occurs [4]
TurboID/miniTurbo	Rapid proximity labeling (∼10 min) in living cells [61]	Capture transient interactions between MOB and NDR kinases with high temporal resolution
GST-Tag Vectors	Express bait protein (MOB) for pull-down assays [59]	Validate direct binding between purified MOB1 and NDR1 kinase domains [6] [12]
Streptavidin Beads	Capture biotinylated proteins from BioID experiments [57]	Isolate and identify MOB-proximal proteins (including NDR kinases) from cell lysates
Phospho-Specific Antibodies	Detect activation-specific phosphorylation of NDR [4]	Monitor NDR phosphorylation at Thr444/442 as a functional readout of MOB-dependent activation [4]
Membrane-Targeting Constructs	Recruit proteins to specific subcellular locations [4]	Test the effect of membrane localization on MOB-mediated NDR activation (e.g., mp-hMOB1) [4]

The orthogonal application of BioID and pull-down assays provides a robust framework for validating and characterizing MOB-NDR protein interactions within the broader context of Hippo signaling research. While BioID excels at capturing the spatial and temporal dynamics of these interactions in living cells, pull-down assays offer precision in confirming direct binding and mapping molecular interfaces. For researchers investigating MOB-NDR biology, integrating these complementary methods with initial co-immunoprecipitation findings enables the construction of high-confidence interaction networks, ultimately advancing our understanding of this crucial regulatory axis in cell growth and death pathways.

Combining Co-IP with Mass Spectrometry for Complex Characterization

Protein-protein interactions are fundamental to cellular signaling, and the interaction between MOB (Monopolar spindle-one-binder) proteins and NDR (Nuclear Dbf2-related) kinases represents a crucial regulatory axis conserved across eukaryotes. These interactions govern essential processes including cell polarity, morphogenesis, and septum formation [7]. In filamentous fungi such as Neurospora crassa, this interaction network comprises two distinct NDR kinases (COT1 and DBF2) and multiple MOB proteins (MOB1, MOB2A, MOB2B, and MOB3) that assemble into specific complexes [7]. The MOB1-DBF2 complex is indispensable for septum formation in vegetative cells and during conidiation, while the MOB2-COT1 complex primarily regulates polar tip extension and branching [7] [11]. Understanding the precise composition and dynamics of these complexes is essential for elucidating their biological functions and regulatory mechanisms.

Key MOB-NDR Complexes and Their Biological Functions

Table 1: Core MOB-NDR Complexes in Filamentous Fungi

Complex Component	Gene/Protein Names	Primary Biological Functions	Phenotype of Mutants
NDR Kinase 1	COT1	Regulation of hyphal elongation and branching; cell wall integrity [11]	Growth cessation, hyperbranching, defective conidiation [7] [11]
NDR Kinase 2	DBF2	Septum formation; sexual fruiting body development; ascosporogenesis [7]	Reduced growth, cell lysis, abolished aerial mycelium, defective ascosporogenesis [7]
MOB1	MOB1 (NCU01605)	DBF2/LATS1/2 pathway; septum formation; mitotic exit [7]	Severe growth defect, no conidiation, female sterility [7]
MOB2-type	MOB2A (NCU03314), MOB2B (NCU07460)	COT1 pathway; regulation of polar tip extension; conidiation [7] [11]	Reduced growth, increased branching; distinct roles in macroconidiation [7] [11]
MOB3	MOB3 (NCU07674)	Vegetative cell fusion; fruiting body development; unrelated to NDR signaling [7]	Mild growth and conidiation defects [7]

Recent research has expanded our understanding of MOB proteins in higher eukaryotes. In human cells, seven MOB proteins have been identified, with MOB1's role in the Hippo pathway being well-established. However, proximity-dependent biotin identification (BioID) studies have revealed over 200 interactions for human MOB proteins, with at least 70% being previously unreported, including a unique association between MOB3C and the RNase P complex [63]. This highlights the expanding network of MOB-mediated cellular regulation beyond the classical NDR kinase pathways.

Experimental Workflow for Co-IP-MS

The successful characterization of MOB-NDR complexes requires a meticulously optimized Co-IP-MS workflow that preserves transient interactions and minimizes artifacts.

Figure 1: Comprehensive Co-IP-MS Workflow for MOB-NDR Complex Analysis

Critical Protocol Steps and Optimization

Sample Preparation and Crosslinking: Begin with fresh cell culture or tissue, with cell numbers typically ranging from 10⁷ to 10⁸ cells per IP. For capturing transient interactions in MOB-NDR complexes, a two-step crosslinking approach using disuccinimidyl glutarate (DSG) followed by formaldehyde (FA) is recommended [64]. DSG crosslinks proteins that are in close proximity, stabilizing weak or transient complexes, while formaldehyde preserves these interactions during the IP process. This approach has been shown to increase pull-down efficiency for known interactors [64].

Cell Lysis and Buffer Optimization: Lyse cells using a non-denaturing lysis buffer with low ionic strength (<120mM NaCl) and non-ionic detergents (e.g., NP-40 or Triton X-100) to maintain protein-protein interactions while minimizing disruption [26]. Avoid sonication and vigorous vortexing that could disrupt the MOB-NDR complexes. A typical lysis buffer may contain 40 mM HEPES (pH 7.4), 120 mM NaCl, 1% NP-40, plus protease and phosphatase inhibitors. For chromatin-associated complexes, consider subcellular fractionation to enrich for the target protein [21].

Immunoprecipitation: The choice between direct (pre-immobilized antibody) and indirect (free antibody) methods depends on the application. For MOB-NDR studies, the direct method often yields cleaner results. Use 1-5 µg of specific antibody per 300-500 µg of total protein lysate [21]. Incubate the lysate with antibody-coupled beads for 2-4 hours at 4°C with gentle rotation. Magnetic beads are preferred over agarose beads due to easier handling, lower nonspecific binding, and better compatibility with automation [26].

Wash Steps: Perform 3-4 washes with ice-cold lysis buffer using gentle centrifugation or magnetic separation. Avoid excessive washing that might remove weakly associated complex members. The optimal wash stringency should be determined empirically for each MOB-NDR complex [26].

Elution and Digestion: For downstream MS analysis, elute proteins using mild acidic conditions (0.1-0.2 M glycine, pH 2.5-3.0) or directly digest proteins on-beads. On-bead digestion is often preferred as it avoids antibody contamination in the final sample. Reduce proteins with DTT, alkylate with iodoacetamide, and digest with trypsin overnight at 37°C [65].

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions for MOB-NDR Co-IP-MS

Reagent Category	Specific Examples	Function & Application Notes
Crosslinkers	Disuccinimidyl glutarate (DSG), Formaldehyde	Stabilize transient protein interactions; DSG followed by FA recommended for chromatin complexes [64]
Lysis Buffers	NP-40-based buffers, RIPA buffer (modified)	Extract proteins while preserving interactions; low ionic strength (<120mM NaCl) preferred [26]
Bead Platforms	Magnetic Protein A/G beads, Anti-tag beads (HA, c-Myc)	Capture immune complexes; magnetic beads offer ease of use and lower background [26]
Protease Inhibitors	PMSF, Complete Mini EDTA-free tablets	Prevent protein degradation during extraction and IP
Phosphatase Inhibitors	Sodium fluoride, Sodium orthovanadate, β-glycerophosphate	Preserve phosphorylation states critical for NDR kinase activity [11]
Tag Systems	HA (YPYDVPDYA), c-Myc (EQKLISEEDL), FLAG (DYKDDDDK)	Enable IP with tag-specific antibodies when native antibodies are unavailable [26]
Elution Buffers	Low pH glycine, Laemmli buffer, High salt buffers	Release captured complexes; choice depends on downstream application

Advanced Quantitative Approaches

Traditional Co-IP-MS identifies interacting proteins but provides limited quantitative information about interaction dynamics. Advanced quantitative methods like qPLEX-RIME (quantitative Multiplexed Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins) overcome this limitation by integrating isobaric labelling with tribrid mass spectrometry [64]. This approach enables the study of protein interactome dynamics in a quantitative fashion with increased sensitivity, allowing researchers to monitor temporal changes in MOB-NDR complexes under different physiological conditions or drug treatments [64].

The qPLEX-RIME workflow involves:

• Multiplexing: Using Tandem Mass Tags (TMT-10plex) to label peptides from multiple conditions or time points
• Fractionation: Separating peptides to increase proteome coverage
• MultiNotch MS3 Analysis: Reducing reporter ion interference for more accurate quantification
• Statistical Analysis: Using specialized bioinformatics pipelines (e.g., qPLEXanalyzer) for identifying differential interactions

This method has been successfully applied to characterize the temporal dynamics of the Estrogen Receptor alpha interactome in breast cancer cells and can be adapted for studying MOB-NDR complex dynamics [64].

Data Analysis and Validation

Data Processing and Interactor Selection

Modern IP-MS data analysis has shifted from simple presence/absence comparisons to quantitative differential analysis. After raw data processing, which typically quantifies thousands of proteins across samples, the data must be preprocessed through:

• Logarithmic transformation of quantitative values
• Removal of invalid data (contaminants, reverse database proteins, low-frequency quantitative data)
• Imputation of missing values using distribution-based methods [65]

For identifying high-confidence interactors, current best practices recommend using label-free quantification (LFQ) signal intensities or intensity-based TMT quantification rather than spectral counting [65]. The selection criteria for significant interactions are typically more stringent than in conventional proteomics, often requiring a fold change >10 and a p-value <0.01 between experimental and control groups [65].

Specialized algorithms such as SAINTq (which uses quantitative values based on signal intensity) and platforms like CRAPome (a contaminant repository for affinity purification) are essential for distinguishing true MOB-NDR interactions from nonspecific binders [65].

Visualization and Validation of Protein Networks

Visualizing protein interaction networks helps identify functional modules and complexes within the larger interactome. Tools such as Cytoscape (an open-source platform for network visualization and analysis) and STRINGdb (a database of known and predicted protein-protein interactions) are widely used [66] [67]. These tools enable researchers to:

• Import interaction networks in various formats
• Apply force-directed and other layout algorithms to visualize complexes
• Integrate additional data types (e.g., gene expression, functional annotations)
• Identify densely connected regions representing potential complexes [66] [67]

Validation of interactions identified through Co-IP-MS is essential. Proximity ligation assays (PLA) can confirm interactions in situ, while functional assays such as pre-tRNA cleavage assays for RNase P interactions demonstrate the biological relevance of identified complexes [63] [64]. For MOB-NDR interactions, genetic approaches including analysis of deletion mutants (e.g., Δmob-2a, Δmob-2b) provide functional validation of the physiological relevance of these complexes [7] [11].

Figure 2: MOB-NDR Interaction Network and Functional Outputs

Antigen Competition and Stable Isotope Labeling for Specificity Confirmation

This application note provides a detailed protocol for confirming the specificity of protein-protein interactions identified through co-immunoprecipitation (co-IP), with particular focus on MOB-NDR signaling pathways. We describe an integrated approach combining antigen competition with stable isotope labeling, followed by mass spectrometry analysis, to effectively distinguish true physiological interactions from false positives. This methodology addresses a critical challenge in interaction proteomics, where nonspecific binding frequently leads to inaccurate identifications. The techniques outlined here are particularly valuable for studying complex signaling networks such as the MOB-NDR system, which plays crucial roles in cell proliferation, organ size control, and the DNA damage response [68] [69].

The Challenge of Specificity in Co-Immunoprecipitation

Co-immunoprecipitation serves as a powerful technique for identifying protein-protein interactions under near-physiological conditions by using target-specific antibodies to capture protein complexes from cell lysates [26]. However, a significant limitation of conventional co-IP approaches is the prevalence of nonspecifically precipitated proteins, which can result in large numbers of false-positive identifications [70] [71]. This challenge is particularly acute when studying multifunctional regulatory proteins like MOB1, which can simultaneously interact with multiple signaling complexes including upstream kinases (MST1/2), downstream effectors (LATS1/2, NDR1/2), phosphatase complexes (PP6), and Rho guanine exchange factors (DOCK6-8) [68].

The MOB-NDR interaction network represents a compelling case study for specificity validation, as MOB proteins function as central hubs that coordinate multiple signaling pathways through distinct molecular interfaces [68]. For instance, human MOB1 exhibits phosphorylation-dependent interactions with both upstream MST kinases and downstream LATS/NDR kinases, employing different binding surfaces for each partner [68]. Without rigorous specificity controls, interactions detected through standard co-IP may reflect indirect associations or nonspecific binding rather than direct physiological relevance.

To address these challenges, we present a comprehensive workflow that enhances conventional co-IP through two complementary approaches:

• Antigen Competition: Pre-incubation of the IP antibody with its cognate antigen peptide competitively disrupts specific binding to the target protein, serving as a critical negative control [71].
• Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC): Metabolic incorporation of heavy isotopes allows quantitative comparison between test and control samples, enabling statistical discrimination between true interactions and background binders [70] [71].

When combined with mass spectrometric analysis, this integrated approach provides a robust framework for validating protein-protein interactions, with particular utility for complex systems like the MOB-NDR network [70].

Background

MOB-NDR Signaling Network

The MOB-NDR signaling axis represents an evolutionarily conserved pathway with critical functions in cell cycle regulation, centrosome duplication, and DNA damage response [68] [69]. MOB proteins function as essential co-activators of NDR kinases, with human MOB1A/B facilitating the activation of both LATS1/2 and NDR1/2 kinases within the Hippo pathway [68]. The molecular basis of these interactions involves distinct structural mechanisms:

• MOB1-MST1/2 Interaction: Mediated by the MOB1 phosphopeptide-binding domain recognizing phosphorylated motifs in MST1/2 [68]
• MOB1-LATS/NDR Interaction: Occurs through a separate protein interaction surface on MOB1 [68]
• Regulatory Phosphorylation: MOB1 phosphorylation at T12 and T35 differentially regulates its interactions with upstream and downstream kinases [68]

Recent interaction proteomics analyses have revealed that MOB1 can associate with at least three distinct signaling complexes in a phosphorylation-dependent manner, highlighting the necessity of specificity validation in mapping these networks [68].

Co-Immunoprecipitation Principles

Co-immunoprecipitation exploits the specific binding between an antibody and its target antigen (the "bait" protein) to isolate native protein complexes from cell lysates [26]. As outlined in Figure 1, the technique involves several key steps: cell lysis under non-denaturing conditions, antibody-antigen complex formation, capture using protein A/G-coated beads, washing to remove non-specifically bound proteins, and elution of the purified complex for downstream analysis [26] [21].

Table 1: Key Advantages and Limitations of Co-Immunoprecipitation

Advantages	Limitations
Studies interactions under near-physiological conditions	May not detect low-affinity or transient interactions
Can identify novel binding partners without prior hypothesis	Cannot distinguish direct from indirect interactions
Compatible with multiple detection methods (WB, MS)	Antibody binding may interfere with protein interactions
Applicable to endogenous proteins in native cellular environments	Nonspecific binding can yield false positives

A critical consideration in co-IP experimental design is the choice between endogenous protein detection and tagged protein approaches. As summarized in Table 2, each method offers distinct advantages and limitations for studying protein interactions [30].

Table 2: Comparison of Endogenous vs. Tagged Protein Approaches in Co-IP

Parameter	Endogenous Proteins	Tagged Proteins
Physiological Relevance	High - natural expression levels and localization	Moderate - potential for overexpression artifacts
Epitope Accessibility	May be limited if epitope buried in complex	High - tag typically positioned at terminal
Antibody Availability	Requires well-characterized specific antibodies	Versatile - same tag antibody can be used for multiple baits
Experimental Consistency	Variable due to biological differences	High - standardized detection approach

Materials and Methods

Research Reagent Solutions

Table 3: Essential Research Reagents for Antigen Competition and SILAC Co-IP

Reagent Category	Specific Examples	Function and Application
Cell Culture Labeling	[^15N]-KNO₃, [^13C₆]-Lysine, [^13C₆]-Arginine	Metabolic incorporation of heavy isotopes for quantitative MS comparison
Immunoprecipitation Supports	Protein A/G agarose, Magnetic beads, Anti-tag antibody-coated beads	Solid-phase support for antibody immobilization and complex capture
Lysis Buffers	Non-ionic detergent buffers (NP-40, Triton X-100), Low ionic strength buffers (<120mM NaCl)	Cell lysis while preserving native protein-protein interactions
Tag Systems	HA (YPYDVPDYA), c-Myc (EQKLISEEDL), FLAG (DYKDDDDK)	Epitope tags for standardized immunoprecipitation approaches
Antibody Validation	Antigen peptides for competition, Isotype-matched control antibodies	Specificity controls to distinguish true interactions from background

Stable Isotope Labeling Protocol

Metabolic Labeling with SILAC

• Cell Culture Preparation:

  • Prepare SILAC media containing either "light" ([¹⁴N]) or "heavy" ([¹⁵N]) isotopes of nitrogen [71]
  • For mammalian cells, use arginine and lysine-free DMEM supplemented with 10% dialyzed FBS [72]
  • Add "light" L-lysine (500 μM) and L-arginine (170 μM) to control media [72]
  • Add "heavy" [¹⁵N]-L-lysine and [¹⁵N]-L-arginine to experimental media [71] [72]

• Labeling Procedure:

  • Culture cells in respective SILAC media for at least 5-6 cell divisions to achieve >95% isotope incorporation [72]
  • Validate incorporation efficiency by mass spectrometry before proceeding with experiments
  • Treat cells according to experimental design (e.g., DNA damage inducers for MOB-NDR studies)

Cell Lysis and Protein Extraction

• Lysis Buffer Preparation:

  • 50 mM Tris-HCl (pH 7.5)
  • 150 mM NaCl (optimize between 120-1000 mM based on interaction stability) [26]
  • 1% NP-40 or Triton X-100 [26]
  • Complete EDTA-free protease inhibitor cocktail
  • PhosSTOP phosphatase inhibitor cocktail
  • Note: Low ionic strength buffers with non-ionic detergents are less likely to disrupt protein-protein interactions [26]

• Lysis Procedure:

  • Wash cells with ice-cold PBS
  • Add lysis buffer (500 μL per 10⁷ cells) and incubate on ice for 30 minutes with gentle agitation [21]
  • Clarify lysates by centrifugation at 16,000 × g for 15 minutes at 4°C
  • Determine protein concentration using BCA assay
  • Reserve 1-10% of lysate as "input" control for downstream analysis [21]

Antigen Competition Co-Immunoprecipitation

Pre-clearing and Antibody Complex Formation

• Pre-clearing Step:

  • Incubate 1-2 mg of total protein lysate with 20 μL protein A/G beads for 1 hour at 4°C
  • Centrifuge at 2,500 × g for 5 minutes and transfer supernatant to new tube

• Antigen Competition Setup:

  • Divide pre-cleared lysate into two equal aliquots (experimental and competition control)
  • To competition control aliquot: Add 5-10 μg of antigenic peptide (corresponding to the antibody epitope)
  • To experimental aliquot: Add equivalent volume of peptide dilution buffer
  • Incubate both aliquots for 1 hour at 4°C with rotation

• Immunoprecipitation:

  • Add specific antibody against target protein (e.g., anti-MOB1, anti-NDR1) to both aliquots
  • Recommended antibody concentration: 1-5 μg per mg total protein [26]
  • Incubate overnight at 4°C with continuous rotation
  • Add 40 μL protein A/G beads and incubate for additional 2 hours
  • Pellet beads by gentle centrifugation (2,500 × g, 5 minutes)

Washing and Elution

• Wash Procedure:

  • Wash beads 3-4 times with 1 mL lysis buffer
  • Perform washes quickly and gently to preserve weak interactions [26]
  • Avoid vortexing or harsh agitation during washes [26]

• Elution Methods:

  • For downstream mass spectrometry: Elute with 2× Laemmli buffer at 95°C for 10 minutes
  • For non-denaturing applications: Elute with 0.5 mg/mL antigen peptide in lysis buffer for 1 hour at 4°C
  • Centrifuge at 2,500 × g for 5 minutes and collect supernatant

Mass Spectrometric Analysis and Data Processing

• Sample Preparation:

  • Combine light and heavy SILAC-labeled co-IP eluates in 1:1 protein ratio
  • Reduce with DTT, alkylate with iodoacetamide, and digest with trypsin
  • Desalt peptides using C18 stage tips

• LC-MS/MS Analysis:

  • Separate peptides using nano-flow LC system with 2-4 hour gradient
  • Analyze using high-resolution mass spectrometer (Orbitrap or similar)
  • Acquire data-dependent MS/MS spectra for peptide identification

• Data Processing:

  • Process raw files using quantitative proteomics software (MaxQuant, Andromeda) [71]
  • Search data against appropriate protein sequence database
  • Apply false discovery rate (FDR) threshold of <1% at protein and peptide levels
  • Calculate heavy:light (H:L) ratios for all identified proteins

Data Analysis and Interpretation

Specificity Validation Criteria

True specific interactions are identified by applying the following criteria:

• Significant Enrichment: Proteins with H:L ratio >> 1 in non-competition samples
• Competition Sensitivity: Significant reduction in H:L ratio in antigen competition samples
• Statistical Significance: p-value < 0.05 from triplicate experiments
• Reproducibility: Identified in multiple independent experiments

Table 4: Quantitative Data Interpretation Guidelines

H:L Ratio (Non-competition)	H:L Ratio (Competition)	Interpretation
> 5	< 2	High-confidence specific interaction
2-5	< 1.5	Moderate-confidence specific interaction
> 5	> 4	Non-specific binding
< 2	< 2	Non-specific or background binding

MOB-NDR Interaction Case Study

When applied to the MOB-NDR system, this approach successfully validates known interactions while filtering nonspecific binders:

• True Positives: MOB1 interactions with MST1/2, LATS1/2, and NDR1/2 show high H:L ratios (>5) in standard co-IP that are dramatically reduced (<2) in antigen competition controls [68]
• Context-Dependent Interactions: MOB1 associations with PP6 phosphatase and DOCK6-8 complexes exhibit distinct regulation patterns, potentially involving different binding modes than those used for MST kinase interactions [68]
• Phosphorylation-Dependent Interactions: MOB1 interactions with upstream kinases show characteristic phosphorylation dependence, with optimal phosphopeptide binding consensus matching MST1/2 phosphorylation sites [68]

Troubleshooting

Common Optimization Strategies

• Low Signal-to-Noise Ratio: Titrate antibody concentration to maximize specific binding while minimizing background [26]
• Interaction Disruption: Optimize lysis and wash buffer ionic strength (120-1000 mM NaCl) to preserve weak interactions [26]
• Antibody Interference: Consider tagged protein approaches with anti-tag antibodies if endogenous antibody binding disrupts protein complexes [30]
• Transient Interactions: Apply chemical crosslinking before lysis to stabilize weak or transient interactions [26]

Quality Control Measures

• Antibody Specificity: Validate antibodies using knockout cell lines when available [26]
• Input Controls: Always reserve input samples (1-10% of lysate) for comparison to IP samples [21]
• Bead Controls: Include beads-only controls to identify nonspecific bead-binding proteins
• Isotype Controls: Use isotype-matched non-specific antibodies to control for antibody nonspecificity

The integration of antigen competition with stable isotope labeling provides a robust framework for validating protein-protein interactions identified through co-immunoprecipitation. This approach is particularly valuable for complex signaling networks like the MOB-NDR pathway, where multiple simultaneous interactions occur through distinct molecular interfaces. The protocol outlined here enables researchers to distinguish true physiological interactions from artifactual associations, thereby increasing confidence in interaction proteomics data and facilitating more accurate mapping of cellular signaling networks.

Visualizations

MOB-NDR Signaling Pathway Overview

Antigen Competition SILAC Co-IP Workflow

Within the broader scope of research on MOB-NDR protein interactions detected via co-immunoprecipitation, a critical next step is the functional validation of these complexes. The Monopolar spindle-One-Binder (MOB) family of proteins, particularly MOB1A/B, are well-established regulators of the Hippo pathway, acting as essential adaptors that mediate interactions between core kinases such as MST1/2 and LATS1/2 [1]. Beyond this canonical role, emerging proximity labeling studies have uncovered a vast and previously unappreciated network of interactions for other MOB proteins, like the specific association of MOB3C with the RNase P complex [1]. Establishing the functional consequences of these interactions—specifically, how they regulate kinase activity and subsequently influence cellular phenotypes—is paramount for understanding their roles in tissue homeostasis, cell cycle dynamics, and disease pathogenesis such as cancer [1]. This application note provides detailed protocols and frameworks for transitioning from the initial discovery of protein-protein interactions to their comprehensive functional validation, with a focus on NDR kinase activity and resultant phenotypic changes.

---

Systematic proximity-dependent biotin identification (BioID) screens of all seven human MOB proteins in HEK293 and HeLa cell lines have revealed a complex landscape of interactions. The following table consolidates key quantitative findings from these studies, providing a basis for prioritizing interactions for functional validation [1].

Table 1: Summary of MOB Protein Proximity Interactomes from BioID Screens

MOB Protein	Total Proximity Interactors	Previously Known Interactions (BioGrid)	Key Novel and Established Interactors
MOB1A/B	Not Specified (Top hits analyzed)	48	LATS1/2, STK3/4 (MST1/2), PP6 phosphatase complex, DOCK6-8, LRCH1-3 [1]
MOB2	Not Specified (Top hits analyzed)	Not Specified	STK38, STK38L (NDR1/2 kinases) [1]
MOB3A/B/C	>200 (Combined for all MOBs)	0 (None reported on BioGrid)	MOB3C-specific: 7 out of 10 subunits of the RNase P complex [1]
MOB4	Not Specified (Top hits analyzed)	12	STRIPAK complex components (e.g., Striatin) [1]
All MOBs Combined	226	62 (27% of total dataset)	54 interactors shared between HEK293 and HeLa cell lines [1]

Table 2: Specificity of MOB Protein Interactions and Associated Functional Pathways

MOB Protein / Subfamily	High-Specificity Interactors (MoSS Score)	Proposed Functional Pathway or Complex	Potential Cellular Phenotype
MOB1A/B	LATS1/2, STK3/4	Core Hippo Pathway	Regulation of YAP/TAZ activity, tissue growth, cell proliferation [1]
MOB2	STK38 (NDR2), STK38L (NDR1)	NDR Kinase Signaling	Cell cycle control, centrosome duplication, cytoskeletal organization [1]
MOB3C	POP1, RPP25, RPP30, RPP38, RPP40, POP7, RPP25L	RNase P Complex	tRNA 5' end maturation, fundamental RNA processing [1]
MOB4	Striatin (STRN)	STRIPAK Complex	Phosphoregulation, cell signaling, cell morphology [1]
MOB1/3 Shared	MAP4K4, PTPN14	Non-canonical Hippo / YAP Regulation	Alternative pathways controlling YAP/TAZ oncogenic activity [1]

---

Experimental Protocols for Functional Validation

Protocol 1: Co-immunoprecipitation (Co-IP) and Kinase Activity Assay for MOB-NDR Complexes

This protocol details the process for validating MOB-NDR interactions identified by mass spectrometry and directly measuring the functional output on NDR kinase activity.

I. Materials and Reagents

• Lysis Buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1x protease inhibitor cocktail, 1x phosphatase inhibitor cocktail.
• Wash Buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Triton X-100.
• Kinase Reaction Buffer: 25 mM Tris-HCl (pH 7.5), 5 mM β-glycerophosphate, 2 mM DTT, 0.1 mM Na₃VOâ‚„, 10 mM MgClâ‚‚.
• Antibodies: Anti-NDR1/2 (STK38/38L), anti-MOB2 (or other MOB of interest), species-matched control IgG, Protein A/G magnetic beads.
• Substrate: Recombinant histone H3 or a validated NDR peptide substrate.
• Other Reagents: ATP, [γ-³²P]ATP (for radioisotopic assay) or ADP-Glo Kinase Assay kit (for luminescent assay).

II. Procedure

• Cell Lysis and Pre-clearing:
  • Culture HEK293 or HeLa cells expressing your protein of interest and harvest at 70-80% confluence.
  • Lyse cells in 500 µL of ice-cold Lysis Buffer per 10-cm dish for 30 minutes with gentle rotation at 4°C.
  • Centrifuge the lysate at 16,000 × g for 15 minutes at 4°C. Transfer the supernatant to a new tube.

• Co-immunoprecipitation:

  • Incubate 500 µg of total protein lysate with 2 µg of specific anti-MOB or anti-NDR antibody (or control IgG) for 2 hours at 4°C with rotation.
  • Add 25 µL of pre-washed Protein A/G magnetic beads and incubate for an additional 1 hour.
  • Pellet the beads and wash three times with 500 µL of Wash Buffer.

• On-Bead Kinase Activity Assay:

  • Resuspend the washed beads in 30 µL of Kinase Reaction Buffer.
  • Add the substrate (e.g., 2 µg of histone H3) and 100 µM ATP (with or without [γ-³²P]ATP for detection).
  • Incubate the reaction at 30°C for 30 minutes with gentle shaking.
  • Terminate the reaction by heating at 95°C for 5 minutes (or as required by the detection method).

• Detection and Analysis:

  • Option A (Radioisotopic): Spot the reaction supernatant on a phosphocellulose membrane, wash extensively to remove unincorporated ATP, and quantify radioactivity by scintillation counting.
  • Option B (Luminescent): Transfer the reaction supernatant to a new plate and use the ADP-Glo Kit according to the manufacturer's instructions to measure ADP generation, which is proportional to kinase activity.
  • Normalize kinase activity to the amount of immunoprecipitated protein as determined by Western blot.

Protocol 2: Functional Validation of MOB3C-RNase P Interaction using pre-tRNA Cleavage Assay

This protocol serves as a proof-of-concept for validating the functional significance of a novel MOB interaction outside the kinase signaling context, specifically for the MOB3C-RNase P complex [1].

I. Materials and Reagents

• Affinity Purified Complex: MOB3C and associated proteins purified via immunoprecipitation or tandem affinity purification from cell lysates.
• Control: MOB1A purified under identical conditions.
• Substrate: In vitro transcribed, radiolabeled pre-tRNA.
• Reaction Buffer: 50 mM HEPES-KOH (pH 7.5), 100 mM NHâ‚„Cl, 10 mM MgClâ‚‚, 2 mM DTT, 0.05% NP-40.
• Detection Materials: Urea-polyacrylamide gel (8-10%), autoradiography equipment or phosphorimager.

II. Procedure

• Isolate the Protein Complex:
  • Perform a large-scale immunoprecipitation of FLAG-tagged MOB3C and MOB1A (control) from cell lysates as described in Protocol 1, steps 1-2.
  • Elute the bound complexes using FLAG peptide or low-pH glycine buffer. Neutralize the eluate immediately.

• Set Up the RNase P Activity Reaction:

  • In a nuclease-free tube, combine the following:
    • 2 µL of affinity-purified MOB3C or MOB1A (control) complex.
    • 1 µL of radiolabeled pre-tRNA substrate (~50,000 cpm).
    • 7 µL of Reaction Buffer.
  • Mix gently and incubate at 37°C for 30 minutes.

• Analyze the Reaction Products:

  • Stop the reaction by adding 10 µL of Urea-TBE loading dye.
  • Denature the samples at 95°C for 5 minutes and immediately place on ice.
  • Resolve the reaction products on a denaturing urea-PAGE gel.
  • Visualize the results using autoradiography or a phosphorimager. Successful cleavage of the 5' leader sequence from the pre-tRNA by the MOB3C-associated RNase P complex will result in a shorter, faster-migrating band corresponding to mature tRNA, which should be absent in the MOB1A control pulldown.

---

Signaling Pathways and Experimental Workflows

The following diagrams, generated using Graphviz, illustrate the core signaling pathways and experimental workflows discussed in this note. The color palette adheres to the specified guidelines, ensuring sufficient contrast for readability.

Diagram Title: MOB Protein Signaling Pathways and Phenotypes

Diagram Title: Functional Validation Experimental Workflow

---

The Scientist's Toolkit: Research Reagent Solutions

The following table details key reagents essential for executing the functional validation protocols described herein.

Table 3: Essential Research Reagents for MOB-NDR Interaction and Functional Studies

Reagent / Assay Type	Specific Example(s)	Function in Experimental Pipeline
Proximity Labeling Kits	BioID (BirA*), TurboID	Initial Discovery: Unbiased identification of proximal protein interactions in live cells, as used to map the MOB interactome [1].
Co-IP Validated Antibodies	Anti-MOB1 (A/B), Anti-MOB2, Anti-NDR1/2 (STK38/38L), Anti-FLAG M2 Antibody	Interaction Validation: Specific immunoprecipitation of endogenous or tagged MOB and NDR proteins to confirm interactions from MS data.
Kinase Activity Assays	ADP-Glo Kinase Assay, Radioactive ([γ-³²P]ATP) Filter-Binding Assays	Functional Output Measurement: Quantification of phosphate transfer from ATP to a substrate, determining the activity of NDR kinases upon MOB binding.
Phospho-Specific Antibodies	Phospho-NDR (Thr444/Thr442), Phospho-LATS, Phospho-YAP (Ser127)	Downstream Signaling Readout: Detection of specific phosphorylation events by Western blot to confirm pathway activation or inhibition.
Allosteric Kinase Regulators	Monobodies (e.g., for AurA, Bcr-Abl), Rapamycin-based chemical inducers of dimerization (e.g., for RapR-PAK1)	Mechanistic Studies: Tool compounds for precise, allosteric control of kinase activity to establish causal links in signaling pathways [73].
Kinase Activity Inference Tools	RoKAI (Robust Kinase Activity Inference)	Bioinformatic Analysis: Network-based computational framework that uses phosphoproteomics data to infer changes in kinase activity, robust to missing data [74].

Conclusion

Mastering Co-IP for MOB-NDR interaction studies requires integrating robust methodological execution with deep biological understanding of these evolutionarily conserved complexes. The systematic approach outlined—from foundational biology through optimized protocols, comprehensive troubleshooting, and rigorous validation—provides a framework for generating reliable, reproducible data. Future directions should focus on elucidating the structural basis of MOB-NDR interactions, understanding context-dependent complex formation in disease states, and exploiting these interactions for therapeutic intervention, particularly in cancer where Hippo pathway components show significant promise. The integration of emerging techniques like proximity labeling with traditional Co-IP will continue to expand our understanding of MOB protein networks beyond their canonical NDR kinase partnerships.

References

• 1. Mapping the MOB proteins' proximity network reveals a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10480535/]
• 2. Atypical Hippo signaling network: uncovering novel ... [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1610471/full]
• 3. The Structure of an NDR/LATS Kinase–Mob Complex Reveals ... [https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002146]
• 4. Human NDR Kinases Are Rapidly Activated by MOB Proteins ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC1234321/]
• 5. Ndr/Lats Kinases Bind Specific Mob-Family Coactivators ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8341033/]
• 6. Differential NDR/LATS Interactions with the Human MOB ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2937529/]
• 7. Two NDR kinase–MOB complexes function as distinct ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4617822/]
• 8. Human Mob Proteins Regulate the NDR1 and NDR2 ... [https://www.sciencedirect.com/science/article/pii/S0021925820665796]
• 9. Stable MOB1 interaction with Hippo/MST is not essential ... [https://www.nature.com/articles/s41467-017-00795-y]
• 10. NDR2 kinase: A review of its physiological role and ... [https://www.sciencedirect.com/science/article/pii/S0141813025042084]
• 11. The N-terminal region of the Neurospora NDR kinase ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4603829/]
• 12. Mechanism of Activation of NDR (Nuclear Dbf2-related) ... [https://www.sciencedirect.com/science/article/pii/S0021925820730991]
• 13. An optimized co-immunoprecipitation protocol for the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8920916/]
• 14. Immunoprecipitation and co-immunoprecipitation protocol [https://www.abcam.com/en-us/technical-resources/protocols/immunoprecipitation]
• 15. MOB (Mps one Binder) Proteins in the Hippo Pathway and ... [https://www.mdpi.com/2073-4409/8/6/569]
• 16. The Role of the Cell Integrity Pathway in Septum Assembly ... [https://www.mdpi.com/2309-608X/7/9/729]
• 17. A Hippo Pathway-Related GCK Controls Both Sexual and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6116960/]
• 18. The components and regulation of the Hippo pathway and its ... [https://cancerci.biomedcentral.com/articles/10.1186/s12935-025-03946-0]
• 19. MOB control: Reviewing a conserved family of kinase regulators [https://pmc.ncbi.nlm.nih.gov/articles/PMC3398134/]
• 20. Regulation of Protein Interactions by Mps One Binder ... [https://www.sciencedirect.com/science/article/pii/S1535947620323732]
• 21. Co-immunoprecipitation (Co-IP): The Complete Guide [https://www.antibodies.com/applications/co-immunoprecipitation]
• 22. The value of coimmunoprecipitation (Co-IP) assays in drug ... [https://pubmed.ncbi.nlm.nih.gov/40289752/]
• 23. ChromoTek GFP-Trap® Agarose [https://www.ptglab.com/products/GFP-Trap-Agarose-gta.htm?srsltid=AfmBOopJk8cCsZ0XspuOeunNiiQQmqk8LXYzwUhx2KRnX0k8ueYjLihW]
• 24. GFP-Trap for immunoprecipitation [https://www.ptglab.com/products/featured-products/gfp-trap-for-immunoprecipitation/?srsltid=AfmBOopoEUI9-GZ4OGAsCMX8vuOb8SzydieRAhRVYgOYfpB8iw1ImcYu]
• 25. GFP-Trap Affinity Reagents [https://www.bulldog-bio.com/product/gfp-trap-affinity-reagents/?srsltid=AfmBOoqL-NbcyXiyLQAlrFugDovDvUfw0FY2-8JkPODgNe-XISfpwE25]
• 26. Co-Immunoprecipitation (Co-IP) [https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/co-immunoprecipitation-co-ip.html]
• 27. Cell Lysis Buffers: How to Select the Best One for Your ... [https://synapse.patsnap.com/article/cell-lysis-buffers-how-to-select-the-best-one-for-your-sample]
• 28. Membrane protein structure in live cells [https://pmc.ncbi.nlm.nih.gov/articles/PMC5862532/]
• 29. - Co (Co-IP) | Thermo Fisher Scientific - RU Immunoprecipitation [https://www.thermofisher.com/ru/ru/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/co-immunoprecipitation-co-ip.html]
• 30. The principle and method of co-immunoprecipitation (Co-IP) [https://www.mblbio.com/bio/g/support/method/co-immunoprecipitation.html]
• 31. Immunoprecipitation Data Analysis in Biological Research [https://www.creative-proteomics.com/resource/immunoprecipitation-data-analysis-biological-research.htm]
• 32. A new immunoprecipitation-real time quantitative PCR assay ... [https://arthritis-research.biomedcentral.com/articles/10.1186/ar3858]
• 33. Co-immunoprecipitation (Co-IP) Controls [https://www.antibodies.com/applications/co-immunoprecipitation/co-ip-controls]
• 34. How to conduct a Co-immunoprecipitation (Co-IP) [https://www.ptglab.com/news/blog/how-to-conduct-a-co-immunoprecipitation-co-ip/?srsltid=AfmBOopjMG2GWDo_t_fLfxrJdY-4vXTHpWwcVET4uldmPsQ16MpYhQ_O]
• 35. Co-immunoprecipitation and semi-quantitative ... [https://www.sciencedirect.com/science/article/pii/S2666166721003518]
• 36. Quantitative Multiplex co-Immunoprecipitation [https://pmc.ncbi.nlm.nih.gov/articles/PMC8195492/]
• 37. NDR kinase SAX-1 controls dendrite branch-specific ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12259037/]
• 38. An optimized co-immunoprecipitation protocol for the ... [https://www.sciencedirect.com/science/article/pii/S2666166722001149]
• 39. An optimized co-immunoprecipitation protocol for the analysis ... [https://pubmed.ncbi.nlm.nih.gov/35300004/]
• 40. Overview of Protein–Protein Interaction Analysis [https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-protein-protein-interaction-analysis.html]
• 41. Protein-Protein Interaction Detection: Methods and Analysis [https://pmc.ncbi.nlm.nih.gov/articles/PMC3947875/]
• 42. Improving protein solubility and activity by introducing ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7334598/]
• 43. Computational design and evaluation of optimal bait sets ... [https://www.nature.com/articles/s41467-025-64383-1]
• 44. Co-immunoprecipitation and semi-quantitative immunoblotting ... [https://pubmed.ncbi.nlm.nih.gov/34278331/]
• 45. How to obtain a low background in immunoprecipitation ... [https://www.ptglab.com/news/blog/how-to-obtain-a-low-background-in-immunoprecipitation-assays/?srsltid=AfmBOoqIpS8qxO2EJfmEnaEHrMtfPoHjZ0eXHgURdEIgcB3v_cKVOy-V]
• 46. Dealing with high background in IP [https://www.abcam.com/en-us/technical-resources/troubleshooting/high-background-ip]
• 47. Co-Immunoprecipitation Kits Comprehensive Market Study [https://www.datainsightsmarket.com/reports/co-immunoprecipitation-kits-223238]
• 48. Protease Inhibitors 101: Best Practices for Use in the Lab [https://bitesizebio.com/58195/protease-inhibitors-101/]
• 49. Protein storage: How to increase protein stability? [https://www.susupport.com/blogs/knowledge/protein-storage-how-to-increase-protein-stability]
• 50. Probing the modulation of enzyme kinetics by multi- ... [https://www.nature.com/articles/s41467-025-61631-2]
• 51. Cross-linking immunoprecipitation-MS (xIP-MS) [https://pmc.ncbi.nlm.nih.gov/articles/PMC4813705/]
• 52. Blocking Buffers for Western Blot and ELISA [https://www.thermofisher.com/kr/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/blocking-buffers-western-blot-elisa.html]
• 53. Blocking with immunizing peptide protocol [https://www.abcam.com/en-us/technical-resources/protocols/blocking-with-immunizing-peptides]
• 54. Sheet Protector Strategy for Western Blot to Reduce ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12462392/]
• 55. 2024 Guide to Quantitative Western Blot Publication [https://www.thermofisher.com/blog/life-in-the-lab/2023-guide-to-quantitative-western-blot-publication/]
• 56. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7096357/]
• 57. BioID as a Tool for Protein-Proximity Labeling in Living Cells [https://pmc.ncbi.nlm.nih.gov/articles/PMC6583792/]
• 58. Proximity labeling and affinity capture compared [https://www.sciencedirect.com/science/article/pii/S0021925822011693]
• 59. Pull-Down Assays | Thermo Fisher Scientific - ES [https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/pull-down-assays.html]
• 60. Proximity labeling [https://en.wikipedia.org/wiki/Proximity_labeling]
• 61. Proximity Labeling: A Powerful Tool for Protein Complex ... [https://blog.addgene.org/proximity-labeling-a-powerful-tool-for-protein-complex-purification-and-proteomic-mapping]
• 62. Protein-Protein Interactions: Pull-Down Assays [https://pubmed.ncbi.nlm.nih.gov/28667618/]
• 63. Mapping the MOB proteins' proximity network reveals a ... [https://www.sciencedirect.com/science/article/pii/S0021925823021518]
• 64. A quantitative mass spectrometry-based approach to ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5998130/]
• 65. IP-MS Data Analysis [https://www.creative-proteomics.com/resource/ip-ms-data-analysis.htm]
• 66. Integrated web visualizations for protein-protein interaction ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4466863/]
• 67. Visualization of protein interaction networks: problems and ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-14-S1-S1]
• 68. Regulation of Protein Interactions by Mps One Binder (MOB1 ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5461541/]
• 69. Regulation of DNA damage responses and cell cycle ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4276419/]
• 70. Identification and validation of protein-protein interactions ... [https://pubmed.ncbi.nlm.nih.gov/25059616/]
• 71. Identification and Validation of Protein - Protein by... Interactions [https://link.springer.com/protocol/10.1007/978-1-4939-1142-4_17]
• 72. Benchmarking stable isotope labeling based quantitative ... [https://www.sciencedirect.com/science/article/abs/pii/S187439191200704X]
• 73. Allosteric regulation of kinase activity in living cells - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10635643/]
• 74. Robust inference of kinase activity using functional networks [https://www.nature.com/articles/s41467-021-21211-6]